The Biggest Pharma Share Moves of the Year So Far

<!DOCTYPE html> <html class="ArticlePage" lang="en-US" data-lead="nested"> <head> <meta charset="UTF-8"> <meta property="og:title" content="The Biggest Pharma Share Moves of the Year So Far"> <meta property="og:url" content="https://www.biospace.com/business/the-biggest-pharma-share-moves-of-the-year-so-far"> <meta property="og:image" content="https://static.biospace.com/dims4/default/20e28ac/2147483647/strip/true/crop/1365x768+0+0/resize/1440x810!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fa0%2Fc1%2F4c84971549e6a5f0e2465c08b5c6%2Fistock-1464159306.jpg"> <meta property="og:image:url" content="https://static.biospace.com/dims4/default/20e28ac/2147483647/strip/true/crop/1365x768+0+0/resize/1440x810!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fa0%2Fc1%2F4c84971549e6a5f0e2465c08b5c6%2Fistock-1464159306.jpg"> <meta property="og:image:width" content="1440"> <meta property="og:image:height" content="810"> <meta property="og:image:type" content="image/jpeg"> <meta property="og:image:alt" content="Contemporary art collage. Conceptual design. Making financial strategy. Employees sitting on company graph, creating analytics. Way to financial growth. Concept of business, brainstorming, team"> <meta property="og:description" content="Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share price. Other companies have not been so lucky."> <meta property="og:site_name" content="BioSpace"> <meta property="og:type" content="article"> <meta property="article:author" content="https://www.biospace.com/annalee-armstrong"> <meta property="article:published_time" content="2024-11-27T13:56:22.285"> <meta property="article:modified_time" content="2024-11-27T13:56:22.285"> <meta property="article:section" content="Business"> <meta property="article:tag" content="Featured"> <meta property="article:tag" content="Feature"> <meta property="article:tag" content="BioPharm Executive"> <meta property="article:tag" content="Drug pricing"> <meta property="article:tag" content="Listicle"> <meta name="twitter:card" content="summary_large_image"/> <meta name="twitter:description" content="Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share price. Other companies have not been so lucky."/> <meta name="twitter:image" content="https://static.biospace.com/dims4/default/20e28ac/2147483647/strip/true/crop/1365x768+0+0/resize/1440x810!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fa0%2Fc1%2F4c84971549e6a5f0e2465c08b5c6%2Fistock-1464159306.jpg"/> <meta name="twitter:image:alt" content="Contemporary art collage. Conceptual design. Making financial strategy. Employees sitting on company graph, creating analytics. Way to financial growth. Concept of business, brainstorming, team"/> <meta name="twitter:site" content="@biospace"/> <meta name="twitter:title" content="The Biggest Pharma Share Moves of the Year So Far"/> <meta property="fb:app_id" content="2120989681618413"> <link rel="alternate" href="https://www.biospace.com/business/the-biggest-pharma-share-moves-of-the-year-so-far" hreflang="en-US" /><style type="text/css">:root { --color-border-theme: #EFEFEF; --color-footer-bg-theme: #222222; --color-footer-text-theme: #ffffff; --color-link-text-theme: #222222; --color-button-bg-theme: #D02C24; --color-button-border-theme: #D02C24; --color-button-hover-text-theme: #D02C24; } </style> <style type="text/css">:root { --button-border-radius:0; } </style> <style type="text/css">:root { --font-1: "Arial"; --font-2: "Times"; } body { --font-1: "Helvetica"; --font-2: "Merriweather"; --font-page-titles: var(--font-1); --font-list-titles: var(--font-1); --font-promo-titles: var(--font-1); --font-description: var(--font-1); --font-quote: Helvetica; --font-rte-body: var(--font-1); } </style> <link data-cssvarsponyfill="true" class="Webpack-css" rel="stylesheet" href="https://static.biospace.com/resource/0000018c-e9c4-deef-a1fd-fbfe1e4b0000/styles/default/All.min.5b16cc29da43f3d4bcfed6f0abc095c4.gz.css"> <meta name="viewport" content="width=device-width, initial-scale=1, minimum-scale=1, maximum-scale=5"><title>The Biggest Pharma Share Moves of the Year So Far - BioSpace</title><meta name="description" content="Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share price. Other companies have not been so lucky."><link rel="canonical" href="https://www.biospace.com/business/the-biggest-pharma-share-moves-of-the-year-so-far"><meta name="brightspot.contentId" content="00000193-6b74-d74b-a9db-6fff6ba20000"><link rel="apple-touch-icon" sizes="180x180" href="/apple-touch-icon.png"> <link rel="icon" type="image/png" href="/favicon-32x32.png"> <link rel="icon" type="image/png" href="/favicon-16x16.png"> <script type="application/ld+json">{"@context":"http://schema.org","@type":"","@graph":[{"@context":"http://schema.org","@type":"Article","articleBody":"Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share price. Other companies have not been so lucky. The most dramatic positive share moves of the year for the top pharma companies tell compelling stories of blockbuster drug sales, exciting drug approvals and competitor misses. And on the flip side, companies with noticeable dips in share prices faced clinical failures, market pressures and looming patent expirations. Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share price. It’s no surprise, with blockbuster Zepbound approved for weight loss at the end of 2023. Lilly also seemingly flew just below the radar of Congress, which continues to push for lower drug prices, as rival Novo Nordisk landed right in the crosshairs of Sen. Bernie Sanders. Looking at companies that haven’t been as successful, Pfizer has fallen over 10% this year amid pressures from an activist investor. Merck, nearing a patent cliff for cancer juggernaut Keytruda, has fallen more than 7%. https://public.flourish.studio/visualisation/20418285/ Below, we recap the stories behind the share moves for six pharmas this year. All market cap and share moves are as of Tuesday afternoon at 1:30 p.m. ET. Share price is previous day’s close. Eli LillyYTD Share Change: 37% Market Cap: $716.2 billion Share Price: $755 Lilly’s market cap has grown by $162.8 billion since December 31, 2023. With its stock peaking in September at around $960 per share, Lilly can definitely call this year a win. Shareholders can too. They have received over $1.6 billion in dividends and share repurchases, CEO David Ricks noted on a third-quarter earnings call. Driving Lilly’s share rally is its obesity portfolio, which began with the November 2023 approval of Zepbound (tirzepatide) by the FDA. As of the end of September, Zepbound was approved in 10 countries with launches in 12 more to come, according to the company. Lilly management told Leerink Partners analysts that China is a near-term priority, with that launch potentially coming in 2025. Once again, though, Lilly is behind rival Novo Nordisk, which recently launched its obesity therapy Wegovy (semaglutide) in China. Wegovy also enjoyed frontrunner advantage in the U.S. market following Wegovy’s FDA approval in June 2021, though Lilly is gaining ground fast. Leerink Partners said the sky is the limit for Lilly’s shares. The positive news flow in obesity and diabetes is expected to continue, with further health benefits confirmed as research rolls out. The company also has a robust pipeline of obesity meds, including additional GLP-1 options such as oral orforglipron and another injectable, retatrutide, with Phase III results expected in 2025 and 2026, respectively. Lilly is also spending cash to bring in more pipeline assets, executing licensing deals in the past year with Fauna Bio and Haya Therapeutics as well as buying out Versanis Bio and Morphic Holding. And then there’s Alzheimer’s, where Lilly just received approval for disease-modifying treatment Kisunla. The FDA nod puts Lilly up against Biogen and Eisai’s Leqembi. Pressures to Lilly’s stock include pricing queries, slowing demand and payer constraints, Leerink Partners noted. There’s also a ton of impending competition beyond Novo, such as Amgen’s obesity candidate MariTide, which is moving into Phase III trials following a hotly anticipated readout this week. PfizerYTD Share Change: -10.77% Market Cap: $145.6 billion Share Price: $26.17 Pfizer is undergoing a “normalization” of its COVID-19 business, Leerink Partners wrote in a note to clients earlier this month. But is there anything normal about what happened with Pfizer’s COVID franchise? Perhaps a better way to put it is that the New York pharma is out of the honeymoon phase that occurred after it developed the first approved COVID-19 vaccine, Comirnaty, and followed that up with one of the most widely used therapeutics, Paxlovid. While both are still in use, the franchise has faced significant headwinds as the pandemic waned and vaccination rates dropped. The company’s shares hit a high of about $60 in December 2021. This year, they have sunk more than 9% to where they currently sit at around $26. The decline has led activist investor Starboard Value to come out of the woodwork to push for change, specifically pointing the finger at CEO Albert Bourla. But that campaign faded just as quickly as it sprung up after Pfizer reported a third quarter earnings beat. Leerink Partners said that Pfizer has been successful this year in transitioning Paxlovid from a U.S. government market model to the commercial market, where it will rely on disease outbreaks rather than large purchase orders from governments. Elsewhere, Pfizer has products like Eliquis that are driving revenue; however, that therapy was one of the drugs picked for the first round of Medicare drug price negotiations. But Guggenheim analyst Vamil Divan warned after the earnings release at the end of the October that investors are still worried about the stiff patent cliffs that Pfizer is facing across its portfolio. Just this week, another competitor hit Pfizer’s portfolio, with BridgeBio receiving an FDA nod for Attruby in transthyretin amyloid cardiomyopathy. Pfizer markets tafamidis as Vyndaqel and Vyndamax in the heart indication, while Alnylam has Amvuttra, currently approved for ATTR amyloidosis and under review by the FDA in ATTR-CM as of this week. Pfizer is also in a tight race with GSK and now Moderna in the repiratory syncytial virus vaccine market. Earlier in the pipeline, Pfizer is expecting results for an oral obesity candidate called danuglipron early in 2025. This will be a defining moment, as a win could catapult Pfizer back into the big leagues alongside Eli Lilly and Novo Nordisk. AmgenYTD Share Change: -5.92% Market Cap: $145.6 billion Share Price: $294 Treading around a share decline of about 1.22% last week, Amgen’s stock took a steep turn on Tuesday. Keenly awaited data from the Phase II MariTide study showed weight loss of 20%, on the low end of analyst expectations. The data were comparable to Phase III results for Lilly’s tirzepatide in a similar population. The news sent the company’s shares down 8% to $270.79 apiece on Tuesday, losing about $23 in value. BMO Capital Markets’ Evan Seigerman had called the pending readout a “make or break” moment for Amgen’s shares. That certainly seems to be the case. At the end of Tuesday, about $7.53 billion in market cap had been wiped out. Jefferies urged investors to keep calm and carry on, to buy the dip and understand that beating the incumbent therapies was always going to be tough for Amgen. With so much anticipation and competition in this space, a clear beat was unlikely. “The setup was always going to be challenging: obesity trade has been difficult and other peers have all traded down recently, market has high expectations on ‘differentiation’ and Wall Street always wants higher efficacy,” Jefferies wrote. The firm expects Amgen’s stock to slowly creep back to normal “as investors digest” the data. Prior to the readout, BMO’s Seigerman summed up the stakes for MariTide: “Investors have been whipsawed through the MariTide development story throughout 2024. With potentially $60 billion in market cap on the line, the stakes couldn’t be higher...gotta love year-end biotech readouts!” VertexYTD Share Change: 13.35% Market Cap: $118.6 billion Share Price: $461 Vertex is the undisputed leader in cystic fibrosis (CF), with products such as Trikafta, Kalydeco, Symdeko and now Casgevy following its late 2023 approval, and it seems that franchise still has room to grow. William Blair’s analysts were pleased to see the company raise guidance after the third quarter. Vertex will also start to see revenue from the gene therapy Casgevy, which it developed in partnership with CRISPR Therapeutics. Patients have finally begun receiving infusions of the sickle cell disease treatment. The CF franchise is moving from $9 billion yearly revenue toward William Blair’s estimate of $12 billion in peak sales. In addition, 2025 stands to be a big year for Vertex on the regulatory front, with two FDA decision dates coming up in January, for the CF drug vanzacaftor triple (vanza triple) and oral pain med suzetrigine. That means Vertex could have two launches at the beginning of 2025. The pain therapy is perhaps the most exciting, with so much room in that market for non-addictive and more tolerable options. MerckYTD Share Change: -7.46% Market Cap: $255.5 billion Share Price: $101 Merck’s story has been defined by Keytruda for years—and rightfully so. The mega-blockbuster has reinvented the cancer space, spidering off into dozens of indications, with a clinical program still churning out data in an attempt to garner even more FDA clearances. But in recent years, the tenor has changed. Investors have wanted to know what’s next. This year especially has brought news that Keytruda may have finally hit its limit, with failures or trial discontinuations in colorectal cancer, non-small cell lung cancer, cutaneous squamous cell carcinoma and small cell lung cancer. Merck’s shares have been on the slide since July, when executives revealed a delay in shipments of HPV vaccine Gardasil in China. CFO Caroline Litchfield said the slow down may mean that Merck will ship fewer than its full-year contracted doses by the end of the year. The Chinese market represents about 60–70% of Gardasil’s sales, CEO Robert Davis said on the second quarter call. The vaccine brought in $2.31 billion in the third quarter, down 11% from the year prior as demand continued to decline in China. BMO Capital Markets analysts see some glimmer of hope in Merck’s pipeline, though, especially a 2023 partnership with ADC expert Daiichi Sankyo (also among this year’s top pharma movers; see chart above). Merck’s Prometheus buyout for a clutch of inflammation and immunology assets and prospects in the cardiovascular portfolio also has a lot of potential, according to the firm. Earlier this week, Merck announced that a Phase III trial for Winrevair in pulmonary arterial hypertension in a broader population was stopped early because of overwhelming efficacy. The company plans to submit the data to the FDA to expand the drug’s label, which already includes patients with group I PAH. Sales of the drug have already hit $219 million this year, BMO reported. Novo NordiskYTD Share Change: 2.76% Market Cap: $475.5 billion Share Price: $104 Novo’s market cap has risen substantially over the past couple of years following its Wegovy approval. It hit a high of $642.9 billion in June of this year, with all of 2024 resembling a rolling hill, not unlike some found in the rural countryside of its Danish homeland. In June, Novo’s shares peaked at about $127 apiece, but have since fallen back to near the $106 where they started the year. Its ups and downs over the past year track with the news flow surrounding the GLP-1 space. Novo bumped up on Tuesday with a two-pronged hit of positive news: the Biden administration proposed covering weight loss drugs for patients on Medicare and Medicaid and Amgen’s MariTide weight loss data ended up on the low end of expectations. This pharma, which is literally remaking its country’s fortunes, will be a headline story for years to come.","articleSection":"Business, News","author":[{"@context":"http://schema.org","@type":"Person","affiliation":"<i>BioSpace<\/i>","email":"annalee.armstrong@biospace.com","@id":"https://www.biospace.com/annalee-armstrong/#person","image":{"@context":"http://schema.org","@type":"ImageObject","width":240,"@id":"https://www.biospace.com/annalee-armstrong/#author-image","inLanguage":"en-US","url":"https://static.biospace.com/dims4/default/5cc7c89/2147483647/strip/false/crop/814x1086+0+0/resize/180x240!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F7f%2Fec%2Fc5c8cb664814929f5b56ccee83e6%2F5e7219dc-ab50-41ec-9a8f-35771e48c041-1-105-c.jpeg","height":180},"mainEntityOfPage":{"@type":"WebPage","@id":"https://www.biospace.com/annalee-armstrong/"},"name":"Annalee Armstrong","memberOf":{"@id":"https://www.biospace.com/#organization"},"sameAs":["https://www.linkedin.com/in/annalee-armstrong\n\n"],"jobTitle":"Senior Editor","url":"https://www.biospace.com/annalee-armstrong"}],"copyrightHolder":{"@id":"https://www.biospace.com/#organization"},"copyrightYear":"2025","datePublished":"2024-11-27T13:56:22.285Z","dateModified":"2024-11-27T13:56:22.285Z","headline":"The Biggest Pharma Share Moves of the Year So Far","@id":"https://www.biospace.com/business/the-biggest-pharma-share-moves-of-the-year-so-far/#article","image":[{"@context":"http://schema.org","@type":"ImageObject","width":768,"inLanguage":"en-US","url":"https://static.biospace.com/dims4/default/1d469e6/2147483647/strip/false/crop/1366x768+0+0/resize/1366x768!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fa0%2Fc1%2F4c84971549e6a5f0e2465c08b5c6%2Fistock-1464159306.jpg","height":1366},{"@context":"http://schema.org","@type":"ImageObject","width":675,"inLanguage":"en-US","url":"https://static.biospace.com/dims4/default/cbc7375/2147483647/strip/false/crop/1365x768+0+0/resize/1200x675!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fa0%2Fc1%2F4c84971549e6a5f0e2465c08b5c6%2Fistock-1464159306.jpg","height":1200}],"inLanguage":"en-US","mainEntityOfPage":{"@id":"https://www.biospace.com/business/the-biggest-pharma-share-moves-of-the-year-so-far/#webpage"},"isPartOf":{"@id":"https://www.biospace.com/business/the-biggest-pharma-share-moves-of-the-year-so-far/#webpage"},"publisher":{"@id":"https://www.biospace.com/#organization"}},{"@context":"http://schema.org","@type":"Organization","@id":"https://www.biospace.com/#organization","name":"BioSpace","sameAs":["https://www.facebook.com/biospacecommunity","https://www.linkedin.com/company/biospaceinc/","https://x.com/biospace","https://www.instagram.com/biospacenews/"],"url":"https://www.biospace.com"},{"@context":"http://schema.org","@type":"Website","description":"BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. ","@id":"https://www.biospace.com/#website","inLanguage":"en-US","name":"BioSpace","publisher":{"@id":"https://www.biospace.com/#organization"},"url":"https://www.biospace.com"},{"@context":"http://schema.org","@type":"WebPage","potentialAction":[{"@context":"http://schema.org","@type":"ReadAction","target":"https://www.biospace.com/business/the-biggest-pharma-share-moves-of-the-year-so-far"}],"breadcrumb":{"@type":"BreadcrumbList","itemListElement":[{"@context":"http://schema.org","@type":"ListItem","item":"https://www.biospace.com/news","name":"News","position":1},{"@context":"http://schema.org","@type":"ListItem","item":"https://www.biospace.com/business","name":"Business","position":2}]},"@id":"https://www.biospace.com/business/the-biggest-pharma-share-moves-of-the-year-so-far/#webpage","inLanguage":"en-US","primaryImageOfPage":{"@id":"https://www.biospace.com/business/the-biggest-pharma-share-moves-of-the-year-so-far/#primaryimage"},"name":"The Biggest Pharma Share Moves of the Year So Far","isPartOf":{"@id":"https://www.biospace.com/#website"},"datePublished":"2024-11-27T13:56:22.285Z","dateModified":"2024-11-27T13:56:22.285Z","url":"https://www.biospace.com/business/the-biggest-pharma-share-moves-of-the-year-so-far"},{"@context":"http://schema.org","@type":"ImageObject","caption":"Contemporary art collage. Conceptual design. Making financial strategy. Employees sitting on company graph, creating analytics. Way to financial growth. Concept of business, brainstorming, team","width":675,"@id":"https://www.biospace.com/business/the-biggest-pharma-share-moves-of-the-year-so-far/#primaryimage","inLanguage":"en-US","url":"https://static.biospace.com/dims4/default/cbc7375/2147483647/strip/false/crop/1365x768+0+0/resize/1200x675!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fa0%2Fc1%2F4c84971549e6a5f0e2465c08b5c6%2Fistock-1464159306.jpg","height":1200}]}</script>  <script src="https://static.biospace.com/resource/0000018c-e9c4-deef-a1fd-fbfe1e4b0000/webcomponents-loader/webcomponents-loader.ce44f83d1399e8dd41e607b70e0642c9.gz.js"></script> <script> /** This allows us to load the IE polyfills via feature detection so that they do not load needlessly in the browsers that do not need them. It also ensures they are loaded non async so that they load before the rest of our JS. */ var head = document.getElementsByTagName('head')[0]; if (!window.CSS || !window.CSS.supports || !window.CSS.supports('--fake-var', 0)) { var script = document.createElement('script'); script.setAttribute('src', "https://static.biospace.com/resource/0000018c-e9c4-deef-a1fd-fbfe1e4b0000/util/IEPolyfills.min.4e804e24ca7aa61e14b66eca853bb6e7.gz.js"); script.setAttribute('type', 'text/javascript'); script.async = false; head.appendChild(script); } </script> <script src="https://static.biospace.com/resource/0000018c-e9c4-deef-a1fd-fbfe1e4b0000/styles/default/All.min.1cab67a82b75dabbc4513d0c49274e86.gz.js" async></script> <link rel="preconnect" href="https://connect.facebook.net"> <script> window.fbAsyncInit = function() { FB.init({ appId : '2120989681618413', xfbml : true, version : 'v2.9' }); }; (function(d, s, id){ var js, fjs = d.getElementsByTagName(s)[0]; if (d.getElementById(id)) {return;} js = d.createElement(s); js.id = id; js.src = "//connect.facebook.net/en_US/sdk.js"; fjs.parentNode.insertBefore(js, fjs); }(document, 'script', 'facebook-jssdk')); </script> <script async="async" src="https://securepubads.g.doubleclick.net/tag/js/gpt.js"></script> <script type="text/javascript"> // Google tag setup var googletag = googletag || {}; googletag.cmd = googletag.cmd || []; googletag.cmd.push(function () { googletag.pubads().enableSingleRequest() googletag.pubads().enableAsyncRendering() googletag.pubads().disableInitialLoad() googletag.enableServices() }) // setup of ad slots var dfpAdSlotsObject = {} var dfpAdSlots = [] var staticAdSlots = [] </script> <script>var script = document.createElement('script'); script.async = true; script.src = 'https://analytics.ahrefs.com/analytics.js'; script.setAttribute('data-key', 'ijoT0Tuv31/VTArPbpYiGg'); document.getElementsByTagName('head')[0].appendChild(script);</script> <link rel="preconnect" href="https://fonts.googleapis.com"> <link rel="preconnect" href="https://fonts.gstatic.com"> <script> var link = document.createElement('link'); link.setAttribute('href', '//fonts.googleapis.com/css?family=Helvetica:300,400,700|Merriweather:300,400,700&display=swap'); var relList = link.relList; if (relList && relList.supports('preload')) { link.setAttribute('as', 'style'); link.setAttribute('rel', 'preload'); link.setAttribute('onload', 'this.rel="stylesheet"'); link.setAttribute('crossorigin', 'anonymous'); } else { link.setAttribute('rel', 'stylesheet'); } head.appendChild(link); </script>  <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-NBF2TMB');</script>  </head> <body class="Page-body">  <noscript> <iframe src="https://www.googletagmanager.com/ns.html?id=GTM-NBF2TMB" height="0" width="0" style="display:none;visibility:hidden"> </iframe> </noscript>  <svg xmlns="http://www.w3.org/2000/svg" style="display:none" id="iconsMap"> <symbol id="mono-icon-facebook" viewBox="0 0 16 16"> <path fill-rule="evenodd" clip-rule="evenodd" d="M8.66667 6.16667H10.5L10.2708 8H8.66667V13.5H6.28906V8H5V6.16667H6.28906V4.9349C6.28906 4.13281 6.48958 3.52648 6.89062 3.11589C7.29167 2.70529 7.96006 2.5 8.89583 2.5H10.5V4.33333H9.52604C9.16319 4.33333 8.92925 4.39062 8.82422 4.50521C8.71918 4.61979 8.66667 4.81076 8.66667 5.07812V6.16667Z" /> </symbol> <symbol id="mono-icon-google" viewBox="0 0 16 16"> <path fill="currentColor" d="M15.545 6.558a9.42 9.42 0 0 1 .139 1.626c0 2.434-.87 4.492-2.384 5.885h.002C11.978 15.292 10.158 16 8 16A8 8 0 1 1 8 0a7.689 7.689 0 0 1 5.352 2.082l-2.284 2.284A4.347 4.347 0 0 0 8 3.166c-2.087 0-3.86 1.408-4.492 3.304a4.792 4.792 0 0 0 0 3.063h.003c.635 1.893 2.405 3.301 4.492 3.301 1.078 0 2.004-.276 2.722-.764h-.003a3.702 3.702 0 0 0 1.599-2.431H8v-3.08h7.545z"/> </symbol> <symbol id="mono-icon-instagram" viewBox="0 0 17 17"> <g> <path fill-rule="evenodd" d="M8.281 4.207c.727 0 1.4.182 2.022.545a4.055 4.055 0 0 1 1.476 1.477c.364.62.545 1.294.545 2.021 0 .727-.181 1.4-.545 2.021a4.055 4.055 0 0 1-1.476 1.477 3.934 3.934 0 0 1-2.022.545c-.726 0-1.4-.182-2.021-.545a4.055 4.055 0 0 1-1.477-1.477 3.934 3.934 0 0 1-.545-2.021c0-.727.182-1.4.545-2.021A4.055 4.055 0 0 1 6.26 4.752a3.934 3.934 0 0 1 2.021-.545zm0 6.68a2.54 2.54 0 0 0 1.864-.774 2.54 2.54 0 0 0 .773-1.863 2.54 2.54 0 0 0-.773-1.863 2.54 2.54 0 0 0-1.864-.774 2.54 2.54 0 0 0-1.863.774 2.54 2.54 0 0 0-.773 1.863c0 .727.257 1.348.773 1.863a2.54 2.54 0 0 0 1.863.774zM13.45 4.03c-.023.258-.123.48-.299.668a.856.856 0 0 1-.65.281.913.913 0 0 1-.668-.28.913.913 0 0 1-.281-.669c0-.258.094-.48.281-.668a.913.913 0 0 1 .668-.28c.258 0 .48.093.668.28.187.188.281.41.281.668zm2.672.95c.023.656.035 1.746.035 3.269 0 1.523-.017 2.62-.053 3.287-.035.668-.134 1.248-.298 1.74a4.098 4.098 0 0 1-.967 1.53 4.098 4.098 0 0 1-1.53.966c-.492.164-1.072.264-1.74.3-.668.034-1.763.052-3.287.052-1.523 0-2.619-.018-3.287-.053-.668-.035-1.248-.146-1.74-.334a3.747 3.747 0 0 1-1.53-.931 4.098 4.098 0 0 1-.966-1.53c-.164-.492-.264-1.072-.299-1.74C.424 10.87.406 9.773.406 8.25S.424 5.63.46 4.963c.035-.668.135-1.248.299-1.74.21-.586.533-1.096.967-1.53A4.098 4.098 0 0 1 3.254.727c.492-.164 1.072-.264 1.74-.3C5.662.394 6.758.376 8.281.376c1.524 0 2.62.018 3.287.053.668.035 1.248.135 1.74.299a4.098 4.098 0 0 1 2.496 2.496c.165.492.27 1.078.317 1.757zm-1.687 7.91c.14-.399.234-1.032.28-1.899.024-.515.036-1.242.036-2.18V7.689c0-.961-.012-1.688-.035-2.18-.047-.89-.14-1.524-.281-1.899a2.537 2.537 0 0 0-1.512-1.511c-.375-.14-1.008-.235-1.899-.282a51.292 51.292 0 0 0-2.18-.035H7.72c-.938 0-1.664.012-2.18.035-.867.047-1.5.141-1.898.282a2.537 2.537 0 0 0-1.512 1.511c-.14.375-.234 1.008-.281 1.899a51.292 51.292 0 0 0-.036 2.18v1.125c0 .937.012 1.664.036 2.18.047.866.14 1.5.28 1.898.306.726.81 1.23 1.513 1.511.398.141 1.03.235 1.898.282.516.023 1.242.035 2.18.035h1.125c.96 0 1.687-.012 2.18-.035.89-.047 1.523-.141 1.898-.282.726-.304 1.23-.808 1.512-1.511z"> </path> </g> </symbol> <symbol id="mono-icon-mailto" viewBox="0 0 16 16"> <path d="M14 3H2C1.86739 3 1.74021 3.05268 1.64645 3.14645C1.55268 3.24021 1.5 3.36739 1.5 3.5V12C1.5 12.2652 1.60536 12.5196 1.79289 12.7071C1.98043 12.8946 2.23478 13 2.5 13H13.5C13.7652 13 14.0196 12.8946 14.2071 12.7071C14.3946 12.5196 14.5 12.2652 14.5 12V3.5C14.5 3.36739 14.4473 3.24021 14.3536 3.14645C14.2598 3.05268 14.1326 3 14 3ZM12.7144 4L8 8.32187L3.28562 4H12.7144ZM13.5 12H2.5V4.63688L7.66187 9.36875C7.75412 9.45343 7.87478 9.50041 8 9.50041C8.12522 9.50041 8.24588 9.45343 8.33813 9.36875L13.5 4.63688V12Z" /> </symbol> <symbol id="mono-icon-print" viewBox="0 0 16 16"> <path d="M13.4169 4.5H12.5V2.5C12.5 2.36739 12.4473 2.24021 12.3536 2.14645C12.2598 2.05268 12.1326 2 12 2H4C3.86739 2 3.74021 2.05268 3.64645 2.14645C3.55268 2.24021 3.5 2.36739 3.5 2.5V4.5H2.58313C1.71 4.5 1 5.17313 1 6V11C1 11.1326 1.05268 11.2598 1.14645 11.3536C1.24021 11.4473 1.36739 11.5 1.5 11.5H3.5V13.5C3.5 13.6326 3.55268 13.7598 3.64645 13.8536C3.74021 13.9473 3.86739 14 4 14H12C12.1326 14 12.2598 13.9473 12.3536 13.8536C12.4473 13.7598 12.5 13.6326 12.5 13.5V11.5H14.5C14.6326 11.5 14.7598 11.4473 14.8536 11.3536C14.9473 11.2598 15 11.1326 15 11V6C15 5.17313 14.29 4.5 13.4169 4.5ZM4.5 3H11.5V4.5H4.5V3ZM11.5 13H4.5V10H11.5V13ZM14 10.5H12.5V9.5C12.5 9.36739 12.4473 9.24021 12.3536 9.14645C12.2598 9.05268 12.1326 9 12 9H4C3.86739 9 3.74021 9.05268 3.64645 9.14645C3.55268 9.24021 3.5 9.36739 3.5 9.5V10.5H2V6C2 5.72438 2.26188 5.5 2.58313 5.5H13.4169C13.7381 5.5 14 5.72438 14 6V10.5ZM12.5 7.25C12.5 7.39834 12.456 7.54334 12.3736 7.66668C12.2912 7.79001 12.1741 7.88614 12.037 7.94291C11.9 7.99968 11.7492 8.01453 11.6037 7.98559C11.4582 7.95665 11.3246 7.88522 11.2197 7.78033C11.1148 7.67544 11.0434 7.5418 11.0144 7.39632C10.9855 7.25083 11.0003 7.10003 11.0571 6.96299C11.1139 6.82594 11.21 6.70881 11.3333 6.6264C11.4567 6.54399 11.6017 6.5 11.75 6.5C11.9489 6.5 12.1397 6.57902 12.2803 6.71967C12.421 6.86032 12.5 7.05109 12.5 7.25Z" /> </symbol> <symbol id="mono-icon-copylink" viewBox="0 0 16 16"> <path d="M10.3537 5.64624C10.4002 5.69268 10.4371 5.74782 10.4622 5.80852C10.4874 5.86922 10.5003 5.93429 10.5003 5.99999C10.5003 6.0657 10.4874 6.13076 10.4622 6.19146C10.4371 6.25216 10.4002 6.30731 10.3537 6.35374L6.35368 10.3537C6.30723 10.4002 6.25208 10.437 6.19138 10.4622C6.13069 10.4873 6.06563 10.5003 5.99993 10.5003C5.93424 10.5003 5.86918 10.4873 5.80849 10.4622C5.74779 10.437 5.69264 10.4002 5.64618 10.3537C5.59973 10.3073 5.56288 10.2521 5.53774 10.1914C5.5126 10.1307 5.49966 10.0657 5.49966 9.99999C5.49966 9.9343 5.5126 9.86924 5.53774 9.80855C5.56288 9.74785 5.59973 9.6927 5.64618 9.64624L9.64618 5.64624C9.69262 5.59975 9.74776 5.56288 9.80846 5.53771C9.86916 5.51255 9.93423 5.4996 9.99993 5.4996C10.0656 5.4996 10.1307 5.51255 10.1914 5.53771C10.2521 5.56288 10.3072 5.59975 10.3537 5.64624ZM13.4749 2.52499C13.1499 2.19995 12.7641 1.94211 12.3394 1.7662C11.9147 1.59028 11.4596 1.49974 10.9999 1.49974C10.5403 1.49974 10.0851 1.59028 9.66046 1.7662C9.2358 1.94211 8.84994 2.19995 8.52493 2.52499L6.64618 4.40312C6.55236 4.49694 6.49966 4.62419 6.49966 4.75687C6.49966 4.88955 6.55236 5.0168 6.64618 5.11062C6.74 5.20444 6.86725 5.25715 6.99993 5.25715C7.13262 5.25715 7.25986 5.20444 7.35368 5.11062L9.23243 3.23562C9.70299 2.7754 10.336 2.51932 10.9942 2.52294C11.6524 2.52657 12.2826 2.78961 12.7481 3.25498C13.2135 3.72035 13.4767 4.35051 13.4804 5.00869C13.4842 5.66688 13.2282 6.29998 12.7681 6.77062L10.8887 8.64937C10.7949 8.74311 10.7421 8.87027 10.7421 9.0029C10.742 9.13552 10.7946 9.26274 10.8884 9.35656C10.9821 9.45038 11.1093 9.50312 11.2419 9.50318C11.3745 9.50323 11.5017 9.45061 11.5956 9.35687L13.4749 7.47499C13.8 7.14998 14.0578 6.76413 14.2337 6.33947C14.4096 5.91481 14.5002 5.45965 14.5002 4.99999C14.5002 4.54034 14.4096 4.08518 14.2337 3.66052C14.0578 3.23586 13.8 2.85 13.4749 2.52499ZM8.64618 10.8887L6.76743 12.7675C6.53623 13.0039 6.26043 13.1921 5.95601 13.3211C5.65158 13.4502 5.32457 13.5176 4.99392 13.5194C4.66326 13.5212 4.33553 13.4575 4.0297 13.3317C3.72387 13.206 3.44602 13.0209 3.21223 12.7871C2.97844 12.5532 2.79335 12.2754 2.6677 11.9695C2.54204 11.6636 2.47831 11.3359 2.48019 11.0053C2.48207 10.6746 2.54952 10.3476 2.67865 10.0432C2.80777 9.73879 2.996 9.46303 3.23243 9.23187L5.11056 7.35374C5.20438 7.25992 5.25709 7.13268 5.25709 6.99999C5.25709 6.86731 5.20438 6.74006 5.11056 6.64624C5.01674 6.55242 4.88949 6.49971 4.75681 6.49971C4.62413 6.49971 4.49688 6.55242 4.40306 6.64624L2.52493 8.52499C1.86852 9.1814 1.49976 10.0717 1.49976 11C1.49976 11.9283 1.86852 12.8186 2.52493 13.475C3.18135 14.1314 4.07163 14.5002 4.99993 14.5002C5.92824 14.5002 6.81852 14.1314 7.47493 13.475L9.35368 11.5956C9.44742 11.5018 9.50005 11.3746 9.49999 11.242C9.49993 11.1093 9.44719 10.9822 9.35337 10.8884C9.25955 10.7947 9.13234 10.7421 8.99971 10.7421C8.86709 10.7422 8.73992 10.7949 8.64618 10.8887Z" /> </symbol> <symbol id="mono-icon-download" viewBox="0 0 32 32" fill="none"> <rect x="0.75" y="0.75" width="30.5" height="30.5" rx="15.25" stroke-width="1.5"/> <path d="M11.1463 15.3538C11.0524 15.2599 10.9997 15.1327 10.9997 15C10.9997 14.8673 11.0524 14.7401 11.1463 14.6462C11.2401 14.5524 11.3673 14.4997 11.5 14.4997C11.6327 14.4997 11.7599 14.5524 11.8537 14.6462L15.5 18.2931V10C15.5 9.86739 15.5527 9.74021 15.6464 9.64645C15.7402 9.55268 15.8674 9.5 16 9.5C16.1326 9.5 16.2598 9.55268 16.3536 9.64645C16.4473 9.74021 16.5 9.86739 16.5 10V18.2931L20.1462 14.6462C20.1927 14.5998 20.2479 14.5629 20.3086 14.5378C20.3692 14.5127 20.4343 14.4997 20.5 14.4997C20.5657 14.4997 20.6308 14.5127 20.6914 14.5378C20.7521 14.5629 20.8073 14.5998 20.8538 14.6462C20.9002 14.6927 20.9371 14.7479 20.9622 14.8086C20.9873 14.8692 21.0003 14.9343 21.0003 15C21.0003 15.0657 20.9873 15.1308 20.9622 15.1914C20.9371 15.2521 20.9002 15.3073 20.8538 15.3538L16.3538 19.8538C16.3073 19.9002 16.2522 19.9371 16.1915 19.9623C16.1308 19.9874 16.0657 20.0004 16 20.0004C15.9343 20.0004 15.8692 19.9874 15.8085 19.9623C15.7478 19.9371 15.6927 19.9002 15.6462 19.8538L11.1463 15.3538ZM21.5 21H10.5C10.3674 21 10.2402 21.0527 10.1464 21.1464C10.0527 21.2402 10 21.3674 10 21.5C10 21.6326 10.0527 21.7598 10.1464 21.8536C10.2402 21.9473 10.3674 22 10.5 22H21.5C21.6326 22 21.7598 21.9473 21.8536 21.8536C21.9473 21.7598 22 21.6326 22 21.5C22 21.3674 21.9473 21.2402 21.8536 21.1464C21.7598 21.0527 21.6326 21 21.5 21Z" /> </symbol> <symbol id="mono-icon-linkedin" viewBox="0 0 16 16" xmlns="http://www.w3.org/2000/svg"> <path fill-rule="evenodd" clip-rule="evenodd" d="M5.14286 13V6.57139H3V13H5.14286ZM4.05327 5.14286C4.36804 5.14286 4.62833 5.03995 4.83414 4.83414C5.03995 4.62833 5.14286 4.38015 5.14286 4.08959C5.14286 3.77482 5.04601 3.51453 4.8523 3.30872C4.65859 3.1029 4.40436 3 4.08959 3C3.77482 3 3.51453 3.1029 3.30872 3.30872C3.1029 3.51453 3 3.77482 3 4.08959C3 4.38015 3.09685 4.62833 3.29056 4.83414C3.48426 5.03995 3.7385 5.14286 4.05327 5.14286ZM13 13V9.32649C13 8.42036 12.7768 7.73466 12.3304 7.26935C11.884 6.80404 11.3036 6.57139 10.5893 6.57139C9.82401 6.57139 9.18626 6.91424 8.67605 7.59996V6.71833H6.57146V13H8.67605V9.4367C8.67605 9.1918 8.70156 9.02037 8.75258 8.92241C8.95666 8.43261 9.3138 8.18772 9.82401 8.18772C10.5383 8.18772 10.8954 8.64077 10.8954 9.5469V13H13Z" /> </symbol> <symbol id="download" xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24"> <g fill="none" fill-rule="evenodd"> <g> <g> <g> <path d="M0 0H24V24H0z" transform="translate(-802.000000, -1914.000000) translate(0.000000, 1756.000000) translate(802.000000, 158.000000)" /> <path fill="currentColor" fill-rule="nonzero" d="M12 2C6.49 2 2 6.49 2 12s4.49 10 10 10 10-4.49 10-10S17.51 2 12 2zm-1 8V6h2v4h3l-4 4-4-4h3zm6 7H7v-2h10v2z" transform="translate(-802.000000, -1914.000000) translate(0.000000, 1756.000000) translate(802.000000, 158.000000)" /> </g> </g> </g> </g> </symbol> <symbol id="mono-icon-pinterest" viewBox="0 0 10 10"> <path d="M7.91041 1.02475C7.22206 0.363947 6.26946 0 5.22811 0C3.6374 0 2.65904 0.652053 2.11841 1.19903C1.45212 1.87311 1.07007 2.76817 1.07007 3.65474C1.07007 4.76789 1.53568 5.62227 2.31539 5.94012C2.36773 5.96157 2.42041 5.97237 2.47205 5.97237C2.63654 5.97237 2.76687 5.86473 2.81203 5.69209C2.83836 5.59305 2.89933 5.34869 2.92586 5.24262C2.98261 5.03314 2.93676 4.93238 2.81297 4.7865C2.58746 4.51967 2.48244 4.20414 2.48244 3.79349C2.48244 2.57374 3.39068 1.27741 5.07403 1.27741C6.4097 1.27741 7.23939 2.03655 7.23939 3.25855C7.23939 4.02968 7.07329 4.74383 6.77159 5.26951C6.56194 5.63479 6.19329 6.0702 5.62735 6.0702C5.38262 6.0702 5.16278 5.96967 5.02407 5.7944C4.89303 5.62871 4.84983 5.41469 4.90254 5.19162C4.96208 4.93959 5.04327 4.6767 5.12184 4.42256C5.26514 3.95837 5.40061 3.51996 5.40061 3.17017C5.40061 2.57188 5.0328 2.16987 4.48543 2.16987C3.78981 2.16987 3.24482 2.8764 3.24482 3.77835C3.24482 4.2207 3.36238 4.55156 3.4156 4.67859C3.32797 5.04988 2.80715 7.25731 2.70836 7.67357C2.65123 7.91655 2.30712 9.83578 2.87668 9.98881C3.5166 10.1607 4.08861 8.29156 4.14684 8.08034C4.19403 7.90857 4.35912 7.25901 4.4603 6.85973C4.76922 7.15729 5.26663 7.35847 5.75061 7.35847C6.66302 7.35847 7.48357 6.94788 8.06113 6.20243C8.62127 5.47938 8.92977 4.4716 8.92977 3.36488C8.92973 2.49968 8.55816 1.64671 7.91041 1.02475Z" /> </symbol> <symbol id="icon-fullscreen" xmlns="http://www.w3.org/2000/svg" fill="white" viewBox="0 0 1024 1024"> <path d="M290 236.4l43.9-43.9a8.01 8.01 0 0 0-4.7-13.6L169 160c-5.1-.6-9.5 3.7-8.9 8.9L179 329.1c.8 6.6 8.9 9.4 13.6 4.7l43.7-43.7L370 423.7c3.1 3.1 8.2 3.1 11.3 0l42.4-42.3c3.1-3.1 3.1-8.2 0-11.3L290 236.4zm352.7 187.3c3.1 3.1 8.2 3.1 11.3 0l133.7-133.6 43.7 43.7a8.01 8.01 0 0 0 13.6-4.7L863.9 169c.6-5.1-3.7-9.5-8.9-8.9L694.8 179c-6.6.8-9.4 8.9-4.7 13.6l43.9 43.9L600.3 370a8.03 8.03 0 0 0 0 11.3l42.4 42.4zM845 694.9c-.8-6.6-8.9-9.4-13.6-4.7l-43.7 43.7L654 600.3a8.03 8.03 0 0 0-11.3 0l-42.4 42.3a8.03 8.03 0 0 0 0 11.3L734 787.6l-43.9 43.9a8.01 8.01 0 0 0 4.7 13.6L855 864c5.1.6 9.5-3.7 8.9-8.9L845 694.9zm-463.7-94.6a8.03 8.03 0 0 0-11.3 0L236.3 733.9l-43.7-43.7a8.01 8.01 0 0 0-13.6 4.7L160.1 855c-.6 5.1 3.7 9.5 8.9 8.9L329.2 845c6.6-.8 9.4-8.9 4.7-13.6L290 787.6 423.7 654c3.1-3.1 3.1-8.2 0-11.3l-42.4-42.4z" /> </symbol> <symbol id="mono-icon-tumblr" viewBox="0 0 512 512"> <g> <path d="M321.2,396.3c-11.8,0-22.4-2.8-31.5-8.3c-6.9-4.1-11.5-9.6-14-16.4c-2.6-6.9-3.6-22.3-3.6-46.4V224h96v-64h-96V48h-61.9 c-2.7,21.5-7.5,44.7-14.5,58.6c-7,13.9-14,25.8-25.6,35.7c-11.6,9.9-25.6,17.9-41.9,23.3V224h48v140.4c0,19,2,33.5,5.9,43.5 c4,10,11.1,19.5,21.4,28.4c10.3,8.9,22.8,15.7,37.3,20.5c14.6,4.8,31.4,7.2,50.4,7.2c16.7,0,30.3-1.7,44.7-5.1 c14.4-3.4,30.5-9.3,48.2-17.6v-65.6C363.2,389.4,342.3,396.3,321.2,396.3z"></path> </g> </symbol> <symbol id="mono-icon-twitter" viewBox="0 0 16 16"> <path d="M8.65379 7.23432L12.1904 3H11.3523L8.2815 6.6766L5.82885 3H3L6.70889 8.55967L3 13H3.83811L7.08097 9.11739L9.67115 13H12.5L8.65379 7.23432ZM7.50589 8.60865L7.1301 8.05503L4.14009 3.64984H5.42737L7.84034 7.20497L8.21613 7.75859L11.3527 12.3797H10.0654L7.50589 8.60865Z" /> </symbol> <symbol id="mono-icon-youtube" viewBox="0 0 512 512"> <g> <path fill-rule="evenodd" d="M508.6,148.8c0-45-33.1-81.2-74-81.2C379.2,65,322.7,64,265,64c-3,0-6,0-9,0s-6,0-9,0c-57.6,0-114.2,1-169.6,3.6 c-40.8,0-73.9,36.4-73.9,81.4C1,184.6-0.1,220.2,0,255.8C-0.1,291.4,1,327,3.4,362.7c0,45,33.1,81.5,73.9,81.5 c58.2,2.7,117.9,3.9,178.6,3.8c60.8,0.2,120.3-1,178.6-3.8c40.9,0,74-36.5,74-81.5c2.4-35.7,3.5-71.3,3.4-107 C512.1,220.1,511,184.5,508.6,148.8z M207,353.9V157.4l145,98.2L207,353.9z"></path> </g> </symbol> <symbol id="mono-icon-tiktok" viewBox="0 0 512 512"> <path d="M412.19,118.66a109.27,109.27,0,0,1-9.45-5.5,132.87,132.87,0,0,1-24.27-20.62c-18.1-20.71-24.86-41.72-27.35-56.43h.1C349.14,23.9,350,16,350.13,16H267.69V334.78c0,4.28,0,8.51-.18,12.69,0,.52-.05,1-.08,1.56,0,.23,0,.47-.05.71,0,.06,0,.12,0,.18a70,70,0,0,1-35.22,55.56,68.8,68.8,0,0,1-34.11,9c-38.41,0-69.54-31.32-69.54-70s31.13-70,69.54-70a68.9,68.9,0,0,1,21.41,3.39l.1-83.94a153.14,153.14,0,0,0-118,34.52,161.79,161.79,0,0,0-35.3,43.53c-3.48,6-16.61,30.11-18.2,69.24-1,22.21,5.67,45.22,8.85,54.73v.2c2,5.6,9.75,24.71,22.38,40.82A167.53,167.53,0,0,0,115,470.66v-.2l.2.2C155.11,497.78,199.36,496,199.36,496c7.66-.31,33.32,0,62.46-13.81,32.32-15.31,50.72-38.12,50.72-38.12a158.46,158.46,0,0,0,27.64-45.93c7.46-19.61,9.95-43.13,9.95-52.53V176.49c1,.6,14.32,9.41,14.32,9.41s19.19,12.3,49.13,20.31c21.48,5.7,50.42,6.9,50.42,6.9V131.27C453.86,132.37,433.27,129.17,412.19,118.66Z"> </path> </symbol> <symbol id="icon-magnify" viewBox="0 0 30 30" xmlns="http://www.w3.org/2000/svg"> <path d="M21.876 18.281l-.314.548L30 27.343 27.343 30l-8.437-8.516-.546.392c-2.083 1.3-4.245 1.951-6.486 1.951-3.28 0-6.08-1.171-8.398-3.515C1.16 17.968 0 15.156 0 11.874c0-3.28 1.159-6.08 3.476-8.398C5.794 1.16 8.595 0 11.876 0c3.282 0 6.079 1.159 8.398 3.476 2.318 2.318 3.477 5.119 3.477 8.4a11.786 11.786 0 0 1-1.875 6.405zm-3.36-13.046c-1.823-1.824-4.037-2.736-6.642-2.736-2.604 0-4.818.912-6.639 2.736-1.824 1.822-2.736 4.035-2.736 6.64 0 2.606.912 4.818 2.736 6.64 1.822 1.823 4.035 2.734 6.64 2.734 2.606 0 4.818-.91 6.64-2.733 1.876-1.875 2.813-4.088 2.813-6.642 0-2.55-.937-4.764-2.812-6.639z" fill-rule="evenodd" /> </symbol> <symbol id="icon-chevron-right" viewBox="0 0 24 24"> <path fill="currentColor" d="M9.62,5.29a.91.91,0,0,0-1.34,0A1,1,0,0,0,8.2,6.61l.08.1,5,5.29-5,5.29a1,1,0,0,0-.08,1.32l.08.1a.91.91,0,0,0,1.25.08l.09-.08L16,12Z" /> </symbol> <symbol id="icon-chevron-down" viewBox="0 0 24 24"> <path fill="currentColor" d="M5.29,9.62a.91.91,0,0,1,0-1.34A1,1,0,0,1,6.61,8.2l.1.08,5.29,5,5.29-5a1,1,0,0,1,1.32-.08l.1.08a.91.91,0,0,1,.08,1.25l-.08.09L12,16Z"/> </symbol> <symbol id="icon-chevron-left" viewBox="0 0 24 24"> <path fill="currentColor" d="M14.38,5.29a.91.91,0,0,1,1.34,0,1,1,0,0,1,.08,1.32l-.08.1-5,5.29,5,5.29a1,1,0,0,1,.08,1.32l-.08.1a.91.91,0,0,1-1.25.08l-.09-.08L8,12Z" /> </symbol> <symbol id="burger-menu" viewBox="0 0 14 10"> <g> <path fill-rule="evenodd" d="M0 5.5v-1h14v1H0zM0 1V0h14v1H0zm0 9V9h14v1H0z"></path> </g> </symbol> <symbol id="close-x" viewBox="0 0 14 14" xmlns="http://www.w3.org/2000/svg"> <g> <path fill-rule="nonzero" d="M6.336 7L0 .664.664 0 7 6.336 13.336 0 14 .664 7.664 7 14 13.336l-.664.664L7 7.664.664 14 0 13.336 6.336 7z"> </path> </g> </symbol> <symbol id="share-more-arrow" viewBox="0 0 512 512" style="enable-background:new 0 0 512 512;"> <g> <g> <path d="M512,241.7L273.643,3.343v156.152c-71.41,3.744-138.015,33.337-188.958,84.28C30.075,298.384,0,370.991,0,448.222v60.436 l29.069-52.985c45.354-82.671,132.173-134.027,226.573-134.027c5.986,0,12.004,0.212,18.001,0.632v157.779L512,241.7z M255.642,290.666c-84.543,0-163.661,36.792-217.939,98.885c26.634-114.177,129.256-199.483,251.429-199.483h15.489V78.131 l163.568,163.568L304.621,405.267V294.531l-13.585-1.683C279.347,291.401,267.439,290.666,255.642,290.666z"> </path> </g> </g> </symbol> <symbol id="chevron" viewBox="0 0 100 100"> <g> <path d="M22.4566257,37.2056786 L-21.4456527,71.9511488 C-22.9248661,72.9681457 -24.9073712,72.5311671 -25.8758148,70.9765924 L-26.9788683,69.2027424 C-27.9450684,67.6481676 -27.5292733,65.5646602 -26.0500598,64.5484493 L20.154796,28.2208967 C21.5532435,27.2597011 23.3600078,27.2597011 24.759951,28.2208967 L71.0500598,64.4659264 C72.5292733,65.4829232 72.9450684,67.5672166 71.9788683,69.1217913 L70.8750669,70.8956413 C69.9073712,72.4502161 67.9241183,72.8848368 66.4449048,71.8694118 L22.4566257,37.2056786 Z" id="Transparent-Chevron" transform="translate(22.500000, 50.000000) rotate(90.000000) translate(-22.500000, -50.000000) "></path> </g> </symbol> <symbol id="chevron-down" viewBox="0 0 10 6" xmlns="http://www.w3.org/2000/svg"> <path d="M5.108 4.088L.965.158a.587.587 0 0 0-.8 0 .518.518 0 0 0 0 .758L5.13 5.625 9.845.905a.517.517 0 0 0-.021-.758.588.588 0 0 0-.8.02l-3.916 3.92z" fill-rule="evenodd" /> </symbol> <symbol id="chevron-up" viewBox="0 0 284.929 284.929" xmlns="http://www.w3.org/2000/svg"> <path d="M282.082 195.285L149.028 62.24c-1.901-1.903-4.088-2.856-6.562-2.856s-4.665.953-6.567 2.856L2.856 195.285C.95 197.191 0 199.378 0 201.853c0 2.474.953 4.664 2.856 6.566l14.272 14.271c1.903 1.903 4.093 2.854 6.567 2.854s4.664-.951 6.567-2.854l112.204-112.202 112.208 112.209c1.902 1.903 4.093 2.848 6.563 2.848 2.478 0 4.668-.951 6.57-2.848l14.274-14.277c1.902-1.902 2.847-4.093 2.847-6.566.001-2.476-.944-4.666-2.846-6.569z" /> </symbol> <symbol id="icon-activity" viewBox="0 0 20 20"> <g fill="currentColor" fill-rule="evenodd"> <path d="M4 4h16v2H4zM0 4h2v2H0zM4 9h14v2H4zM0 9h2v2H0zM4 14h10v2H4zM0 14h2v2H0z"/> </g> </symbol> <symbol id="icon-arrow-down" viewBox="0 0 10 6" xmlns="http://www.w3.org/2000/svg"> <path d="M5.108 4.088L.965.158a.587.587 0 0 0-.8 0 .518.518 0 0 0 0 .758L5.13 5.625 9.845.905a.517.517 0 0 0-.021-.758.588.588 0 0 0-.8.02l-3.916 3.92z" fill="inherit" fill-rule="evenodd" /> </symbol> <symbol id="icon-arrow-right" viewBox="0 0 15 11"> <path d="m9.91.876.088.067 4.5 4 .014.013.044.045-.058-.058a.757.757 0 0 1 .192.266c.039.09.06.19.06.295l-.006.095a.748.748 0 0 1-.169.386l-.019.022a.755.755 0 0 1-.044.045l-.014.012-4.5 4a.75.75 0 0 1-1.074-1.04l.078-.08 3.023-2.69H1A.75.75 0 0 1 .898 4.76L1 4.754h11.026l-3.024-2.69a.75.75 0 0 1-.13-.97l.067-.088a.75.75 0 0 1 .971-.13z" fill-rule="nonzero" /> </symbol> <symbol id="icon-star" viewBox="0 0 24 24"> <g fill="none" fill-rule="evenodd"> <path d="M0 0L24 0 24 24 0 24z"/> <path d="M0 0L24 0 24 24 0 24z"/> <path fill="currentColor" d="M12 18.324L19.416 22.8 17.448 14.364 24 8.688 15.372 7.956 12 0 8.628 7.956 0 8.688 6.552 14.364 4.584 22.8z"/> </g> </symbol> <symbol id="icon-wand" viewBox="0 0 24 24"> <g fill="none" fill-rule="evenodd"> <path d="M0.003 0L24.003 0 24.003 24 0.003 24z"/> <path fill="currentColor" d="M24 0l-2.857 1.6L18.286 0l1.6 2.857-1.6 2.857 2.857-1.6L24 5.714l-1.6-2.857L24 0zm-8.719 6.045c-.446-.446-1.166-.446-1.611 0L.334 19.381c-.445.445-.445 1.165 0 1.61l2.674 2.675c.446.445 1.166.445 1.611 0l13.325-13.324c.445-.446.445-1.166 0-1.612L15.28 6.045zm-1.177 6.274l-2.423-2.423 2.789-2.788 2.422 2.422-2.788 2.789z"/> </g> </symbol> <symbol id="icon-note" viewBox="0 0 24 24"> <g fill="none" fill-rule="evenodd"> <path fill="currentColor" d="M24.333 3H5.653C4.187 3 3 4.2 3 5.667l.013 18.666C3.013 25.8 4.2 27 5.667 27H19l8-8V5.667C27 4.2 25.8 3 24.333 3zm-16 6.667h13.334v2.666H8.333V9.667zm6.667 8H8.333V15H15v2.667zM17.667 25v-7.333H25L17.667 25z" /> </g> </symbol> <symbol id="icon-warning" viewBox="0 0 24 24"> <g fill="none" fill-rule="evenodd"> <path d="M0 0L24 0 24 24 0 24z"/> <path fill="currentColor" d="M0 22.727h24L12 2 0 22.727zm13.09-3.272h-2.18v-2.182h2.18v2.182zm0-4.364h-2.18v-4.364h2.18v4.364z"/> </g> </symbol> <symbol id="play-arrow" viewBox="0 0 30 30"> <g fill-rule="evenodd"> <path d="M9 9l12 6-12 6z"></path> </g> </symbol> <symbol id="play-icon" viewBox="0 0 50 50" xmlns="http://www.w3.org/2000/svg"> <g stroke="none" stroke-width="1" fill="none" fill-rule="nonzero"> <circle fill="currentColor" cx="25" cy="25" r="24" /> <polygon fill="#FFFFFF" points="18 36.25 18 13.75 33 25" /> </g> </symbol> <symbol id="player-play" viewBox="0 0 40 40"> <path fill="currentColor" d="M17.6 27.8l9.34-7c.54-.4.54-1.2 0-1.6l-9.34-7c-.66-.5-1.6-.02-1.6.8v14c0 .82.94 1.3 1.6.8zM20 0C8.96 0 0 8.96 0 20s8.96 20 20 20 20-8.96 20-20S31.04 0 20 0zm0 38c-9.922 0-18-8.078-18-18S10.078 2 20 2s18 8.078 18 18-8.078 18-18 18z" /> </symbol> <symbol id="player-pause" viewBox="0 0 40 40"> <path fill="currentColor" d="M20 0C8.96 0 0 8.96 0 20s8.96 20 20 20 20-8.96 20-20S31.04 0 20 0zm0 38c-9.922 0-18-8.078-18-18S10.078 2 20 2s18 8.078 18 18-8.078 18-18 18zm-4-26c.552 0 1 .448 1 1v14c0 .552-.448 1-1 1s-1-.448-1-1V13c0-.552.448-1 1-1zm8 0c.552 0 1 .448 1 1v14c0 .552-.448 1-1 1s-1-.448-1-1V13c0-.552.448-1 1-1z" /> </symbol> <symbol id="grid" viewBox="0 0 32 32"> <g> <path d="M6.4,5.7 C6.4,6.166669 6.166669,6.4 5.7,6.4 L0.7,6.4 C0.233331,6.4 0,6.166669 0,5.7 L0,0.7 C0,0.233331 0.233331,0 0.7,0 L5.7,0 C6.166669,0 6.4,0.233331 6.4,0.7 L6.4,5.7 Z M19.2,5.7 C19.2,6.166669 18.966669,6.4 18.5,6.4 L13.5,6.4 C13.033331,6.4 12.8,6.166669 12.8,5.7 L12.8,0.7 C12.8,0.233331 13.033331,0 13.5,0 L18.5,0 C18.966669,0 19.2,0.233331 19.2,0.7 L19.2,5.7 Z M32,5.7 C32,6.166669 31.766669,6.4 31.3,6.4 L26.3,6.4 C25.833331,6.4 25.6,6.166669 25.6,5.7 L25.6,0.7 C25.6,0.233331 25.833331,0 26.3,0 L31.3,0 C31.766669,0 32,0.233331 32,0.7 L32,5.7 Z M6.4,18.5 C6.4,18.966669 6.166669,19.2 5.7,19.2 L0.7,19.2 C0.233331,19.2 0,18.966669 0,18.5 L0,13.5 C0,13.033331 0.233331,12.8 0.7,12.8 L5.7,12.8 C6.166669,12.8 6.4,13.033331 6.4,13.5 L6.4,18.5 Z M19.2,18.5 C19.2,18.966669 18.966669,19.2 18.5,19.2 L13.5,19.2 C13.033331,19.2 12.8,18.966669 12.8,18.5 L12.8,13.5 C12.8,13.033331 13.033331,12.8 13.5,12.8 L18.5,12.8 C18.966669,12.8 19.2,13.033331 19.2,13.5 L19.2,18.5 Z M32,18.5 C32,18.966669 31.766669,19.2 31.3,19.2 L26.3,19.2 C25.833331,19.2 25.6,18.966669 25.6,18.5 L25.6,13.5 C25.6,13.033331 25.833331,12.8 26.3,12.8 L31.3,12.8 C31.766669,12.8 32,13.033331 32,13.5 L32,18.5 Z M6.4,31.3 C6.4,31.766669 6.166669,32 5.7,32 L0.7,32 C0.233331,32 0,31.766669 0,31.3 L0,26.3 C0,25.833331 0.233331,25.6 0.7,25.6 L5.7,25.6 C6.166669,25.6 6.4,25.833331 6.4,26.3 L6.4,31.3 Z M19.2,31.3 C19.2,31.766669 18.966669,32 18.5,32 L13.5,32 C13.033331,32 12.8,31.766669 12.8,31.3 L12.8,26.3 C12.8,25.833331 13.033331,25.6 13.5,25.6 L18.5,25.6 C18.966669,25.6 19.2,25.833331 19.2,26.3 L19.2,31.3 Z M32,31.3 C32,31.766669 31.766669,32 31.3,32 L26.3,32 C25.833331,32 25.6,31.766669 25.6,31.3 L25.6,26.3 C25.6,25.833331 25.833331,25.6 26.3,25.6 L31.3,25.6 C31.766669,25.6 32,25.833331 32,26.3 L32,31.3 Z" id=""></path> </g> </symbol> <symbol id="filter" viewBox="0 0 16 12"> <path d="M0 2V0h16v2H0zm2.4 5V5h11.2v2H2.4zm2.4 5v-2h6.4v2H4.8z"></path> </symbol> <symbol id="icon-filter" viewBox="0 0 512 512"> <path fill="currentColor" d="M487.976 0H24.028C2.71 0-8.047 25.866 7.058 40.971L192 225.941V432c0 7.831 3.821 15.17 10.237 19.662l80 55.98C298.02 518.69 320 507.493 320 487.98V225.941l184.947-184.97C520.021 25.896 509.338 0 487.976 0z"> </path> </symbol> <symbol id="icon-radio-on" viewBox="0 0 24 24"> <path fill="currentColor" fill-rule="nonzero" d="M12 7c-2.76 0-5 2.24-5 5s2.24 5 5 5 5-2.24 5-5-2.24-5-5-5zm0-5C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.42 0-8-3.58-8-8s3.58-8 8-8 8 3.58 8 8-3.58 8-8 8z" /> </symbol> <symbol id="icon-radio-off" viewBox="0 0 24 24"> <path fill="currentColor" fill-rule="nonzero" d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.42 0-8-3.58-8-8s3.58-8 8-8 8 3.58 8 8-3.58 8-8 8z" /> </symbol> <symbol id="icon-pause" viewBox="0 0 13 16"> <rect width="4.636" height="16" rx="2.318" /> <rect width="4.636" height="16" x="7.727" rx="2.318" /> </symbol> <symbol id="icon-plus" viewBox="0 0 14 14" height="14px" width="14px"> <path d="M13, 6H8V1A1, 1, 0, 0, 0, 6, 1V6H1A1, 1, 0, 0, 0, 1, 8H6v5a1, 1, 0, 0, 0, 2, 0V8h5a1, 1, 0, 0, 0, 0-2Z" /> </symbol> <symbol id="icon-minus" viewBox="0 0 14 14" height="14px" width="14px"> <path d="M13, 8H1A1, 1, 0, 0, 1, 1, 6H13a1, 1, 0, 0, 1, 0, 2Z" /> </symbol> <symbol id="amazon-alexa" fill="none" viewBox="0 0 14 14"> <path clip-rule="evenodd" d="m52.4998 105c-28.9946 0-52.4998-23.5055-52.4998-52.5003 0-26.6214 19.8151-48.61142 45.5003-52.03433v10.57883c0 2.9832-1.8814 5.6636-4.7091 6.6127-14.8197 4.9787-25.4216 19.1433-25.0311 35.7287.4754 20.1911 16.923 36.0663 37.1187 35.8628 20.122-.2035 36.3714-16.5785 36.3714-36.7487 0-.4597-.0113-.9172-.0283-1.3721-.004-.102-.0072-.2048-.0113-.307-.0194-.4228-.0452-.8446-.0784-1.2639-.0097-.1335-.0234-.2666-.0355-.3998-.0259-.2928-.0558-.5837-.0889-.8739-.0372-.3297-.08-.6576-.1261-.9838-.0202-.1492-.0404-.2988-.063-.4467-4.4995-29.6389-43.1025-46.296896-43.3144-46.388077 2.2893-.304462 4.6239-.464423 6.9955-.464423 28.9951 0 52.5002 23.5048 52.5002 52.4997 0 28.9948-23.5051 52.5003-52.5002 52.5003z" fill="#5fcaf4" fill-rule="evenodd" transform="matrix(.133333 0 0 -.133333 0 14)" /> </symbol> <symbol id="apple" viewBox="0 0 511.86 511.86"> <rect fill="#822cbe" width="511.86" height="511.86" rx="113.87" /> <path fill="#ffffff" d="M240.44,448.26c-15.27-5.46-18.54-12.88-24.81-56.38-7.28-50.55-8.87-81.84-4.65-91.75,5.59-13.14,20.78-20.6,42-20.68,21.07-.09,36.39,7.44,42,20.68,4.24,9.89,2.65,41.2-4.64,91.75-4.95,35.32-7.67,44.25-14.5,50.25-9.38,8.31-22.69,10.61-35.32,6.14Zm-65.22-51.87c-52.73-25.94-86.51-69.82-98.79-128.2-3.07-15.07-3.59-51-.69-64.84,7.68-37.11,22.36-66.13,46.75-91.79,35.15-37.06,80.37-56.65,130.7-56.65,49.82,0,94.86,19.23,129.16,55.18,26.1,27.13,40.77,55.84,48.28,93.67,2.56,12.59,2.56,46.92.17,61.08a181.4,181.4,0,0,1-69.1,113c-13,9.79-44.7,26.89-49.82,26.89-1.88,0-2.05-1.94-1.19-9.81,1.53-12.63,3.07-15.25,10.23-18.26,11.44-4.77,30.89-18.63,42.83-30.61a163,163,0,0,0,42.82-75.41c4.44-17.57,3.93-56.64-1-74.73C390,138.36,343.1,93.66,285.61,81.72c-16.73-3.42-47.1-3.42-64,0-58.18,11.94-106.29,58.86-121,117.89-3.92,16-3.92,55.11,0,71.15,9.73,39.07,35,74.9,68.08,96.23a147.45,147.45,0,0,0,17.58,10.07c7.16,3.07,8.7,5.63,10.06,18.25.85,7.68.68,9.9-1.19,9.9-1.2,0-9.9-3.75-19.11-8.19ZM175.9,327c-17.75-14.16-33.44-39.28-39.93-63.91-3.92-14.88-3.92-43.17.17-58,10.75-40.06,40.27-71.12,81.22-85.71,14-4.94,45-6,62.27-2.25C339,130.33,381.15,189.79,373,248.77c-3.24,23.77-11.43,43.29-25.93,61.42-7.17,9.16-24.57,24.54-27.64,24.54-.51,0-1-5.8-1-12.87V309l8.88-10.58c33.44-40.06,31.05-96-5.46-132.74-14.16-14.29-30.54-22.69-51.7-26.56-13.65-2.53-16.55-2.53-30.88-.17-21.76,3.55-38.61,12-53.58,26.78C148.94,202,146.55,258.29,180,298.38L188.8,309v13c0,7.17-.57,13-1.27,13s-5.63-3.41-10.92-7.68Zm59.2-69.66c-15.18-7.07-23.37-20.39-23.54-37.76,0-15.61,8.7-29.23,23.71-37.2,9.56-5,26.45-5,36,0a46.34,46.34,0,0,1,22.18,26.85c9.9,33.65-25.76,63.13-58,48.07Z" transform="translate(-0.14 -0.14)" /> <circle fill="#ffffff" cx="255.74" cy="221.24" r="42.55" /> <path fill="#ffffff" d="M260,280.42a83.61,83.61,0,0,1,14.25,2.9,51.55,51.55,0,0,1,14.26,7.13c3.76,2.73,6.49,5.56,8.19,9s2.56,7.54,3.07,14.25c.34,6.72.34,16-1.19,33.44s-4.61,42.79-7,59.08-4.09,23.55-6.31,28.84a25.82,25.82,0,0,1-18.94,16.55,41,41,0,0,1-9.89.85,42.41,42.41,0,0,1-9.9-.85c-3.92-.86-9-2.39-12.8-5.46-3.92-3.07-6.48-7.51-8.53-13.31s-3.58-12.8-5.63-26.79-4.78-34.8-6.48-50.67-2.39-26.79-2.53-34.13.17-11,1-14.5a28.93,28.93,0,0,1,4.09-9.38,31.14,31.14,0,0,1,6.83-7,27.87,27.87,0,0,1,8-4.3A60.8,60.8,0,0,1,241.35,283c4.43-.85,9.55-1.7,12.18-2.05a13.34,13.34,0,0,1,5.56,0Z" transform="translate(-0.14 -0.14)" /> </symbol> <symbol id="google" fill="none" viewBox="0 0 14 14"> <path d="m0 0v2.12148.84795 2.12148h1.75v-2.12148-.84795-2.12148z" fill="#fab908" transform="translate(6.125 4.45453)" /> <path d="m.875 1.75c.48325 0 .875-.39175.875-.875 0-.483249-.39175-.875-.875-.875-.483249 0-.875.391751-.875.875 0 .48325.391751.875.875.875z" fill="#0066d9" transform="translate(0 5.64764)" /> <path d="m.875 1.75c.48325 0 .875-.39175.875-.875 0-.483249-.39175-.875-.875-.875-.483249 0-.875.391751-.875.875 0 .48325.391751.875.875.875z" fill="#0066d9" transform="translate(0 6.60236)" /> <path d="m1.75 0h-1.75v.954546h1.75z" fill="#0066d9" transform="translate(0 6.52264)" /> <path d="m.875 1.75c.48325 0 .875-.39175.875-.875 0-.483249-.39175-.875-.875-.875-.483249 0-.875.391751-.875.875 0 .48325.391751.875.875.875z" fill="#4285f4" transform="translate(12.25 6.60236)" /> <path d="m.875 1.75c.48325 0 .875-.39175.875-.875 0-.483249-.39175-.875-.875-.875-.483249 0-.875.391751-.875.875 0 .48325.391751.875.875.875z" fill="#4285f4" transform="translate(12.25 5.64764)" /> <path d="m1.75 0h-1.75v.954546h1.75z" fill="#4285f4" transform="matrix(-1 0 0 -1 14 7.47736)" /> <path d="m.875 1.75c.48325 0 .875-.39175.875-.875 0-.483249-.39175-.875-.875-.875-.483249 0-.875.391751-.875.875 0 .48325.391751.875.875.875z" fill="#ea4335" transform="translate(3.02274 8.51141)" /> <path d="m.875 1.75c.48325 0 .875-.39175.875-.875 0-.483249-.39175-.875-.875-.875-.483249 0-.875.391751-.875.875 0 .48325.391751.875.875.875z" fill="#ea4335" transform="translate(3.02274 9.46594)" /> <path d="m1.75 0h-1.75v.954546h1.75z" fill="#ea4335" transform="translate(3.02274 9.38641)" /> <path d="m.875 1.75c.48325 0 .875-.39175.875-.875 0-.483249-.39175-.875-.875-.875-.483249 0-.875.391751-.875.875 0 .48325.391751.875.875.875z" fill="#ea4335" transform="translate(3.02274 2.78406)" /> <path d="m.875 1.75c.48325 0 .875-.39175.875-.875 0-.483249-.39175-.875-.875-.875-.483249 0-.875.391751-.875.875 0 .48325.391751.875.875.875z" fill="#ea4335" transform="translate(3.02274 5.88641)" /> <path d="m1.75 0h-1.75v3.12216h1.75z" fill="#ea4335" transform="translate(3.02274 3.65906)" /> <path d="m.875 1.75c.48325 0 .875-.39175.875-.875 0-.483249-.39175-.875-.875-.875-.483249 0-.875.391751-.875.875 0 .48325.391751.875.875.875z" fill="#34a853" transform="translate(9.22726 3.73859)" /> <path d="m.875 1.75c.48325 0 .875-.39175.875-.875 0-.483249-.39175-.875-.875-.875-.483249 0-.875.391751-.875.875 0 .48325.391751.875.875.875z" fill="#34a853" transform="translate(9.22726 2.78406)" /> <path d="m1.75 0h-1.75v.954546h1.75z" fill="#34a853" transform="matrix(-1 0 0 -1 10.9773 4.61359)" /> <g fill="#fab908"> <path d="m.875 1.75c.48325 0 .875-.39175.875-.875 0-.483249-.39175-.875-.875-.875-.483249 0-.875.391751-.875.875 0 .48325.391751.875.875.875z" transform="translate(6.125 .954529)" /> <path d="m.875 1.75c.48325 0 .875-.39175.875-.875 0-.483249-.39175-.875-.875-.875-.483249 0-.875.391751-.875.875 0 .48325.391751.875.875.875z" transform="translate(6.125)" /> <path d="m1.75 0h-1.75v.954546h1.75z" transform="matrix(-1 0 0 -1 7.875 1.82953)" /> <path d="m.875 1.75c.48325 0 .875-.39175.875-.875 0-.483249-.39175-.875-.875-.875-.483249 0-.875.391751-.875.875 0 .48325.391751.875.875.875z" transform="translate(6.125 12.25)" /> <path d="m.875 1.75c.48325 0 .875-.39175.875-.875 0-.483249-.39175-.875-.875-.875-.483249 0-.875.391751-.875.875 0 .48325.391751.875.875.875z" transform="translate(6.125 11.2955)" /> <path d="m1.75 0h-1.75v.954546h1.75z" transform="matrix(-1 0 0 -1 7.875 13.125)" /> </g> <path d="m.875 1.75c.48325 0 .875-.39175.875-.875 0-.483249-.39175-.875-.875-.875-.483249 0-.875.391751-.875.875 0 .48325.391751.875.875.875z" fill="#34a853" transform="translate(9.22726 9.46594)" /> <path d="m.875 1.75c.48325 0 .875-.39175.875-.875 0-.483249-.39175-.875-.875-.875-.483249 0-.875.391751-.875.875 0 .48325.391751.875.875.875z" fill="#34a853" transform="translate(9.22726 6.36359)" /> <path d="m1.75 0h-1.75v3.10227h1.75z" fill="#34a853" transform="matrix(-1 0 0 -1 10.9773 10.3409)" /> <path d="m.875 1.75c.48325 0 .875-.39175.875-.875 0-.483249-.39175-.875-.875-.875-.483249 0-.875.391751-.875.875 0 .48325.391751.875.875.875z" fill="#fab908" transform="translate(6.125 3.57953)" /> <path d="m.875 1.75c.48325 0 .875-.39175.875-.875 0-.483249-.39175-.875-.875-.875-.483249 0-.875.391751-.875.875 0 .48325.391751.875.875.875z" fill="#fab908" transform="translate(6.125 8.67047)" /> </symbol> <symbol id="npr-one" viewBox="0 0 15 16"> <g clip-rule="evenodd" fill-rule="evenodd"> <path d="m-.00000001 3.99903 3.11681001 1.9192c.6747-1.24356 1.93544-2.08032 3.37935-2.08032v-3.83791c-2.77571 0-5.1993 1.60843-6.49616001 3.99903z" fill="#d61900" transform="translate(1.00378)" /> <path d="m3.78823 5.28599c-.12325-.40495-.18984-.83705-.18984-1.28579 0-.75804.19011-1.4688.52217-2.081-1.53085-.942623-2.25153-1.386398-3.11681-1.91919993-.638301 1.17671993-1.00375 2.54287993-1.00375 4.00019993 0 1.45723.365449 2.82349 1.00375 4.0002l1.97257-1.21466z" fill="#f30" transform="translate(0 4.00128)" /> <path d="m-.00000001 1.21467c1.29686001 2.3906 3.72045001 3.99903 6.49616001 3.99903v-3.83801c-1.15017 0-2.18402-.530854-2.89814-1.37539816h-1.62563l.00018-.00029136z" fill="#83aeed" transform="translate(1.00378 10.7867)" /> <path d="m6.49625 1.9192-3.1168-1.91919949c-.67471 1.24355949-1.93535 2.08022949-3.37944981 2.08022949v3.838c2.77589981 0 5.19938981-1.60843 6.49624981-3.99903z" fill="#3266cc" transform="translate(7.50012 10.0768)" /> <path d="m.522174 4.0002c0 .75815-.190114 1.46881-.52217447 2.08101l3.11681047 1.91919c.63839-1.17671 1.00375-2.54297 1.00375-4.0002 0-1.45732-.36536-2.82348-1.00375-4.00019993-.86528.53280193-1.58596.97657693-3.11681047 1.91919993.33206047.6122.52217447 1.32296.52217447 2.081z" fill="#3a3a3a" transform="translate(10.8795 4.00128)" /> <path d="m.00000019 3.83791c1.44409981 0 2.70473981.83676 3.37944981 2.08032l3.1168-1.9192c-1.29686-2.3906-3.72044-3.99903-6.49624981-3.99903z" fill="#191919" transform="translate(7.50012)" /> </g> </symbol> <symbol id="overcast" viewBox="0 0 365 365" fill="none"> <g xmlns="http://www.w3.org/2000/svg" id="surface1"> <path style=" stroke:none;fill-rule:nonzero;fill:rgb(96.099854%,49.398804%,12.5%);fill-opacity:1;" d="M 90.179688 274.820313 C 66.550781 251.195313 51.9375 218.554688 51.9375 182.5 C 51.9375 146.445313 66.550781 113.804688 90.179688 90.179688 L 101.789063 101.789063 C 81.136719 122.445313 68.359375 150.980469 68.359375 182.5 C 68.359375 214.019531 81.136719 242.554688 101.789063 263.210938 Z M 125.890625 239.109375 C 111.402344 224.621094 102.441406 204.609375 102.441406 182.5 C 102.441406 160.390625 111.402344 140.378906 125.890625 125.890625 L 137.503906 137.503906 C 125.988281 149.019531 118.863281 164.925781 118.863281 182.5 C 118.863281 200.074219 125.988281 215.980469 137.503906 227.496094 Z M 227.496094 227.496094 C 239.011719 215.980469 246.136719 200.074219 246.136719 182.5 C 246.136719 164.925781 239.011719 149.019531 227.496094 137.503906 L 239.109375 125.890625 C 253.597656 140.378906 262.558594 160.390625 262.558594 182.5 C 262.558594 204.609375 253.597656 224.621094 239.109375 239.109375 Z M 274.820313 274.820313 L 263.210938 263.210938 C 283.863281 242.554688 296.640625 214.019531 296.640625 182.5 C 296.640625 150.980469 283.863281 122.445313 263.210938 101.789063 L 274.820313 90.179688 C 298.449219 113.804688 313.0625 146.445313 313.0625 182.5 C 313.0625 218.554688 298.449219 251.195313 274.820313 274.820313 Z M 182.5 16.640625 C 90.898438 16.640625 16.640625 90.898438 16.640625 182.5 C 16.640625 255.765625 64.148438 317.933594 130.039063 339.886719 L 172.632813 212.101563 C 160.238281 207.972656 151.296875 196.28125 151.296875 182.5 C 151.296875 165.265625 165.265625 151.296875 182.5 151.296875 C 199.734375 151.296875 213.703125 165.265625 213.703125 182.5 C 213.703125 196.28125 204.761719 207.972656 192.367188 212.101563 L 234.960938 339.886719 C 300.851563 317.933594 348.359375 255.765625 348.359375 182.5 C 348.359375 90.898438 274.101563 16.640625 182.5 16.640625 Z M 202.902344 347.109375 C 195.519531 341.375 188.371094 335.058594 181.539063 328.164063 C 174.933594 334.996094 168.046875 341.269531 160.945313 346.96875 C 168 347.882813 175.195313 348.359375 182.5 348.359375 C 189.40625 348.359375 196.214844 347.933594 202.902344 347.109375 Z M 191.792969 316.824219 C 200.890625 327.066406 210.65625 336.113281 220.847656 343.898438 C 221.527344 343.734375 222.203125 343.570313 222.878906 343.402344 L 205.261719 299.355469 C 200.972656 305.472656 196.472656 311.300781 191.792969 316.824219 Z M 182.257813 305.34375 C 187.945313 298.007813 193.300781 290.164063 198.257813 281.84375 L 182.5 242.453125 L 166.550781 282.324219 C 171.425781 290.464844 176.679688 298.148438 182.257813 305.34375 Z M 143.78125 343.804688 C 153.617188 336.28125 163.054688 327.59375 171.875 317.78125 C 167.367188 312.621094 163.03125 307.179688 158.894531 301.46875 L 142.121094 343.402344 C 142.671875 343.539063 143.226563 343.671875 143.78125 343.804688 Z M 182.5 364.796875 C 81.820313 364.796875 0.207031 283.179688 0.207031 182.5 C 0.207031 81.820313 81.820313 0.203125 182.5 0.203125 C 283.179688 0.203125 364.796875 81.820313 364.796875 182.5 C 364.796875 283.179688 283.179688 364.796875 182.5 364.796875 " /> <path style=" stroke:none;fill-rule:nonzero;fill:rgb(100%,100%,100%);fill-opacity:1;" d="M 90.179688 274.820313 L 90.324219 274.675781 C 66.734375 251.085938 52.140625 218.496094 52.140625 182.5 C 52.140625 146.503906 66.730469 113.914063 90.324219 90.324219 L 90.179688 90.179688 L 90.03125 90.324219 L 101.644531 101.9375 L 101.789063 101.789063 L 101.644531 101.644531 C 80.953125 122.339844 68.15625 150.925781 68.15625 182.5 C 68.15625 214.074219 80.953125 242.660156 101.644531 263.355469 L 101.789063 263.210938 L 101.644531 263.0625 L 90.03125 274.675781 L 90.179688 274.820313 L 90.324219 274.675781 L 90.179688 274.820313 L 90.324219 274.96875 L 102.082031 263.210938 L 101.9375 263.0625 C 81.316406 242.445313 68.566406 213.964844 68.566406 182.5 C 68.566406 151.035156 81.316406 122.554688 101.9375 101.9375 L 102.082031 101.789063 L 90.179688 89.886719 L 90.03125 90.03125 C 66.367188 113.695313 51.730469 146.390625 51.730469 182.5 C 51.730469 218.609375 66.367188 251.304688 90.03125 274.96875 L 90.179688 275.113281 L 90.324219 274.96875 Z M 125.890625 239.109375 L 126.035156 238.964844 C 111.582031 224.515625 102.644531 204.550781 102.644531 182.5 C 102.644531 160.449219 111.582031 140.484375 126.035156 126.035156 L 125.890625 125.890625 L 125.742188 126.035156 L 137.355469 137.648438 L 137.503906 137.503906 L 137.355469 137.355469 C 125.804688 148.910156 118.660156 164.871094 118.660156 182.5 C 118.660156 200.128906 125.804688 216.089844 137.355469 227.644531 L 137.503906 227.496094 L 137.355469 227.351563 L 125.742188 238.964844 L 125.890625 239.109375 L 126.035156 238.964844 L 125.890625 239.109375 L 126.035156 239.257813 L 137.792969 227.496094 L 137.648438 227.351563 C 126.167969 215.871094 119.070313 200.015625 119.070313 182.5 C 119.070313 164.984375 126.167969 149.128906 137.648438 137.648438 L 137.792969 137.503906 L 125.890625 125.597656 L 125.742188 125.742188 C 111.21875 140.269531 102.234375 160.335938 102.234375 182.5 C 102.234375 204.664063 111.21875 224.730469 125.742188 239.257813 L 125.890625 239.402344 L 126.035156 239.257813 Z M 227.496094 227.496094 L 227.644531 227.644531 C 239.195313 216.089844 246.339844 200.128906 246.339844 182.5 C 246.339844 164.871094 239.195313 148.910156 227.644531 137.355469 L 227.496094 137.503906 L 227.644531 137.648438 L 239.257813 126.035156 L 239.109375 125.890625 L 238.964844 126.035156 C 253.417969 140.484375 262.355469 160.449219 262.355469 182.5 C 262.355469 204.550781 253.417969 224.515625 238.964844 238.964844 L 239.109375 239.109375 L 239.257813 238.964844 L 227.644531 227.351563 L 227.496094 227.496094 L 227.644531 227.644531 L 227.496094 227.496094 L 227.351563 227.644531 L 239.109375 239.402344 L 239.257813 239.257813 C 253.78125 224.730469 262.765625 204.664063 262.765625 182.5 C 262.765625 160.335938 253.78125 140.269531 239.257813 125.742188 L 239.109375 125.597656 L 227.207031 137.503906 L 227.351563 137.648438 C 238.832031 149.128906 245.929688 164.984375 245.929688 182.5 C 245.929688 200.015625 238.832031 215.871094 227.351563 227.351563 L 227.207031 227.496094 L 227.351563 227.644531 Z M 274.820313 274.820313 L 274.96875 274.675781 L 263.355469 263.0625 L 263.210938 263.210938 L 263.355469 263.355469 C 284.046875 242.660156 296.84375 214.074219 296.84375 182.5 C 296.84375 150.925781 284.046875 122.339844 263.355469 101.644531 L 263.210938 101.789063 L 263.355469 101.9375 L 274.96875 90.324219 L 274.820313 90.179688 L 274.675781 90.324219 C 298.265625 113.914063 312.855469 146.503906 312.855469 182.5 C 312.855469 218.496094 298.265625 251.085938 274.675781 274.675781 L 274.820313 274.820313 L 274.96875 274.675781 L 274.820313 274.820313 L 274.96875 274.96875 C 298.632813 251.304688 313.269531 218.609375 313.269531 182.5 C 313.269531 146.390625 298.632813 113.695313 274.96875 90.03125 L 274.820313 89.886719 L 262.917969 101.789063 L 263.0625 101.9375 C 283.683594 122.554688 296.433594 151.035156 296.433594 182.5 C 296.433594 213.964844 283.683594 242.445313 263.0625 263.0625 L 262.917969 263.210938 L 274.820313 275.113281 L 274.96875 274.96875 Z M 182.5 16.640625 L 182.5 16.433594 C 90.785156 16.433594 16.433594 90.785156 16.433594 182.5 C 16.433594 255.859375 64.003906 318.097656 129.972656 340.082031 L 130.167969 340.144531 L 172.894531 211.972656 L 172.699219 211.90625 C 160.382813 207.804688 151.503906 196.191406 151.503906 182.5 C 151.503906 173.941406 154.972656 166.191406 160.582031 160.582031 C 166.191406 154.972656 173.9375 151.503906 182.5 151.503906 C 191.058594 151.503906 198.808594 154.972656 204.417969 160.582031 C 210.027344 166.191406 213.496094 173.9375 213.496094 182.5 C 213.496094 196.191406 204.617188 207.804688 192.300781 211.90625 L 192.105469 211.972656 L 234.832031 340.144531 L 235.027344 340.082031 C 301 318.097656 348.566406 255.859375 348.566406 182.5 C 348.566406 90.785156 274.214844 16.433594 182.5 16.433594 L 182.5 16.84375 C 228.246094 16.84375 269.65625 35.386719 299.636719 65.363281 C 329.613281 95.34375 348.15625 136.753906 348.15625 182.5 C 348.15625 255.675781 300.703125 317.765625 234.898438 339.691406 L 234.960938 339.886719 L 235.15625 339.820313 L 192.5625 212.035156 L 192.367188 212.101563 L 192.433594 212.296875 C 204.910156 208.140625 213.90625 196.375 213.910156 182.5 C 213.90625 165.152344 199.847656 151.09375 182.5 151.089844 C 165.152344 151.09375 151.09375 165.152344 151.089844 182.5 C 151.09375 196.375 160.089844 208.140625 172.566406 212.296875 L 172.632813 212.101563 L 172.4375 212.035156 L 129.84375 339.820313 L 130.039063 339.886719 L 130.101563 339.691406 C 64.296875 317.765625 16.84375 255.675781 16.84375 182.5 C 16.84375 136.753906 35.386719 95.34375 65.363281 65.363281 C 95.34375 35.386719 136.753906 16.84375 182.5 16.84375 Z M 202.902344 347.109375 L 203.027344 346.949219 C 195.652344 341.21875 188.511719 334.90625 181.683594 328.019531 L 181.535156 327.867188 L 181.390625 328.019531 C 174.792969 334.847656 167.910156 341.113281 160.816406 346.808594 L 160.441406 347.109375 L 160.917969 347.171875 C 167.984375 348.089844 175.1875 348.566406 182.5 348.566406 C 189.414063 348.566406 196.230469 348.136719 202.925781 347.316406 L 203.417969 347.253906 L 203.027344 346.949219 L 202.902344 347.109375 L 202.875 346.90625 C 196.199219 347.726563 189.398438 348.15625 182.5 348.15625 C 175.203125 348.15625 168.019531 347.679688 160.972656 346.765625 L 160.945313 346.96875 L 161.074219 347.128906 C 168.179688 341.421875 175.078125 335.144531 181.6875 328.304688 L 181.539063 328.164063 L 181.394531 328.308594 C 188.230469 335.210938 195.386719 341.53125 202.773438 347.273438 L 202.902344 347.109375 L 202.875 346.90625 Z M 191.792969 316.824219 L 191.636719 316.964844 C 200.742188 327.210938 210.519531 336.269531 220.722656 344.058594 L 220.800781 344.117188 L 220.894531 344.097656 C 221.574219 343.9375 222.253906 343.769531 222.929688 343.601563 L 223.15625 343.542969 L 205.3125 298.929688 L 205.09375 299.238281 C 200.808594 305.347656 196.3125 311.171875 191.636719 316.695313 L 191.519531 316.832031 L 191.636719 316.964844 L 191.792969 316.824219 L 191.949219 316.960938 C 196.632813 311.429688 201.136719 305.59375 205.429688 299.472656 L 205.261719 299.355469 L 205.070313 299.433594 L 222.6875 343.476563 L 222.878906 343.402344 L 222.828125 343.203125 C 222.152344 343.371094 221.476563 343.535156 220.800781 343.695313 L 220.847656 343.898438 L 220.972656 343.734375 C 210.789063 335.957031 201.035156 326.917969 191.945313 316.691406 L 191.792969 316.824219 L 191.949219 316.960938 Z M 182.257813 305.34375 L 182.421875 305.46875 C 188.113281 298.128906 193.472656 290.273438 198.433594 281.945313 L 198.484375 281.859375 L 182.5 241.898438 L 166.320313 282.34375 L 166.375 282.429688 C 171.253906 290.578125 176.511719 298.269531 182.097656 305.46875 L 182.257813 305.679688 L 182.421875 305.46875 L 182.257813 305.34375 L 182.421875 305.21875 C 176.847656 298.03125 171.597656 290.351563 166.726563 282.21875 L 166.550781 282.324219 L 166.742188 282.402344 L 182.5 243.003906 L 198.066406 281.917969 L 198.257813 281.84375 L 198.078125 281.738281 C 193.128906 290.050781 187.777344 297.890625 182.097656 305.21875 L 182.257813 305.34375 L 182.421875 305.21875 Z M 143.78125 343.804688 L 143.90625 343.96875 C 153.75 336.4375 163.199219 327.738281 172.027344 317.917969 L 172.152344 317.785156 L 172.03125 317.648438 C 167.527344 312.492188 163.195313 307.054688 159.058594 301.351563 L 158.839844 301.046875 L 141.84375 343.542969 L 142.070313 343.601563 C 142.625 343.738281 143.179688 343.871094 143.734375 344.007813 L 143.828125 344.027344 L 143.90625 343.96875 L 143.78125 343.804688 L 143.828125 343.605469 C 143.273438 343.472656 142.722656 343.339844 142.171875 343.203125 L 142.121094 343.402344 L 142.3125 343.476563 L 159.085938 301.546875 L 158.894531 301.46875 L 158.726563 301.589844 C 162.871094 307.304688 167.207031 312.753906 171.722656 317.917969 L 171.875 317.78125 L 171.722656 317.644531 C 162.910156 327.445313 153.480469 336.128906 143.65625 343.644531 L 143.78125 343.804688 L 143.828125 343.605469 Z M 182.5 364.796875 L 182.5 364.589844 C 132.21875 364.589844 86.695313 344.210938 53.742188 311.257813 C 20.792969 278.304688 0.410156 232.78125 0.410156 182.5 C 0.410156 132.21875 20.792969 86.695313 53.742188 53.742188 C 86.695313 20.789063 132.21875 0.410156 182.5 0.410156 C 232.78125 0.410156 278.304688 20.789063 311.257813 53.742188 C 344.210938 86.695313 364.589844 132.21875 364.589844 182.5 C 364.589844 232.78125 344.210938 278.304688 311.257813 311.257813 C 278.304688 344.210938 232.78125 364.589844 182.5 364.589844 L 182.5 365 C 283.292969 365 365 283.292969 365 182.5 C 365 81.707031 283.292969 0 182.5 0 C 81.707031 0 0 81.707031 0 182.5 C 0 283.292969 81.707031 365 182.5 365 L 182.5 364.796875 " /> </g> </symbol> <symbol id="pandora" viewBox="0 0 180 200"> <g id="bg"> <rect fill="#FFFFFF" width="180" height="200" /> </g> <g id="icons"> <g> <path fill="#019FEE" d="M160.7,74.2c-0.9-8.8-3.4-17.1-8.8-24.4c-4.1-5.6-9.4-9.8-15.6-13c-6-3-12.3-5-19-5.9l0,0 c-3.9-0.6-7.8-0.9-11.8-0.9H43.8c-0.4,0-0.7,0.3-0.7,0.7l0,0c0,46.1,0,92.2,0,138.3v0.1c0,0.4,0.3,0.7,0.7,0.7l0,0 c12.3,0,24.7,0,37,0c3.3,0,6-2.7,6.1-5.9c0-0.3,0-0.6,0-0.7c0-8.6,0-17.1,0-25.5v-0.3c0-0.4,0.3-0.7,0.7-0.7c0,0,0,0,0.1,0 c3.1,0,6.4,0,9.6,0c2.4,0,4.9,0,7.3-0.3c7.8-0.6,15.7-2,23.1-5c2.3-0.9,4.6-2,6.9-3.1c9-4.9,15.8-11.7,20.6-20.8 c2.3-4.6,3.9-9.4,4.9-14.6c0.6-2.7,0.9-5.4,1-8.3c0-0.1,0-0.1,0-0.3s0-0.1,0-0.3v-7c0,0,0,0,0-0.1C160.9,76,160.8,75.1,160.7,74.2 z" /> </g> </g> </symbol> <symbol id="pocket-casts" viewBox="0 0 39 36" style="enable-background:new 0 0 39 36;"> <g> <path fill="#F44336" d="M18,36c9.9,0,18-8,18-18S28,0,18,0S0,8,0,18S8,36,18,36L18,36L18,36z" /> <path fill="#FFFFFF" d="M17.8,27.1c-4.8-0.2-8.7-4.1-8.7-9c0-5,4.1-9,9-9s8.9,3.9,9,8.7c0,0.2,0.1,0.3,0.3,0.3H30 c0.2,0,0.3-0.1,0.3-0.3C30.1,11.2,24.7,5.9,18,5.9c-6.8,0-12.3,5.5-12.3,12.3c0,6.7,5.3,12.1,11.9,12.3c0.2,0,0.3-0.1,0.3-0.3v-2.6 C18.1,27.2,17.9,27.1,17.8,27.1L17.8,27.1L17.8,27.1z M18.1,11c-3.9,0-7.1,3.2-7.1,7.1c0,3.8,3,6.9,6.8,7.1c0.2,0,0.3-0.1,0.3-0.3 v-2.1c0-0.2-0.1-0.3-0.3-0.3c-2.3-0.2-4.1-2.1-4.1-4.4c0-2.4,2-4.4,4.4-4.4c2.3,0,4.2,1.8,4.4,4.1c0,0.2,0.2,0.3,0.3,0.3h2.1 c0.2,0,0.3-0.2,0.3-0.3C25,14,21.9,11,18.1,11L18.1,11L18.1,11z" /> </g> </symbol> <symbol id="rss" viewBox="0 0 12 12"> <path d="m1.59148 8.7795c-.878186.0032-1.58780186.71645-1.58566708 1.5938.00213478.8773.71521308 1.5871 1.59340708 1.5861.87819-.0011 1.58954-.7126 1.58955-1.59-.0032-.879-.71739-1.58991-1.59729-1.5899zm-1.59147997-4.7118v2.32108c1.48808997.00154 2.91461997.59358 3.96575997 1.64589 1.05115 1.05231 1.64082 2.47873 1.63927 3.96533h2.32333c.00464-2.10318-.82881-4.12172-2.31634-5.60999-1.48753-1.48826-3.5068-2.32386-5.61201997-2.32231zm0-4.06189726v2.32108726c5.33125997.00952 9.65431997 4.31803 9.67666997 9.64411h2.32333c-.0096-6.61422-5.37938-11.97100707-11.99999997-11.9710001z" fill="#257BBC" /> </symbol> <symbol id="spotify" viewBox="0 0 170.1 170.1" style="enable-background:new 0 0 170.1 170.1;" xml:space="preserve"> <g> <g> <g> <path fill="#1ED760" d="M85,1.3C38.8,1.3,1.3,38.8,1.3,85c0,46.3,37.5,83.7,83.7,83.7c46.3,0,83.7-37.5,83.7-83.7 C168.8,38.8,131.3,1.3,85,1.3z M123.4,122.1c-1.5,2.5-4.7,3.2-7.2,1.7c-19.7-12-44.4-14.7-73.6-8.1c-2.8,0.6-5.6-1.1-6.2-3.9 c-0.6-2.8,1.1-5.6,3.9-6.2c31.9-7.3,59.3-4.2,81.3,9.3C124.2,116.4,124.9,119.6,123.4,122.1z M133.7,99.3c-1.9,3.1-5.9,4-9,2.2 c-22.5-13.8-56.8-17.8-83.4-9.8c-3.5,1-7.1-0.9-8.1-4.3c-1-3.5,0.9-7.1,4.4-8.1c30.4-9.2,68.2-4.8,94.1,11.1 C134.6,92.2,135.6,96.2,133.7,99.3z M134.6,75.5c-27-16-71.5-17.5-97.3-9.7c-4.1,1.3-8.5-1.1-9.8-5.2c-1.3-4.1,1.1-8.5,5.2-9.8 c29.6-9,78.8-7.2,109.8,11.2c3.7,2.2,4.9,7,2.7,10.7C143.1,76.5,138.3,77.7,134.6,75.5z" /> </g> </g> </g> </symbol> <symbol id="stitcher" viewBox="0 0 122.88 51.61" style="enable-background:new 0 0 122.88 51.61"> <g> <polygon fill="#3590C5" points="0,10.14 21.5,10.14 21.5,49.15 0,49.15 0,10.14" /> <polygon fill="#C53827" points="101.38,7.99 122.88,7.99 122.88,43.93 101.38,43.93 101.38,7.99" /> <polygon fill="#EC8B24" points="76.19,0 97.69,0 97.69,46.7 76.19,46.7 76.19,0" /> <polygon fill="#FBC618" points="51,6.76 72.5,6.76 72.5,51.61 51,51.61 51,6.76" /> <polygon fill="#612268" points="25.5,3.07 47,3.07 47,46.39 25.5,46.39 25.5,3.07" /> </g> </symbol> <symbol id="tuneIn" viewBox="56 56 200 88" fill="none"> <g id="Logos"> <g id="Logo__x2013__Horizontal_1A_12_"> <g id="Logo_2_"> <path fill="#1C203C" d="M95,96.8v4c0,0.4-0.4,0.8-0.8,0.8h-5c-0.2,0-0.4,0.2-0.4,0.4v21.2c0,0.4-0.4,0.8-0.8,0.8h-4 c-0.4,0-0.8-0.4-0.8-0.8V102c0-0.2-0.2-0.4-0.4-0.4h-5c-0.4,0-0.8-0.4-0.8-0.8v-4c0-0.4,0.4-0.8,0.8-0.8h16.4 C94.6,96,95,96.4,95,96.8z M117,96h-4c-0.4,0-0.8,0.4-0.8,0.8v18.8c0,1.8-1.4,3.2-3.9,3.2c-2.4,0-3.8-1.4-3.8-3.2V96.8 c0-0.4-0.4-0.8-0.8-0.8h-4c-0.4,0-0.8,0.4-0.8,0.8v18.8c0,4.8,4,8.8,9.4,8.8c5.5,0,9.5-4,9.5-8.8V96.8 C117.8,96.4,117.4,96,117,96z M139.6,96h-4c-0.4,0-0.8,0.4-0.8,0.8v15c0,0.2-0.3,0.3-0.4,0.1l-5.5-15.2c-0.1-0.4-0.4-0.7-1-0.7 h-4.8c-0.4,0-0.8,0.4-0.8,0.8v26.4c0,0.4,0.4,0.8,0.8,0.8h4c0.4,0,0.8-0.4,0.8-0.8v-13.8c0-0.2,0.3-0.3,0.4-0.1l5.4,14 c0.1,0.3,0.4,0.7,1.1,0.7h4.7c0.4,0,0.8-0.4,0.8-0.8V96.8C140.4,96.4,140,96,139.6,96z M160.3,118.4h-9.5c-0.2,0-0.4-0.2-0.4-0.4 v-4.8c0-0.2,0.2-0.4,0.4-0.4h9c0.4,0,0.8-0.4,0.8-0.8v-4c0-0.4-0.4-0.8-0.8-0.8h-9c-0.2,0-0.4-0.2-0.4-0.4V102 c0-0.2,0.2-0.4,0.4-0.4h9.3c0.4,0,0.8-0.4,0.8-0.8v-4c0-0.4-0.4-0.8-0.8-0.8h-14.5c-0.4,0-0.8,0.4-0.8,0.8v26.4 c0,0.4,0.4,0.8,0.8,0.8h14.7c0.4,0,0.8-0.4,0.8-0.8v-4C161.1,118.8,160.7,118.4,160.3,118.4z M256,59v62c0,1.7-1.3,3-3,3h-69v17 c0,1.7-1.3,3-3,3H59c-1.7,0-3-1.3-3-3V79c0-1.7,1.3-3,3-3h119V59c0-1.7,1.3-3,3-3h72C254.7,56,256,57.3,256,59z M178,82H62.5 c-0.3,0-0.5,0.2-0.5,0.5v55c0,0.3,0.2,0.5,0.5,0.5h115c0.3,0,0.5-0.2,0.5-0.5V82z M213.8,99.4c0-0.4-0.4-0.8-0.8-0.8h-3.4 c-0.2,0-0.4-0.2-0.4-0.4V81.8c0-0.2,0.2-0.4,0.4-0.4h3c0.4,0,0.8-0.4,0.8-0.8v-3.8c0-0.4-0.4-0.8-0.8-0.8h-12.4 c-0.4,0-0.8,0.4-0.8,0.8v3.8c0,0.4,0.4,0.8,0.8,0.8h3c0.2,0,0.4,0.2,0.4,0.4v16.4c0,0.2-0.2,0.4-0.4,0.4h-3.4 c-0.4,0-0.8,0.4-0.8,0.8v3.8c0,0.4,0.4,0.8,0.8,0.8H213c0.4,0,0.8-0.4,0.8-0.8V99.4z M236.2,76.8c0-0.4-0.4-0.8-0.8-0.8h-4 c-0.4,0-0.8,0.4-0.8,0.8v15c0,0.2-0.3,0.3-0.4,0.1l-5.5-15.2c-0.1-0.4-0.4-0.7-1-0.7H219c-0.4,0-0.8,0.4-0.8,0.8v26.4 c0,0.4,0.4,0.8,0.8,0.8h4c0.4,0,0.8-0.4,0.8-0.8V89.4c0-0.2,0.3-0.3,0.4-0.1l5.4,14c0.1,0.3,0.4,0.7,1.1,0.7h4.7 c0.4,0,0.8-0.4,0.8-0.8V76.8z" /> </g> </g> </g> </symbol> <symbol id="icon-launch" viewBox="0 0 24 24"> <path d="M0 0h24v24H0z" fill="none"/> <path d="M19 19H5V5h7V3H5c-1.11 0-2 .9-2 2v14c0 1.1.89 2 2 2h14c1.1 0 2-.9 2-2v-7h-2v7zM14 3v2h3.59l-9.83 9.83 1.41 1.41L19 6.41V10h2V3h-7z"/> </symbol> <symbol id="globe" viewBox="0 0 16 16" > <path d="M8 1.25C6.66498 1.25 5.35994 1.64588 4.2499 2.38758C3.13987 3.12928 2.27471 4.18349 1.76382 5.41689C1.25292 6.65029 1.11925 8.00749 1.3797 9.31686C1.64015 10.6262 2.28303 11.829 3.22703 12.773C4.17104 13.717 5.37377 14.3598 6.68314 14.6203C7.99252 14.8808 9.34971 14.7471 10.5831 14.2362C11.8165 13.7253 12.8707 12.8601 13.6124 11.7501C14.3541 10.6401 14.75 9.33502 14.75 8C14.748 6.2104 14.0362 4.49466 12.7708 3.22922C11.5053 1.96378 9.78961 1.25199 8 1.25ZM6.69188 10.75H9.30813C9.02459 11.6137 8.5808 12.4163 8 13.1156C7.4192 12.4163 6.97541 11.6137 6.69188 10.75ZM6.33813 9.25C6.22063 8.42081 6.22063 7.57919 6.33813 6.75H9.66188C9.77938 7.57919 9.77938 8.42081 9.66188 9.25H6.33813ZM2.75 8C2.74998 7.57873 2.80098 7.15901 2.90188 6.75H4.82625C4.72458 7.58023 4.72458 8.41977 4.82625 9.25H2.90188C2.80098 8.84099 2.74998 8.42127 2.75 8ZM9.30813 5.25H6.69188C6.97541 4.38627 7.4192 3.58372 8 2.88438C8.5808 3.58372 9.02459 4.38627 9.30813 5.25ZM11.1738 6.75H13.0981C13.3006 7.57103 13.3006 8.42897 13.0981 9.25H11.1738C11.2754 8.41977 11.2754 7.58023 11.1738 6.75ZM12.47 5.25H10.875C10.6716 4.51628 10.3788 3.81036 10.0031 3.14812C11.0254 3.5729 11.8883 4.30815 12.47 5.25ZM6 3.14812C5.62323 3.81021 5.32936 4.51614 5.125 5.25H3.53C4.1125 4.30765 4.97659 3.57234 6 3.14812ZM3.53 10.75H5.125C5.32936 11.4839 5.62323 12.1898 6 12.8519C4.97659 12.4277 4.1125 11.6923 3.53 10.75ZM10.0031 12.8519C10.3788 12.1896 10.6716 11.4837 10.875 10.75H12.47C11.8883 11.6918 11.0254 12.4271 10.0031 12.8519Z"/> </symbol> <svg id="phone" viewBox="0 0 16 16" xmlns="http://www.w3.org/2000/svg"> <path d="M14 9.67473L11.0569 8.35535L11.0456 8.35035C10.8543 8.26788 10.6454 8.23467 10.4379 8.25378C10.2305 8.27289 10.0312 8.3437 9.85813 8.45973C9.83388 8.47596 9.81051 8.49349 9.78813 8.51223L8.39375 9.69973C7.58125 9.2591 6.74188 8.4266 6.30063 7.6241L7.49188 6.20785C7.51103 6.18499 7.52877 6.16099 7.545 6.13598C7.65799 5.96357 7.72659 5.7659 7.74469 5.56057C7.76279 5.35524 7.72984 5.14861 7.64875 4.9591C7.64683 4.95547 7.64516 4.95171 7.64375 4.94785L6.325 1.99973C6.21676 1.75318 6.03201 1.54803 5.7981 1.41464C5.5642 1.28126 5.29357 1.22672 5.02625 1.2591C4.11899 1.37828 3.28612 1.82365 2.68322 2.51201C2.08031 3.20037 1.74859 4.08466 1.75 4.99973C1.75 10.1004 5.89938 14.2497 11 14.2497C11.9151 14.2511 12.7994 13.9194 13.4877 13.3165C14.1761 12.7136 14.6214 11.8807 14.7406 10.9735C14.773 10.7062 14.7185 10.4355 14.5851 10.2016C14.4517 9.96772 14.2466 9.78297 14 9.67473ZM11 12.7497C8.94534 12.7472 6.97554 11.9299 5.52267 10.4771C4.0698 9.02419 3.25249 7.05439 3.25 4.99973C3.24857 4.48191 3.42437 3.97919 3.74818 3.57511C4.07199 3.17103 4.52432 2.88991 5.03 2.77848L6.20625 5.40348L5.00875 6.82973C4.9894 6.85279 4.97145 6.877 4.955 6.90223C4.83697 7.08257 4.76758 7.29037 4.75356 7.50545C4.73954 7.72053 4.78138 7.93559 4.875 8.12973C5.46375 9.33473 6.67688 10.5397 7.89438 11.1297C8.08982 11.2224 8.30595 11.2627 8.52165 11.2469C8.73736 11.231 8.94525 11.1594 9.125 11.0391C9.14917 11.0228 9.17234 11.0051 9.19438 10.986L10.5963 9.7941L13.2213 10.9697C13.1098 11.4754 12.8287 11.9277 12.4246 12.2516C12.0205 12.5754 11.5178 12.7512 11 12.7497Z" /> </svg> <svg id="email-company" viewBox="0 0 16 16" xmlns="http://www.w3.org/2000/svg"> <path d="M14 2.75H2C1.80109 2.75 1.61032 2.82902 1.46967 2.96967C1.32902 3.11032 1.25 3.30109 1.25 3.5V12C1.25 12.3315 1.3817 12.6495 1.61612 12.8839C1.85054 13.1183 2.16848 13.25 2.5 13.25H13.5C13.8315 13.25 14.1495 13.1183 14.3839 12.8839C14.6183 12.6495 14.75 12.3315 14.75 12V3.5C14.75 3.30109 14.671 3.11032 14.5303 2.96967C14.3897 2.82902 14.1989 2.75 14 2.75ZM12.0719 4.25L8 7.9825L3.92812 4.25H12.0719ZM2.75 11.75V5.205L7.49312 9.55313C7.63146 9.67997 7.81232 9.75033 8 9.75033C8.18768 9.75033 8.36854 9.67997 8.50688 9.55313L13.25 5.205V11.75H2.75Z" /> </svg> </svg> <bsp-header class="Page-header"> <div class="Page-header-hamburger-menu"> <div class="Page-header-hamburger-menu-wrapper"> <div class="Page-header-hamburger-menu-content"> <nav class="Navigation" data-nav-align="center"> <ul class="Navigation-items"> <li class="Navigation-items-item"><div class="NavigationItem has-menu"> <div class="NavigationItem-text"> <a href="https://www.biospace.com/news">News</a> <div class="NavigationItem-more"> <button aria-label="More"><svg class="chevron"><use xlink:href="#chevron-down"></use></svg></button> </div> </div> <ul class="NavigationItem-items"> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/drug-development"><span class="NavigationLink-text">Drug Development</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/fda"><span class="NavigationLink-text">FDA</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/drug-delivery"><span class="NavigationLink-text">Drug Delivery</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/deals"><span class="NavigationLink-text">Deals</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/business"><span class="NavigationLink-text">Business</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/policy"><span class="NavigationLink-text">Policy</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/cell-and-gene-therapy"><span class="NavigationLink-text">Cell and Gene Therapy</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/weight-loss"><span class="NavigationLink-text">Weight Loss</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/rare-diseases"><span class="NavigationLink-text">Rare Disease</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/cancer"><span class="NavigationLink-text">Cancer</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/job-trends"><span class="NavigationLink-text">Job Trends</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/artificial-intelligence"><span class="NavigationLink-text">Artificial Intelligence</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/nextgen"><span class="NavigationLink-text">NextGen: Top Start Ups to Watch</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/podcasts"><span class="NavigationLink-text">Podcasts</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/reports"><span class="NavigationLink-text">Reports</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/webinars"><span class="NavigationLink-text">Webinars</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/search-press-releases"><span class="NavigationLink-text">Press Releases</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/latest-news-press-releases"><span class="NavigationLink-text">All News & Releases</span></a> </li> </ul> </div> </li> <li class="Navigation-items-item"><div class="NavigationItem "> <div class="NavigationItem-text"> <a href="https://www.biospace.com/insights/">Insights</a> </div> </div> </li> <li class="Navigation-items-item"><div class="NavigationItem "> <div class="NavigationItem-text"> <a href="https://jobs.biospace.com/searchjobs/">Jobs</a> </div> </div> </li> <li class="Navigation-items-item"><div class="NavigationItem "> <div class="NavigationItem-text"> <a href="https://www.biospace.com/career-advice">Career Advice</a> </div> </div> </li> <li class="Navigation-items-item"><div class="NavigationItem "> <div class="NavigationItem-text"> <a href="https://www.biospace.com/companies">Companies</a> </div> </div> </li> <li class="Navigation-items-item"><div class="NavigationItem "> <div class="NavigationItem-text"> <a href="https://www.biospace.com/hotbeds">Hotbeds</a> </div> </div> </li> <li class="Navigation-items-item"><div class="NavigationItem has-menu"> <div class="NavigationItem-text"> <span>More</span> <div class="NavigationItem-more"> <button aria-label="More"><svg class="chevron"><use xlink:href="#chevron-down"></use></svg></button> </div> </div> <ul class="NavigationItem-items"> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/best-places-to-work"><span class="NavigationLink-text">Best Places to Work</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/employer-resources"><span class="NavigationLink-text">Employer Resources</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://employer.biospace.com/pricing/"><span class="NavigationLink-text">Post Jobs</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/talent-solutions"><span class="NavigationLink-text">Talent Solutions</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/advertise"><span class="NavigationLink-text">Advertise</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/press-release-solutions"><span class="NavigationLink-text">Submit a Press Release</span></a> </li> </ul> </div> </li> </ul> </nav> <div class="ButtonNavigation"> <a href="https://www.biospace.com/subscribe-to-newsletters" class="Button" data-theme="secondary">SUBSCRIBE</a> </div> </div> </div> </div> <div class="Page-header-bar"> <button class="Page-header-menu-trigger" aria-expanded="false"><svg class="burger-menu"><use xlink:href="#burger-menu"></use></svg><svg class="close-x"><use xlink:href="#close-x"></use></svg><span class="label">Menu</span></button> <div class="Page-header-bar-logo"><a aria-label="home page" href="/" > <picture> <source type="image/webp" width="250" height="67" srcset="https://static.biospace.com/dims4/default/9075aee/2147483647/strip/true/crop/496x132+0+0/resize/250x67!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fe4%2Fed%2F07b192644c508cbc301bc9ae721c%2Flogo.png 1x,https://static.biospace.com/dims4/default/b360a3f/2147483647/strip/true/crop/496x132+0+0/resize/500x134!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fe4%2Fed%2F07b192644c508cbc301bc9ae721c%2Flogo.png 2x"/> <source width="250" height="67" srcset="https://static.biospace.com/dims4/default/193f35f/2147483647/strip/true/crop/496x132+0+0/resize/250x67!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fe4%2Fed%2F07b192644c508cbc301bc9ae721c%2Flogo.png 1x,https://static.biospace.com/dims4/default/d12264c/2147483647/strip/true/crop/496x132+0+0/resize/500x134!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fe4%2Fed%2F07b192644c508cbc301bc9ae721c%2Flogo.png 2x"/> <img class="Image" alt="BioSpace logo" srcset="https://static.biospace.com/dims4/default/193f35f/2147483647/strip/true/crop/496x132+0+0/resize/250x67!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fe4%2Fed%2F07b192644c508cbc301bc9ae721c%2Flogo.png 1x,https://static.biospace.com/dims4/default/d12264c/2147483647/strip/true/crop/496x132+0+0/resize/500x134!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fe4%2Fed%2F07b192644c508cbc301bc9ae721c%2Flogo.png 2x" width="250" height="67" src="https://static.biospace.com/dims4/default/193f35f/2147483647/strip/true/crop/496x132+0+0/resize/250x67!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fe4%2Fed%2F07b192644c508cbc301bc9ae721c%2Flogo.png" > </picture> </a> </div> <div class="Page-header-button-navigation"> <a href="https://www.biospace.com/subscribe-to-newsletters" class="Button" data-theme="secondary">SUBSCRIBE</a> </div> <div class="Page-header-end"> <bsp-search-overlay class="SearchOverlay"> <button class="SearchOverlay-search-button"> <svg class="icon-magnify"> <use xlink:href="#icon-magnify"></use> </svg> <span class="sr-only"> Show Search </span> <svg class="close-x"> <use xlink:href="#close-x"></use> </svg> </button> </bsp-search-overlay> </div> </div> <div class="Page-header-navigation"> <nav class="Navigation" data-nav-align="center"> <ul class="Navigation-items"> <li class="Navigation-items-item"><div class="NavigationItem has-menu"> <div class="NavigationItem-text"> <a href="https://www.biospace.com/news">News</a> <div class="NavigationItem-more"> <button aria-label="More"><svg class="chevron"><use xlink:href="#chevron-down"></use></svg></button> </div> </div> <ul class="NavigationItem-items"> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/drug-development"><span class="NavigationLink-text">Drug Development</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/fda"><span class="NavigationLink-text">FDA</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/drug-delivery"><span class="NavigationLink-text">Drug Delivery</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/deals"><span class="NavigationLink-text">Deals</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/business"><span class="NavigationLink-text">Business</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/policy"><span class="NavigationLink-text">Policy</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/cell-and-gene-therapy"><span class="NavigationLink-text">Cell and Gene Therapy</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/weight-loss"><span class="NavigationLink-text">Weight Loss</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/rare-diseases"><span class="NavigationLink-text">Rare Disease</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/cancer"><span class="NavigationLink-text">Cancer</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/job-trends"><span class="NavigationLink-text">Job Trends</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/artificial-intelligence"><span class="NavigationLink-text">Artificial Intelligence</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/nextgen"><span class="NavigationLink-text">NextGen: Top Start Ups to Watch</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/podcasts"><span class="NavigationLink-text">Podcasts</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/reports"><span class="NavigationLink-text">Reports</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/webinars"><span class="NavigationLink-text">Webinars</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/search-press-releases"><span class="NavigationLink-text">Press Releases</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/latest-news-press-releases"><span class="NavigationLink-text">All News & Releases</span></a> </li> </ul> </div> </li> <li class="Navigation-items-item"><div class="NavigationItem "> <div class="NavigationItem-text"> <a href="https://www.biospace.com/insights/">Insights</a> </div> </div> </li> <li class="Navigation-items-item"><div class="NavigationItem "> <div class="NavigationItem-text"> <a href="https://jobs.biospace.com/searchjobs/">Jobs</a> </div> </div> </li> <li class="Navigation-items-item"><div class="NavigationItem "> <div class="NavigationItem-text"> <a href="https://www.biospace.com/career-advice">Career Advice</a> </div> </div> </li> <li class="Navigation-items-item"><div class="NavigationItem "> <div class="NavigationItem-text"> <a href="https://www.biospace.com/companies">Companies</a> </div> </div> </li> <li class="Navigation-items-item"><div class="NavigationItem "> <div class="NavigationItem-text"> <a href="https://www.biospace.com/hotbeds">Hotbeds</a> </div> </div> </li> <li class="Navigation-items-item"><div class="NavigationItem has-menu"> <div class="NavigationItem-text"> <span>More</span> <div class="NavigationItem-more"> <button aria-label="More"><svg class="chevron"><use xlink:href="#chevron-down"></use></svg></button> </div> </div> <ul class="NavigationItem-items"> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/best-places-to-work"><span class="NavigationLink-text">Best Places to Work</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/employer-resources"><span class="NavigationLink-text">Employer Resources</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://employer.biospace.com/pricing/"><span class="NavigationLink-text">Post Jobs</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/talent-solutions"><span class="NavigationLink-text">Talent Solutions</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/advertise"><span class="NavigationLink-text">Advertise</span></a> </li> <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/press-release-solutions"><span class="NavigationLink-text">Submit a Press Release</span></a> </li> </ul> </div> </li> </ul> </nav> </div> <div class="SearchOverlay-search-overlay"> <form class="SearchOverlay-search-form" action="https://www.biospace.com/search#nt=navsearch" novalidate="" autocomplete="off"> <label class="SearchOverlay-search-label"> <input placeholder="Keyword Search..." type="text" class="SearchOverlay-search-input" name="q" required="true"> <span class="sr-only"> Search Query </span> <button type="submit" class="SearchOverlay-search-submit"> <svg> <use xlink:href="#icon-magnify"></use> </svg> <span class="sr-only">Submit Search</span> </button> </label> </form> </div> </bsp-header> <div class="Page-above" data-modulewell><div id="googleAda79b544e-79c8-4b46-8a15-93a4e5924b31" data-module class="GoogleDfpAd" data-hide-on-mobile="true" data-slot-name="21692246607/biospace_article" data-slot-sizes="[[728, 90]]" data-slot-adSizeMap="[[[992, 1], [728, 90]]]" data-targeting-data="{"id":"00000193-6b74-d74b-a9db-6fff6ba20000","type":"article","tags":["Drug pricing"],"category":"Business","companies":["Eli Lilly and Company","Novo Nordisk","Pfizer","Vertex Pharmaceuticals","Amgen"]}"> <span class="GoogleDfpAd-placeholder"></span> </div> <div id="googleAd5714c2ab-d684-49bc-bcdf-2c8b1c079a7b" data-module class="GoogleDfpAd" data-hide-on-desktop="true" data-slot-name="21692246607/biospace_article" data-slot-sizes="[[300, 50]]" data-slot-adSizeMap="[[[320, 1], [300, 50]]]" data-targeting-data="{"id":"00000193-6b74-d74b-a9db-6fff6ba20000","type":"article","tags":["Drug pricing"],"category":"Business","companies":["Eli Lilly and Company","Novo Nordisk","Pfizer","Vertex Pharmaceuticals","Amgen"]}"> <span class="GoogleDfpAd-placeholder"></span> </div> </div> <div class="Page-content"> <div class="Page-twoColumn"> <main class="Page-main" data-module data-padding="none"> <div class="ArticlePage-lede"> <div class="ArticlePage-lede-content"> <div class="Page-breadcrumbs"><a class="Link" href="https://www.biospace.com/news">News</a>  <svg class="chevron"><use xlink:href="#chevron"></use></svg> <a class="Link" href="https://www.biospace.com/business">Business</a> </div> <h1 class="Page-headline">The Biggest Pharma Share Moves of the Year So Far</h1> <div class="ArticlePage-actions-wrapper"> <div class="Page-byline"><div class="Page-datePublished">November 27, 2024 <span class="divider">|</span> </div><div class="Page-readTime">9 min read <span class="divider">|</span> </div><div class="Page-authors"><a class="Link" href="https://www.biospace.com/annalee-armstrong">Annalee Armstrong</a></div></div> <div class="Page-actions"> <div class="ActionBar"> <ul class="ActionBar-items"> <li class="ActionBar-items-item"><a class="ActionLink" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.biospace.com%2Fbusiness%2Fthe-biggest-pharma-share-moves-of-the-year-so-far&text=The%20Biggest%20Pharma%20Share%20Moves%20of%20the%20Year%20So%20Far" target="_blank" data-social-service="twitter"> <svg><use xlink:href="#mono-icon-twitter" /></svg><span>Twitter</span> </a> </li> <li class="ActionBar-items-item"><a class="ActionLink" href="https://www.linkedin.com/shareArticle?url=https%3A%2F%2Fwww.biospace.com%2Fbusiness%2Fthe-biggest-pharma-share-moves-of-the-year-so-far&mini=true&title=The%20Biggest%20Pharma%20Share%20Moves%20of%20the%20Year%20So%20Far&summary=Eli%20Lilly%20topped%20the%20list%20of%20the%2020%20biggest%20pharmas%20by%20market%20cap%20with%20a%20more%20than%2039%25%20improvement%20year-to-date%20in%20its%20share%20price.%20Other%20companies%20have%20not%20been%20so%20lucky.&source=BioSpace" target="_blank" data-social-service="linkedin"> <svg><use xlink:href="#mono-icon-linkedin"></use></svg><span>LinkedIn</span> </a> </li> <li class="ActionBar-items-item"> <a class="ActionLink" href="https://www.facebook.com/dialog/share?app_id=2120989681618413&display=popup&href=https%3A%2F%2Fwww.biospace.com%2Fbusiness%2Fthe-biggest-pharma-share-moves-of-the-year-so-far" target="_blank" data-social-service="facebook"> <svg><use xlink:href="#mono-icon-facebook"></use></svg><span>Facebook</span> </a> </li> <li class="ActionBar-items-item"><a class="ActionLink" href="mailto:?subject=Check%20out%20this%20article%20on%20BioSpace&body=The%20Biggest%20Pharma%20Share%20Moves%20of%20the%20Year%20So%20Far%0A%0Ahttps%3A%2F%2Fwww.biospace.com%2Fbusiness%2Fthe-biggest-pharma-share-moves-of-the-year-so-far%0A%0AEli%20Lilly%20topped%20the%20list%20of%20the%2020%20biggest%20pharmas%20by%20market%20cap%20with%20a%20more%20than%2039%25%20improvement%20year-to-date%20in%20its%20share%20price.%20Other%20companies%20have%20not%20been%20so%20lucky." data-social-service="mailto"> <svg> <use xlink:href="#mono-icon-mailto"></use> </svg> <span> Email </span> </a> </li> <li class="ActionBar-items-item"><a class="ActionLink" href="javascript:window.print()" data-social-service="print"> <svg> <use xlink:href="#mono-icon-print"></use> </svg> <span> Print </span> </a> </li> </ul> </div> </div> </div> </div> </div> <div class="Page-lead"><figure class="Figure"> <picture> <source type="image/webp" width="1000" height="563" srcset="https://static.biospace.com/dims4/default/3520fa6/2147483647/strip/true/crop/1364x768+1+0/resize/568x320!/format/webp/quality/90/?url=https%3A%2F%2Fstatic.biospace.com%2Fa0%2Fc1%2F4c84971549e6a5f0e2465c08b5c6%2Fistock-1464159306.jpg 568w,https://static.biospace.com/dims4/default/f6fe421/2147483647/strip/true/crop/1364x768+1+0/resize/768x432!/format/webp/quality/90/?url=https%3A%2F%2Fstatic.biospace.com%2Fa0%2Fc1%2F4c84971549e6a5f0e2465c08b5c6%2Fistock-1464159306.jpg 768w,https://static.biospace.com/dims4/default/a069ed1/2147483647/strip/true/crop/1364x768+1+0/resize/1000x563!/format/webp/quality/90/?url=https%3A%2F%2Fstatic.biospace.com%2Fa0%2Fc1%2F4c84971549e6a5f0e2465c08b5c6%2Fistock-1464159306.jpg 1000w" sizes="(max-width: 800px) 100vw, 800px"/> <source width="1000" height="563" srcset="https://static.biospace.com/dims4/default/7dbee4e/2147483647/strip/true/crop/1364x768+1+0/resize/568x320!/quality/90/?url=https%3A%2F%2Fstatic.biospace.com%2Fa0%2Fc1%2F4c84971549e6a5f0e2465c08b5c6%2Fistock-1464159306.jpg 568w,https://static.biospace.com/dims4/default/9c8a8da/2147483647/strip/true/crop/1364x768+1+0/resize/768x432!/quality/90/?url=https%3A%2F%2Fstatic.biospace.com%2Fa0%2Fc1%2F4c84971549e6a5f0e2465c08b5c6%2Fistock-1464159306.jpg 768w,https://static.biospace.com/dims4/default/69592f4/2147483647/strip/true/crop/1364x768+1+0/resize/1000x563!/quality/90/?url=https%3A%2F%2Fstatic.biospace.com%2Fa0%2Fc1%2F4c84971549e6a5f0e2465c08b5c6%2Fistock-1464159306.jpg 1000w" sizes="(max-width: 800px) 100vw, 800px"/> <img class="Image" alt="Employees sitting on company graph, creating analytics" srcset="https://static.biospace.com/dims4/default/7dbee4e/2147483647/strip/true/crop/1364x768+1+0/resize/568x320!/quality/90/?url=https%3A%2F%2Fstatic.biospace.com%2Fa0%2Fc1%2F4c84971549e6a5f0e2465c08b5c6%2Fistock-1464159306.jpg 568w,https://static.biospace.com/dims4/default/9c8a8da/2147483647/strip/true/crop/1364x768+1+0/resize/768x432!/quality/90/?url=https%3A%2F%2Fstatic.biospace.com%2Fa0%2Fc1%2F4c84971549e6a5f0e2465c08b5c6%2Fistock-1464159306.jpg 768w,https://static.biospace.com/dims4/default/69592f4/2147483647/strip/true/crop/1364x768+1+0/resize/1000x563!/quality/90/?url=https%3A%2F%2Fstatic.biospace.com%2Fa0%2Fc1%2F4c84971549e6a5f0e2465c08b5c6%2Fistock-1464159306.jpg 1000w" sizes="(max-width: 800px) 100vw, 800px" width="1000" height="563" src="https://static.biospace.com/dims4/default/69592f4/2147483647/strip/true/crop/1364x768+1+0/resize/1000x563!/quality/90/?url=https%3A%2F%2Fstatic.biospace.com%2Fa0%2Fc1%2F4c84971549e6a5f0e2465c08b5c6%2Fistock-1464159306.jpg" > </picture> <div class="Figure-content"><div class="Figure-credit"><p>iStock, <span class="LinkEnhancement"><a class="Link" href="https://www.istockphoto.com/photo/contemporary-art-collage-conceptual-design-making-financial-strategy-employees-gm1464159306-496926539" target="_blank" rel="noopener">master1305</a></span></p></div></div> </figure> </div> <div class="Page-articleBody"> <h2 class="Page-subHeadline">Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share price. Other companies have not been so lucky. </h2> <div class="RichTextArticleBody RichTextBody"> <p>The most dramatic positive share moves of the year for the top pharma companies tell compelling stories of blockbuster drug sales, exciting drug approvals and competitor misses. And on the flip side, companies with noticeable dips in share prices faced clinical failures, market pressures and looming patent expirations.</p><p>Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share price. It’s no surprise, with blockbuster Zepbound approved for weight loss at the end of 2023. Lilly also seemingly flew just below the radar of Congress, which continues to push for lower drug prices, as rival Novo Nordisk <span class="LinkEnhancement"><a class="Link" href="https://www.biospace.com/policy/novo-ceo-sanders-to-face-off-over-us-prices-for-ozempic-and-wegovy">landed right in the crosshairs</a></span> of Sen. Bernie Sanders.</p><p>Looking at companies that haven’t been as successful, Pfizer has fallen over 10% this year amid pressures from an activist investor. Merck, nearing a patent cliff for cancer juggernaut Keytruda, has fallen more than 7%.</p><div class="Enhancement" data-align-center> <div class="Enhancement-item"><iframe src="https://flo.uri.sh/visualisation/20418285/embed" frameborder="0" scrolling="no" height="575" width="700" style="width:100%;" title="Interactive or visual content"></iframe></div> </div><p>Below, we recap the stories behind the share moves for six pharmas this year.</p><p><i>All market cap and share moves are as of Tuesday afternoon at 1:30 p.m. ET. Share price is previous day’s close. </i></p><p></p><p></p><div class="RichTextHeading"> <h3>Eli Lilly</h3> </div> <p><i>YTD Share Change: </i>37%<br><i>Market Cap:</i> $716.2 billion<br><i>Share Price:</i> $755</p><p>Lilly’s market cap has grown by $162.8 billion since December 31, 2023. With its stock peaking in September at around $960 per share, Lilly can definitely call this year a win.</p><p>Shareholders can too. They have received over $1.6 billion in dividends and share repurchases, CEO David Ricks noted on a third-quarter earnings call.</p><p>Driving Lilly’s share rally is its obesity portfolio, which began with the November 2023 approval of Zepbound (tirzepatide) by the FDA. As of the end of September, Zepbound was approved in 10 countries with launches in 12 more to come, according to the company. Lilly management told Leerink Partners analysts that China is a near-term priority, with that launch potentially coming in 2025.</p><p>Once again, though, Lilly is behind rival Novo Nordisk, which recently launched its obesity therapy Wegovy (semaglutide) in China. Wegovy also enjoyed frontrunner advantage in the U.S. market following Wegovy’s FDA approval in June 2021, though Lilly is gaining ground fast.</p><p>Leerink Partners said the sky is the limit for Lilly’s shares. The positive news flow in obesity and diabetes is expected to continue, with further health benefits confirmed as research rolls out. The company also has a robust pipeline of obesity meds, including additional GLP-1 options such as oral orforglipron and another injectable, retatrutide, with Phase III results expected in 2025 and 2026, respectively.</p><p>Lilly is also <span class="LinkEnhancement"><a class="Link" href="https://www.biospace.com/business/lilly-and-novo-spend-billions-to-expand-obesity-pipelines-beyond-glp-1s" target="_blank" rel="noopener"><u>spending cash</u></a></span> to bring in more pipeline assets, executing licensing deals in the past year with <span class="LinkEnhancement"><a class="Link" href="https://www.biospace.com/lilly-fauna-bio-ink-potential-494m-deal-to-find-obesity-drugs" target="_blank" rel="noopener"><u>Fauna Bio</u></a></span> and <span class="LinkEnhancement"><a class="Link" href="https://www.biospace.com/deals/lilly-haya-ink-potential-1b-drug-discovery-deal-to-target-obesity-and-metabolic-conditions" target="_blank" rel="noopener"><u>Haya Therapeutics</u></a></span> as well as buying out <span class="LinkEnhancement"><a class="Link" href="https://investor.lilly.com/news-releases/news-release-details/lilly-acquire-versanis-improve-patient-outcomes-cardiometabolic" target="_blank" rel="noopener"><u>Versanis Bio</u></a></span> and <span class="LinkEnhancement"><a class="Link" href="https://www.biospace.com/business/lilly-pays-3-2b-to-buy-morphic-and-deepen-immunology-gastro-portfolio" target="_blank" rel="noopener"><u>Morphic Holding</u></a></span>.</p><p>And then there’s Alzheimer’s, where Lilly just received approval for disease-modifying treatment Kisunla. The FDA nod puts Lilly up against Biogen and Eisai’s Leqembi.</p><p>Pressures to Lilly’s stock include pricing queries, slowing demand and payer constraints, Leerink Partners noted. There’s also a ton of impending competition beyond Novo, such as Amgen’s obesity candidate MariTide, which is moving into Phase III trials following a hotly anticipated readout this week.</p><p></p><p></p><div class="RichTextHeading"> <h3>Pfizer</h3> </div> <p><i>YTD Share Change:</i> -10.77%<br><i>Market Cap</i>: $145.6 billion<br><i>Share Price:</i> $26.17</p><p>Pfizer is undergoing a “normalization” of its COVID-19 business, Leerink Partners wrote in a note to clients earlier this month. But is there anything normal about what happened with Pfizer’s COVID franchise?</p><p>Perhaps a better way to put it is that the New York pharma is out of the honeymoon phase that occurred after it developed the first approved COVID-19 vaccine, Comirnaty, and followed that up with one of the most widely used therapeutics, Paxlovid. While both are still in use, the franchise has faced significant headwinds as the pandemic waned and vaccination rates dropped.</p><p>The company’s shares hit a high of about $60 in December 2021. This year, they have sunk more than 9% to where they currently sit at around $26. The decline has led <span class="LinkEnhancement"><a class="Link" href="https://www.biospace.com/business/analysts-rally-around-pfizer-ceo-amid-starboard-challenge" target="_blank" rel="noopener"><u>activist investor Starboard Value</u></a></span> to come out of the woodwork to push for change, specifically pointing the finger at CEO Albert Bourla. But that campaign faded just as quickly as it sprung up after Pfizer reported a third quarter <span class="LinkEnhancement"><a class="Link" href="https://www.biospace.com/business/pfizer-exceeds-wall-streets-q3-expectations-amid-activist-investor-pressure" target="_blank" rel="noopener"><u>earnings beat</u></a></span>.</p><p>Leerink Partners said that Pfizer has been successful this year in transitioning Paxlovid from a U.S. government market model to the commercial market, where it will rely on disease outbreaks rather than large purchase orders from governments.</p><p>Elsewhere, Pfizer has products like Eliquis that are driving revenue; however, that therapy was one of the drugs picked for the first round of Medicare drug price negotiations. But Guggenheim analyst Vamil Divan warned after the earnings release at the end of the October that investors are still worried about the stiff patent cliffs that Pfizer is facing across its portfolio.</p><p>Just this week, another competitor hit Pfizer’s portfolio, with BridgeBio receiving an <span class="LinkEnhancement"><a class="Link" href="https://www.biospace.com/drug-development/attr-cm-approval-for-bridgebio-could-trigger-tight-race-with-pfizer">FDA nod for Attruby</a></span> in transthyretin amyloid cardiomyopathy. Pfizer markets tafamidis as Vyndaqel and Vyndamax in the heart indication, while Alnylam has Amvuttra, currently approved for ATTR amyloidosis and under review by the FDA in ATTR-CM <span class="LinkEnhancement"><a class="Link" href="https://www.biospace.com/drug-development/days-after-bridgebio-approval-fda-agrees-to-review-alnylams-amvuttra-in-attr-cm">as of this week</a></span>. Pfizer is also in a tight race with GSK and now Moderna in the repiratory syncytial virus vaccine market.</p><p>Earlier in the pipeline, Pfizer is expecting results for an oral obesity candidate called danuglipron early in 2025. This will be a defining moment, as a win could catapult Pfizer back into the big leagues alongside Eli Lilly and Novo Nordisk.</p><p></p><div class="RichTextHeading"> <h3>Amgen</h3> </div> <p><i>YTD Share Change: </i>-5.92%<br><i>Market Cap</i>: $145.6 billion<br><i>Share Price</i>: $294</p><p>Treading around a share decline of about 1.22% last week, Amgen’s stock took a steep turn on Tuesday. Keenly awaited data from the Phase II MariTide study showed <span class="LinkEnhancement"><a class="Link" href="https://www.biospace.com/drug-development/bulls-disappointed-as-amgens-maritide-demonstrates-20-weight-loss">weight loss of 20%</a></span>, on the low end of analyst expectations. The data were comparable to Phase III results for Lilly’s tirzepatide in a similar population.</p><p>The news sent the company’s shares down 8% to $270.79 apiece on Tuesday, losing about $23 in value. BMO Capital Markets’ Evan Seigerman had called the pending readout a “make or break” moment for Amgen’s shares. That certainly seems to be the case. At the end of Tuesday, about $7.53 billion in market cap had been wiped out.</p><p></p><p></p><p>Jefferies urged investors to keep calm and carry on, to buy the dip and understand that beating the incumbent therapies was always going to be tough for Amgen. With so much anticipation and competition in this space, a clear beat was unlikely.</p><p>“The setup was always going to be challenging: obesity trade has been difficult and other peers have all traded down recently, market has high expectations on ‘differentiation’ and Wall Street always wants higher efficacy,” Jefferies wrote.</p><p>The firm expects Amgen’s stock to slowly creep back to normal “as investors digest” the data.</p><p>Prior to the readout, BMO’s Seigerman summed up the stakes for MariTide: “Investors have been whipsawed through the MariTide development story throughout 2024. With potentially $60 billion in market cap on the line, the stakes couldn’t be higher...gotta love year-end biotech readouts!”</p><p></p><div class="RichTextHeading"> <h3>Vertex</h3> </div> <p><i>YTD Share Change:</i> 13.35%<br><i>Market Cap</i>: $118.6 billion<br><i>Share Price</i>: $461</p><p>Vertex is the undisputed leader in cystic fibrosis (CF), with products such as Trikafta, Kalydeco, Symdeko and now Casgevy following its late 2023 approval, and it seems that franchise still has room to grow. William Blair’s analysts were pleased to see the company raise guidance after the third quarter.</p><p>Vertex will also start to see revenue from the gene therapy Casgevy, which it developed in partnership with CRISPR Therapeutics. Patients have finally begun receiving infusions of the sickle cell disease treatment. The CF franchise is moving from $9 billion yearly revenue toward William Blair’s estimate of $12 billion in peak sales.</p><p>In addition, 2025 stands to be a big year for Vertex on the regulatory front, with two FDA decision dates coming up in January, for the CF drug vanzacaftor triple (vanza triple) and oral pain med suzetrigine. That means Vertex could have two launches at the beginning of 2025. The pain therapy is perhaps the most exciting, with so much room in that market for non-addictive and more tolerable options.</p><p></p><p></p><div class="RichTextHeading"> <h2>Merck</h2> </div> <p><i>YTD Share Change:</i> -7.46%<br><i>Market Cap</i>: $255.5 billion<br><i>Share Price</i>: $101</p><p>Merck’s story has been defined by Keytruda for years—and rightfully so. The mega-blockbuster has reinvented the cancer space, spidering off into dozens of indications, with a clinical program still churning out data in an attempt to garner even more FDA clearances.</p><p>But in recent years, the tenor has changed. Investors have wanted to know what’s next. This year especially has brought news that Keytruda may have finally hit its limit, with failures or trial discontinuations in <span class="LinkEnhancement"><a class="Link" href="https://www.biospace.com/drug-development/mercks-keytruda-combo-fails-in-phase-iii-colorectal-cancer-study" target="_blank" rel="noopener"><u>colorectal cancer</u></a></span>, <span class="LinkEnhancement"><a class="Link" href="https://www.biospace.com/drug-development/merck-axes-two-keytruda-phase-iii-cancer-trials-due-to-disappointing-data" target="_blank" rel="noopener"><u>non-small cell lung cancer</u></a></span>, cutaneous squamous cell carcinoma and <span class="LinkEnhancement"><a class="Link" href="https://www.biospace.com/drug-development/merck-halts-phase-iii-trial-of-keytruda-anti-tigit-combo-in-small-cell-lung-cancer" target="_blank" rel="noopener"><u>small cell lung cancer</u></a></span>.</p><p>Merck’s shares have been on the slide since July, when executives <span class="LinkEnhancement"><a class="Link" href="https://www.merck.com/news/merck-announces-second-quarter-2024-financial-results/" target="_blank" rel="noopener"><u>revealed a delay</u></a></span> in shipments of HPV vaccine Gardasil in China. CFO Caroline Litchfield said the slow down may mean that Merck will ship fewer than its full-year contracted doses by the end of the year. The Chinese market represents about 60–70% of Gardasil’s sales, CEO Robert Davis said on the second quarter call. The vaccine brought in $2.31 billion in the <span class="LinkEnhancement"><a class="Link" href="https://www.merck.com/news/merck-announces-third-quarter-2024-financial-results/" target="_blank" rel="noopener"><u>third quarter</u></a></span>, down 11% from the year prior as demand continued to decline in China.</p><p>BMO Capital Markets analysts see some glimmer of hope in Merck’s pipeline, though, especially a 2023 partnership with ADC expert Daiichi Sankyo (also among this year’s top pharma movers; see chart above). Merck’s Prometheus buyout for a clutch of inflammation and immunology assets and prospects in the cardiovascular portfolio also has a lot of potential, according to the firm.</p><p>Earlier this week, Merck announced that a Phase III trial for Winrevair in pulmonary arterial hypertension in a broader population was stopped early because of overwhelming efficacy. The company plans to submit the data to the FDA to expand the drug’s label, which already includes patients with group I PAH. Sales of the drug have already hit $219 million this year, BMO reported.</p><p></p><div class="RichTextHeading"> <h3>Novo Nordisk</h3> </div> <p><i>YTD Share Change:</i> 2.76%<br><i>Market Cap</i>: $475.5 billion<br><i>Share Price</i>: $104</p><p>Novo’s market cap has risen substantially over the past couple of years following its Wegovy approval. It hit a high of $642.9 billion in June of this year, with all of 2024 resembling a rolling hill, not unlike some found in the rural countryside of its Danish homeland. In June, Novo’s shares peaked at about $127 apiece, but have since fallen back to near the $106 where they started the year.</p><p>Its ups and downs over the past year track with the news flow surrounding the GLP-1 space. Novo bumped up on Tuesday with a two-pronged hit of positive news: the Biden administration proposed covering weight loss drugs for patients on Medicare and Medicaid and Amgen’s MariTide weight loss data ended up on the low end of expectations.</p><p>This pharma, which is literally <span class="LinkEnhancement"><a class="Link" href="https://www.wsj.com/economy/central-banking/americas-obsession-with-weight-loss-drugs-is-affecting-the-economy-of-denmark-22797e5c?mod=hp_lead_pos4" target="_blank" rel="noopener"><u>remaking its country</u></a></span>’s<span class="LinkEnhancement"><a class="Link" href="https://www.wsj.com/economy/central-banking/americas-obsession-with-weight-loss-drugs-is-affecting-the-economy-of-denmark-22797e5c?mod=hp_lead_pos4" target="_blank" rel="noopener"><u> fortunes</u></a></span>, will be a headline story for years to come.<br></p> </div> </div> <div class="Page-articleBelow"> <div class="Page-actions-bottom"> <div class="Page-actions"> <div class="ActionBar"> <ul class="ActionBar-items"> <li class="ActionBar-items-item"><a class="ActionLink" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.biospace.com%2Fbusiness%2Fthe-biggest-pharma-share-moves-of-the-year-so-far&text=The%20Biggest%20Pharma%20Share%20Moves%20of%20the%20Year%20So%20Far" target="_blank" data-social-service="twitter"> <svg><use xlink:href="#mono-icon-twitter" /></svg><span>Twitter</span> </a> </li> <li class="ActionBar-items-item"><a class="ActionLink" href="https://www.linkedin.com/shareArticle?url=https%3A%2F%2Fwww.biospace.com%2Fbusiness%2Fthe-biggest-pharma-share-moves-of-the-year-so-far&mini=true&title=The%20Biggest%20Pharma%20Share%20Moves%20of%20the%20Year%20So%20Far&summary=Eli%20Lilly%20topped%20the%20list%20of%20the%2020%20biggest%20pharmas%20by%20market%20cap%20with%20a%20more%20than%2039%25%20improvement%20year-to-date%20in%20its%20share%20price.%20Other%20companies%20have%20not%20been%20so%20lucky.&source=BioSpace" target="_blank" data-social-service="linkedin"> <svg><use xlink:href="#mono-icon-linkedin"></use></svg><span>LinkedIn</span> </a> </li> <li class="ActionBar-items-item"> <a class="ActionLink" href="https://www.facebook.com/dialog/share?app_id=2120989681618413&display=popup&href=https%3A%2F%2Fwww.biospace.com%2Fbusiness%2Fthe-biggest-pharma-share-moves-of-the-year-so-far" target="_blank" data-social-service="facebook"> <svg><use xlink:href="#mono-icon-facebook"></use></svg><span>Facebook</span> </a> </li> <li class="ActionBar-items-item"><a class="ActionLink" href="mailto:?subject=Check%20out%20this%20article%20on%20BioSpace&body=The%20Biggest%20Pharma%20Share%20Moves%20of%20the%20Year%20So%20Far%0A%0Ahttps%3A%2F%2Fwww.biospace.com%2Fbusiness%2Fthe-biggest-pharma-share-moves-of-the-year-so-far%0A%0AEli%20Lilly%20topped%20the%20list%20of%20the%2020%20biggest%20pharmas%20by%20market%20cap%20with%20a%20more%20than%2039%25%20improvement%20year-to-date%20in%20its%20share%20price.%20Other%20companies%20have%20not%20been%20so%20lucky." data-social-service="mailto"> <svg> <use xlink:href="#mono-icon-mailto"></use> </svg> <span> Email </span> </a> </li> <li class="ActionBar-items-item"><a class="ActionLink" href="javascript:window.print()" data-social-service="print"> <svg> <use xlink:href="#mono-icon-print"></use> </svg> <span> Print </span> </a> </li> </ul> </div> </div> </div> <div class="Page-tags"> <a class="Button" data-size="small" data-style="pill" data-theme="secondary" href="https://www.biospace.com/drug-pricing" >Drug pricing</a> </div> <div class="Page-tags Page-companies"> <a class="Button" data-size="small" data-style="pill" data-theme="secondary" href="https://www.biospace.com/employer/395010/eli-lilly-and-company" >Eli Lilly and Company</a> <a class="Button" data-size="small" data-style="pill" data-theme="secondary" href="https://www.biospace.com/employer/545568/novo-nordisk" >Novo Nordisk</a> <a class="Button" data-size="small" data-style="pill" data-theme="secondary" href="https://www.biospace.com/employer/394762/pfizer" >Pfizer</a> <a class="Button" data-size="small" data-style="pill" data-theme="secondary" href="https://www.biospace.com/employer/395035/vertex-pharmaceuticals" >Vertex Pharmaceuticals</a> <a class="Button" data-size="small" data-style="pill" data-theme="secondary" href="https://www.biospace.com/employer/247739/amgen" >Amgen</a> </div> <div class="Page-authorInfo"> <div class="Author"> <div class="Author-image"> <a href="https://www.biospace.com/annalee-armstrong"> <picture> <source type="image/webp" width="100" height="100" srcset="https://static.biospace.com/dims4/default/d7702e9/2147483647/strip/true/crop/814x814+0+136/resize/100x100!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F7f%2Fec%2Fc5c8cb664814929f5b56ccee83e6%2F5e7219dc-ab50-41ec-9a8f-35771e48c041-1-105-c.jpeg 1x,https://static.biospace.com/dims4/default/3796a16/2147483647/strip/true/crop/814x814+0+136/resize/200x200!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F7f%2Fec%2Fc5c8cb664814929f5b56ccee83e6%2F5e7219dc-ab50-41ec-9a8f-35771e48c041-1-105-c.jpeg 2x"/> <source width="100" height="100" srcset="https://static.biospace.com/dims4/default/42863a3/2147483647/strip/true/crop/814x814+0+136/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F7f%2Fec%2Fc5c8cb664814929f5b56ccee83e6%2F5e7219dc-ab50-41ec-9a8f-35771e48c041-1-105-c.jpeg 1x,https://static.biospace.com/dims4/default/08bdf22/2147483647/strip/true/crop/814x814+0+136/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F7f%2Fec%2Fc5c8cb664814929f5b56ccee83e6%2F5e7219dc-ab50-41ec-9a8f-35771e48c041-1-105-c.jpeg 2x"/> <img class="Image" alt="Annalee Armstrong" srcset="https://static.biospace.com/dims4/default/42863a3/2147483647/strip/true/crop/814x814+0+136/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F7f%2Fec%2Fc5c8cb664814929f5b56ccee83e6%2F5e7219dc-ab50-41ec-9a8f-35771e48c041-1-105-c.jpeg 1x,https://static.biospace.com/dims4/default/08bdf22/2147483647/strip/true/crop/814x814+0+136/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F7f%2Fec%2Fc5c8cb664814929f5b56ccee83e6%2F5e7219dc-ab50-41ec-9a8f-35771e48c041-1-105-c.jpeg 2x" width="100" height="100" src="https://static.biospace.com/dims4/default/42863a3/2147483647/strip/true/crop/814x814+0+136/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F7f%2Fec%2Fc5c8cb664814929f5b56ccee83e6%2F5e7219dc-ab50-41ec-9a8f-35771e48c041-1-105-c.jpeg" loading="lazy" > </picture> </a> </div> <div class="Author-content"> <div class="Author-name"> <a href="https://www.biospace.com/annalee-armstrong"> <picture> <source type="image/webp" width="100" height="100" srcset="https://static.biospace.com/dims4/default/d7702e9/2147483647/strip/true/crop/814x814+0+136/resize/100x100!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F7f%2Fec%2Fc5c8cb664814929f5b56ccee83e6%2F5e7219dc-ab50-41ec-9a8f-35771e48c041-1-105-c.jpeg 1x,https://static.biospace.com/dims4/default/3796a16/2147483647/strip/true/crop/814x814+0+136/resize/200x200!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F7f%2Fec%2Fc5c8cb664814929f5b56ccee83e6%2F5e7219dc-ab50-41ec-9a8f-35771e48c041-1-105-c.jpeg 2x"/> <source width="100" height="100" srcset="https://static.biospace.com/dims4/default/42863a3/2147483647/strip/true/crop/814x814+0+136/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F7f%2Fec%2Fc5c8cb664814929f5b56ccee83e6%2F5e7219dc-ab50-41ec-9a8f-35771e48c041-1-105-c.jpeg 1x,https://static.biospace.com/dims4/default/08bdf22/2147483647/strip/true/crop/814x814+0+136/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F7f%2Fec%2Fc5c8cb664814929f5b56ccee83e6%2F5e7219dc-ab50-41ec-9a8f-35771e48c041-1-105-c.jpeg 2x"/> <img class="Image" alt="Annalee Armstrong" srcset="https://static.biospace.com/dims4/default/42863a3/2147483647/strip/true/crop/814x814+0+136/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F7f%2Fec%2Fc5c8cb664814929f5b56ccee83e6%2F5e7219dc-ab50-41ec-9a8f-35771e48c041-1-105-c.jpeg 1x,https://static.biospace.com/dims4/default/08bdf22/2147483647/strip/true/crop/814x814+0+136/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F7f%2Fec%2Fc5c8cb664814929f5b56ccee83e6%2F5e7219dc-ab50-41ec-9a8f-35771e48c041-1-105-c.jpeg 2x" width="100" height="100" src="https://static.biospace.com/dims4/default/42863a3/2147483647/strip/true/crop/814x814+0+136/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F7f%2Fec%2Fc5c8cb664814929f5b56ccee83e6%2F5e7219dc-ab50-41ec-9a8f-35771e48c041-1-105-c.jpeg" loading="lazy" > </picture> <span>Annalee Armstrong</span></a> </div> <div class="Author-bio RichTextBody"> Annalee Armstrong is senior editor at <i>BioSpace</i>. You can reach her at  <span class="LinkEnhancement"><a class="Link" href="mailto:annalee.armstrong@biospace.com" target="_blank" rel="noopener">annalee.armstrong@biospace.com</a></span>. Follow her on <span class="LinkEnhancement"><a class="Link" href="https://www.linkedin.com/in/annalee-armstrong/" target="_blank" rel="noopener">LinkedIn</a></span>. </div> </div> </div> </div> </div> </main> <aside class="Page-aside"> <div id="googleAd1ce21c32-0b77-469f-95de-39cef8f0a15a" data-module class="GoogleDfpAd" data-slot-name="21692246607/biospace_article" data-slot-sizes="[[300, 600]]" data-slot-adSizeMap="[[[320, 1], [300, 600]]]" data-targeting-data="{"id":"00000193-6b74-d74b-a9db-6fff6ba20000","type":"article","tags":["Drug pricing"],"category":"Business","companies":["Eli Lilly and Company","Novo Nordisk","Pfizer","Vertex Pharmaceuticals","Amgen"]}"> <span class="GoogleDfpAd-placeholder"></span> </div> <div class="PageListRightRailB" data-module data-show-loadmore="true" data-module-title-size="3"> <a class="AnchorLink" href="#latest" id="latest" name="latest"></a> <div class="ModuleHeader"> <div class="ModuleHeader-title">LATEST</div> </div> <ul class="PageList-items" data-with-borders> <li class="PageList-items-item"> <div class="PagePromo" data-image-align-vertical="top" data-image-align-horizontal="right"> <div class="PagePromo-media"><a class="Link" aria-label="Return-to-Office Movement Should Give Life Sciences Employers Pause" href="https://www.biospace.com/job-trends/return-to-office-movement-should-give-life-sciences-employers-pause" ><picture> <source type="image/webp" width="100" height="100" srcset="https://static.biospace.com/dims4/default/deae96a/2147483647/strip/true/crop/836x836+209+0/resize/100x100!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fcc%2F63%2F3dfad74f454b8e37cc5b4ed02ad7%2Fistock-2176089283.jpg 1x,https://static.biospace.com/dims4/default/5be4d88/2147483647/strip/true/crop/836x836+209+0/resize/200x200!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fcc%2F63%2F3dfad74f454b8e37cc5b4ed02ad7%2Fistock-2176089283.jpg 2x"/> <source width="100" height="100" srcset="https://static.biospace.com/dims4/default/f861d14/2147483647/strip/true/crop/836x836+209+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fcc%2F63%2F3dfad74f454b8e37cc5b4ed02ad7%2Fistock-2176089283.jpg 1x,https://static.biospace.com/dims4/default/ddfb6f8/2147483647/strip/true/crop/836x836+209+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fcc%2F63%2F3dfad74f454b8e37cc5b4ed02ad7%2Fistock-2176089283.jpg 2x"/> <img class="Image" alt="Collage showing workspace concept with person’s hands at computer, a globe and a clock" srcset="https://static.biospace.com/dims4/default/f861d14/2147483647/strip/true/crop/836x836+209+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fcc%2F63%2F3dfad74f454b8e37cc5b4ed02ad7%2Fistock-2176089283.jpg 1x,https://static.biospace.com/dims4/default/ddfb6f8/2147483647/strip/true/crop/836x836+209+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fcc%2F63%2F3dfad74f454b8e37cc5b4ed02ad7%2Fistock-2176089283.jpg 2x" width="100" height="100" src="https://static.biospace.com/dims4/default/f861d14/2147483647/strip/true/crop/836x836+209+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fcc%2F63%2F3dfad74f454b8e37cc5b4ed02ad7%2Fistock-2176089283.jpg" loading="lazy" > </picture> </a></div> <div class="PagePromo-content"> <div class="PagePromo-category"> <a class="Link" href="https://www.biospace.com/staff-editorial">Editorial</a> </div> <div class="PagePromo-title"> <a class="Link" href="https://www.biospace.com/job-trends/return-to-office-movement-should-give-life-sciences-employers-pause">Return-to-Office Movement Should Give Life Sciences Employers Pause</a> </div> <div class="PagePromo-byline"><div class="PagePromo-date">March 11, 2025</div><span class="dot"> · </span><div class="PagePromo-readTime">4 min read</div><span class="dot"> · </span><div class="PagePromo-author"><a class="Link" href="https://www.biospace.com/angela-gabriel">Angela Gabriel</a></div></div> </div> </div> </li> <li class="PageList-items-item"> <div class="PagePromo" data-image-align-vertical="top" data-image-align-horizontal="right"> <div class="PagePromo-media"><a class="Link" aria-label="Mineralys’ Hypertension Drug Drops Blood Pressure in Phase II/III, Setting Up Market Clash" href="https://www.biospace.com/drug-development/mineralys-hypertension-drug-drops-blood-pressure-in-phase-ii-iii-setting-up-market-clash" ><picture> <source type="image/webp" width="100" height="100" srcset="https://static.biospace.com/dims4/default/95ecbae/2147483647/strip/true/crop/1414x1414+354+0/resize/100x100!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fab%2F2a%2F609cfbee470f8d694dab8601d23e%2Fistock-1295615803.jpg 1x,https://static.biospace.com/dims4/default/8386480/2147483647/strip/true/crop/1414x1414+354+0/resize/200x200!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fab%2F2a%2F609cfbee470f8d694dab8601d23e%2Fistock-1295615803.jpg 2x"/> <source width="100" height="100" srcset="https://static.biospace.com/dims4/default/cc8d41f/2147483647/strip/true/crop/1414x1414+354+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fab%2F2a%2F609cfbee470f8d694dab8601d23e%2Fistock-1295615803.jpg 1x,https://static.biospace.com/dims4/default/8f32ae8/2147483647/strip/true/crop/1414x1414+354+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fab%2F2a%2F609cfbee470f8d694dab8601d23e%2Fistock-1295615803.jpg 2x"/> <img class="Image" alt="Tiny doctors examining heart health flat vector illustration. Cartoon medical specialists doing checkup of blood pressure, pulse rate and cholesterol. Cardiovascular disease and cardiology concept" srcset="https://static.biospace.com/dims4/default/cc8d41f/2147483647/strip/true/crop/1414x1414+354+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fab%2F2a%2F609cfbee470f8d694dab8601d23e%2Fistock-1295615803.jpg 1x,https://static.biospace.com/dims4/default/8f32ae8/2147483647/strip/true/crop/1414x1414+354+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fab%2F2a%2F609cfbee470f8d694dab8601d23e%2Fistock-1295615803.jpg 2x" width="100" height="100" src="https://static.biospace.com/dims4/default/cc8d41f/2147483647/strip/true/crop/1414x1414+354+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fab%2F2a%2F609cfbee470f8d694dab8601d23e%2Fistock-1295615803.jpg" loading="lazy" > </picture> </a></div> <div class="PagePromo-content"> <div class="PagePromo-category"> <a class="Link" href="https://www.biospace.com/cardiovascular-disease">Cardiovascular disease</a> </div> <div class="PagePromo-title"> <a class="Link" href="https://www.biospace.com/drug-development/mineralys-hypertension-drug-drops-blood-pressure-in-phase-ii-iii-setting-up-market-clash">Mineralys’ Hypertension Drug Drops Blood Pressure in Phase II/III, Setting Up Market Clash</a> </div> <div class="PagePromo-byline"><div class="PagePromo-date">March 10, 2025</div><span class="dot"> · </span><div class="PagePromo-readTime">2 min read</div><span class="dot"> · </span><div class="PagePromo-author"><a class="Link" href="https://www.biospace.com/dan-samorodnitsky">Dan Samorodnitsky</a></div></div> </div> </div> </li> <li class="PageList-items-item"> <div class="PagePromo" data-image-align-vertical="top" data-image-align-horizontal="right"> <div class="PagePromo-media"><a class="Link" aria-label="Novo Dips After CagriSema’s Latest Lower-Than-Expected Weight Loss Readout" href="https://www.biospace.com/drug-development/novo-dips-after-cagrisemas-latest-lower-than-expected-weight-loss-readout" ><picture> <source type="image/webp" width="100" height="100" srcset="https://static.biospace.com/dims4/default/62a067b/2147483647/strip/true/crop/350x350+138+0/resize/100x100!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F92B444EE-D179-4EFC-ADED-FD90CC030876.jpg 1x,https://static.biospace.com/dims4/default/5a22cd9/2147483647/strip/true/crop/350x350+138+0/resize/200x200!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F92B444EE-D179-4EFC-ADED-FD90CC030876.jpg 2x"/> <source width="100" height="100" srcset="https://static.biospace.com/dims4/default/45ee216/2147483647/strip/true/crop/350x350+138+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F92B444EE-D179-4EFC-ADED-FD90CC030876.jpg 1x,https://static.biospace.com/dims4/default/5a1ee84/2147483647/strip/true/crop/350x350+138+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F92B444EE-D179-4EFC-ADED-FD90CC030876.jpg 2x"/> <img class="Image" alt="Pictured: Novo Nordisk's office in Fremont, California" srcset="https://static.biospace.com/dims4/default/45ee216/2147483647/strip/true/crop/350x350+138+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F92B444EE-D179-4EFC-ADED-FD90CC030876.jpg 1x,https://static.biospace.com/dims4/default/5a1ee84/2147483647/strip/true/crop/350x350+138+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F92B444EE-D179-4EFC-ADED-FD90CC030876.jpg 2x" width="100" height="100" src="https://static.biospace.com/dims4/default/45ee216/2147483647/strip/true/crop/350x350+138+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F92B444EE-D179-4EFC-ADED-FD90CC030876.jpg" loading="lazy" > </picture> </a></div> <div class="PagePromo-content"> <div class="PagePromo-category"> <a class="Link" href="https://www.biospace.com/weight-loss">Weight loss</a> </div> <div class="PagePromo-title"> <a class="Link" href="https://www.biospace.com/drug-development/novo-dips-after-cagrisemas-latest-lower-than-expected-weight-loss-readout">Novo Dips After CagriSema’s Latest Lower-Than-Expected Weight Loss Readout</a> </div> <div class="PagePromo-byline"><div class="PagePromo-date">March 10, 2025</div><span class="dot"> · </span><div class="PagePromo-readTime">2 min read</div><span class="dot"> · </span><div class="PagePromo-author"><a class="Link" href="https://www.biospace.com/tristan-manalac">Tristan Manalac</a></div></div> </div> </div> </li> <li class="PageList-items-item"> <div class="PagePromo" data-image-align-vertical="top" data-image-align-horizontal="right"> <div class="PagePromo-media"><a class="Link" aria-label="BMS’ Sotyktu Notches Phase III Win in Psoriatic Arthritis" href="https://www.biospace.com/drug-development/bms-sotyktu-notches-phase-iii-win-in-psoriatic-arthritis" ><picture> <source type="image/webp" width="100" height="100" srcset="https://static.biospace.com/dims4/default/a7e30dc/2147483647/strip/true/crop/1414x1414+278+0/resize/100x100!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F1a%2F0e%2F9378fae94063bee906776754a4b6%2Fistock-2160008492.jpg 1x,https://static.biospace.com/dims4/default/d5b8dcb/2147483647/strip/true/crop/1414x1414+278+0/resize/200x200!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F1a%2F0e%2F9378fae94063bee906776754a4b6%2Fistock-2160008492.jpg 2x"/> <source width="100" height="100" srcset="https://static.biospace.com/dims4/default/b3dbbf0/2147483647/strip/true/crop/1414x1414+278+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F1a%2F0e%2F9378fae94063bee906776754a4b6%2Fistock-2160008492.jpg 1x,https://static.biospace.com/dims4/default/de7e03a/2147483647/strip/true/crop/1414x1414+278+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F1a%2F0e%2F9378fae94063bee906776754a4b6%2Fistock-2160008492.jpg 2x"/> <img class="Image" alt="External view of Bristol Myers Squibb's office California" srcset="https://static.biospace.com/dims4/default/b3dbbf0/2147483647/strip/true/crop/1414x1414+278+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F1a%2F0e%2F9378fae94063bee906776754a4b6%2Fistock-2160008492.jpg 1x,https://static.biospace.com/dims4/default/de7e03a/2147483647/strip/true/crop/1414x1414+278+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F1a%2F0e%2F9378fae94063bee906776754a4b6%2Fistock-2160008492.jpg 2x" width="100" height="100" src="https://static.biospace.com/dims4/default/b3dbbf0/2147483647/strip/true/crop/1414x1414+278+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F1a%2F0e%2F9378fae94063bee906776754a4b6%2Fistock-2160008492.jpg" loading="lazy" > </picture> </a></div> <div class="PagePromo-content"> <div class="PagePromo-category"> <a class="Link" href="https://www.biospace.com/immunology-and-inflammation">Immunology and inflammation</a> </div> <div class="PagePromo-title"> <a class="Link" href="https://www.biospace.com/drug-development/bms-sotyktu-notches-phase-iii-win-in-psoriatic-arthritis">BMS’ Sotyktu Notches Phase III Win in Psoriatic Arthritis</a> </div> <div class="PagePromo-byline"><div class="PagePromo-date">March 10, 2025</div><span class="dot"> · </span><div class="PagePromo-readTime">2 min read</div><span class="dot"> · </span><div class="PagePromo-author"><a class="Link" href="https://www.biospace.com/tristan-manalac">Tristan Manalac</a></div></div> </div> </div> </li> <li class="PageList-items-item"> <div class="PagePromo" data-image-align-vertical="top" data-image-align-horizontal="right"> <div class="PagePromo-media"><a class="Link" aria-label="J&J’s Oral IL-23R Blocker Sets New Standard in Plaque Psoriasis, Beating BMS’ Sotyktu" href="https://www.biospace.com/drug-development/j-js-oral-il-23r-blocker-sets-new-standard-in-plaque-psoriasis-beating-bmss-sotyktu" ><picture> <source type="image/webp" width="100" height="100" srcset="https://static.biospace.com/dims4/default/e36dc81/2147483647/strip/true/crop/1490x1490+261+0/resize/100x100!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Ffe%2F69%2F8cd15be04d01bcca097f6acf632b%2Fistock-2158361110.jpg 1x,https://static.biospace.com/dims4/default/fa37a4b/2147483647/strip/true/crop/1490x1490+261+0/resize/200x200!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Ffe%2F69%2F8cd15be04d01bcca097f6acf632b%2Fistock-2158361110.jpg 2x"/> <source width="100" height="100" srcset="https://static.biospace.com/dims4/default/7993ea4/2147483647/strip/true/crop/1490x1490+261+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Ffe%2F69%2F8cd15be04d01bcca097f6acf632b%2Fistock-2158361110.jpg 1x,https://static.biospace.com/dims4/default/a0cee4f/2147483647/strip/true/crop/1490x1490+261+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Ffe%2F69%2F8cd15be04d01bcca097f6acf632b%2Fistock-2158361110.jpg 2x"/> <img class="Image" alt="Employee competency assessment. Collage of hands holding king and a pawn. Succession planning." srcset="https://static.biospace.com/dims4/default/7993ea4/2147483647/strip/true/crop/1490x1490+261+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Ffe%2F69%2F8cd15be04d01bcca097f6acf632b%2Fistock-2158361110.jpg 1x,https://static.biospace.com/dims4/default/a0cee4f/2147483647/strip/true/crop/1490x1490+261+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Ffe%2F69%2F8cd15be04d01bcca097f6acf632b%2Fistock-2158361110.jpg 2x" width="100" height="100" src="https://static.biospace.com/dims4/default/7993ea4/2147483647/strip/true/crop/1490x1490+261+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Ffe%2F69%2F8cd15be04d01bcca097f6acf632b%2Fistock-2158361110.jpg" loading="lazy" > </picture> </a></div> <div class="PagePromo-content"> <div class="PagePromo-category"> <a class="Link" href="https://www.biospace.com/immunology-and-inflammation">Immunology and inflammation</a> </div> <div class="PagePromo-title"> <a class="Link" href="https://www.biospace.com/drug-development/j-js-oral-il-23r-blocker-sets-new-standard-in-plaque-psoriasis-beating-bmss-sotyktu">J&J’s Oral IL-23R Blocker Sets New Standard in Plaque Psoriasis, Beating BMS’ Sotyktu</a> </div> <div class="PagePromo-byline"><div class="PagePromo-date">March 10, 2025</div><span class="dot"> · </span><div class="PagePromo-readTime">2 min read</div><span class="dot"> · </span><div class="PagePromo-author"><a class="Link" href="https://www.biospace.com/tristan-manalac">Tristan Manalac</a></div></div> </div> </div> </li> </ul> </div> <div id="googleAdc13e6a8d-3954-4940-b7e3-943b87a5178a" data-module class="GoogleDfpAd" data-slot-name="21692246607/biospace_article" data-slot-sizes="[[300, 250]]" data-slot-adSizeMap="[[[320, 1], [300, 250]]]" data-targeting-data="{"id":"00000193-6b74-d74b-a9db-6fff6ba20000","type":"article","tags":["Drug pricing"],"category":"Business","companies":["Eli Lilly and Company","Novo Nordisk","Pfizer","Vertex Pharmaceuticals","Amgen"]}"> <span class="GoogleDfpAd-placeholder"></span> </div> <div class="PageListRightRailB" data-module data-show-loadmore="true" data-module-title-size="3"> <a class="AnchorLink" href="#article-right-rail-featured" id="article-right-rail-featured" name="article-right-rail-featured"></a> <div class="ModuleHeader"> <div class="ModuleHeader-title">FEATURED STORIES</div> </div> <ul class="PageList-items" data-with-borders> <li class="PageList-items-item"> <div class="PagePromo" data-image-align-vertical="top" data-image-align-horizontal="right"> <div class="PagePromo-media"><a class="Link" aria-label="GLP-1 Side Effects Only One Factor Driving Patient Discontinuation Rates" href="https://www.biospace.com/drug-development/glp-1-side-effects-only-one-factor-driving-patient-discontinuation-rates" ><picture> <source type="image/webp" width="100" height="100" srcset="https://static.biospace.com/dims4/default/c7fbf85/2147483647/strip/true/crop/479x479+125+0/resize/100x100!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F07%2Fd5%2Fff3d55bc46aa9f4166c187b66df9%2Fside-effects.jpg 1x,https://static.biospace.com/dims4/default/4a172bd/2147483647/strip/true/crop/479x479+125+0/resize/200x200!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F07%2Fd5%2Fff3d55bc46aa9f4166c187b66df9%2Fside-effects.jpg 2x"/> <source width="100" height="100" srcset="https://static.biospace.com/dims4/default/1c633f2/2147483647/strip/true/crop/479x479+125+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F07%2Fd5%2Fff3d55bc46aa9f4166c187b66df9%2Fside-effects.jpg 1x,https://static.biospace.com/dims4/default/c0256df/2147483647/strip/true/crop/479x479+125+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F07%2Fd5%2Fff3d55bc46aa9f4166c187b66df9%2Fside-effects.jpg 2x"/> <img class="Image" alt="Drug addiction concept, depressed woman with medicine pills. Medical health care and pharmaceutical vector illustration" srcset="https://static.biospace.com/dims4/default/1c633f2/2147483647/strip/true/crop/479x479+125+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F07%2Fd5%2Fff3d55bc46aa9f4166c187b66df9%2Fside-effects.jpg 1x,https://static.biospace.com/dims4/default/c0256df/2147483647/strip/true/crop/479x479+125+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F07%2Fd5%2Fff3d55bc46aa9f4166c187b66df9%2Fside-effects.jpg 2x" width="100" height="100" src="https://static.biospace.com/dims4/default/1c633f2/2147483647/strip/true/crop/479x479+125+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F07%2Fd5%2Fff3d55bc46aa9f4166c187b66df9%2Fside-effects.jpg" loading="lazy" > </picture> </a></div> <div class="PagePromo-content"> <div class="PagePromo-category"> <a class="Link" href="https://www.biospace.com/obesity">Obesity</a> </div> <div class="PagePromo-title"> <a class="Link" href="https://www.biospace.com/drug-development/glp-1-side-effects-only-one-factor-driving-patient-discontinuation-rates">GLP-1 Side Effects Only One Factor Driving Patient Discontinuation Rates</a> </div> <div class="PagePromo-byline"><div class="PagePromo-date">March 10, 2025</div><span class="dot"> · </span><div class="PagePromo-readTime">5 min read</div><span class="dot"> · </span><div class="PagePromo-author"><a class="Link" href="https://www.biospace.com/kate-goodwin">Kate Goodwin</a></div></div> </div> </div> </li> <li class="PageList-items-item"> <div class="PagePromo" data-image-align-vertical="top" data-image-align-horizontal="right"> <div class="PagePromo-media"><a class="Link" aria-label="Novavax Applies Lessons Learned From Turbulent COVID-19 Experience " href="https://www.biospace.com/business/novavax-applies-lessons-learned-from-turbulent-covid-19-experience" ><picture> <source type="image/webp" width="100" height="100" srcset="https://static.biospace.com/dims4/default/2aa648a/2147483647/strip/true/crop/350x350+138+0/resize/100x100!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2FA4364889-562E-4BC0-9F5F-36B41FE19E25.jpg 1x,https://static.biospace.com/dims4/default/5ec9f11/2147483647/strip/true/crop/350x350+138+0/resize/200x200!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2FA4364889-562E-4BC0-9F5F-36B41FE19E25.jpg 2x"/> <source width="100" height="100" srcset="https://static.biospace.com/dims4/default/082934b/2147483647/strip/true/crop/350x350+138+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2FA4364889-562E-4BC0-9F5F-36B41FE19E25.jpg 1x,https://static.biospace.com/dims4/default/91dc030/2147483647/strip/true/crop/350x350+138+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2FA4364889-562E-4BC0-9F5F-36B41FE19E25.jpg 2x"/> <img class="Image" alt="Pictured: Novavax/Getty Images, STR/NurPhoto" srcset="https://static.biospace.com/dims4/default/082934b/2147483647/strip/true/crop/350x350+138+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2FA4364889-562E-4BC0-9F5F-36B41FE19E25.jpg 1x,https://static.biospace.com/dims4/default/91dc030/2147483647/strip/true/crop/350x350+138+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2FA4364889-562E-4BC0-9F5F-36B41FE19E25.jpg 2x" width="100" height="100" src="https://static.biospace.com/dims4/default/082934b/2147483647/strip/true/crop/350x350+138+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2FA4364889-562E-4BC0-9F5F-36B41FE19E25.jpg" loading="lazy" > </picture> </a></div> <div class="PagePromo-content"> <div class="PagePromo-category"> <a class="Link" href="https://www.biospace.com/covid-19">COVID-19</a> </div> <div class="PagePromo-title"> <a class="Link" href="https://www.biospace.com/business/novavax-applies-lessons-learned-from-turbulent-covid-19-experience">Novavax Applies Lessons Learned From Turbulent COVID-19 Experience </a> </div> <div class="PagePromo-byline"><div class="PagePromo-date">March 10, 2025</div><span class="dot"> · </span><div class="PagePromo-readTime">6 min read</div><span class="dot"> · </span><div class="PagePromo-author"><a class="Link" href="https://www.biospace.com/heather-mckenzie">Heather McKenzie</a></div></div> </div> </div> </li> <li class="PageList-items-item"> <div class="PagePromo" data-image-align-vertical="top" data-image-align-horizontal="right"> <div class="PagePromo-media"><a class="Link" aria-label="FDA Faces Challenging Decision on Biomarker-Based Label Restrictions" href="https://www.biospace.com/fda/opinion-fda-faces-challenging-decision-on-biomarker-based-label-restrictions" ><picture> <source type="image/webp" width="100" height="100" srcset="https://static.biospace.com/dims4/default/2b2f052/2147483647/strip/true/crop/887x887+148+0/resize/100x100!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F16%2F8b%2F313016c649a49243e5dd01536463%2Fbottles-of-pills.jpg 1x,https://static.biospace.com/dims4/default/aa3d7e8/2147483647/strip/true/crop/887x887+148+0/resize/200x200!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F16%2F8b%2F313016c649a49243e5dd01536463%2Fbottles-of-pills.jpg 2x"/> <source width="100" height="100" srcset="https://static.biospace.com/dims4/default/7a4b31b/2147483647/strip/true/crop/887x887+148+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F16%2F8b%2F313016c649a49243e5dd01536463%2Fbottles-of-pills.jpg 1x,https://static.biospace.com/dims4/default/d9a3e68/2147483647/strip/true/crop/887x887+148+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F16%2F8b%2F313016c649a49243e5dd01536463%2Fbottles-of-pills.jpg 2x"/> <img class="Image" alt="Close-Up Of Medicine Bottles Against Green Background" srcset="https://static.biospace.com/dims4/default/7a4b31b/2147483647/strip/true/crop/887x887+148+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F16%2F8b%2F313016c649a49243e5dd01536463%2Fbottles-of-pills.jpg 1x,https://static.biospace.com/dims4/default/d9a3e68/2147483647/strip/true/crop/887x887+148+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F16%2F8b%2F313016c649a49243e5dd01536463%2Fbottles-of-pills.jpg 2x" width="100" height="100" src="https://static.biospace.com/dims4/default/7a4b31b/2147483647/strip/true/crop/887x887+148+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F16%2F8b%2F313016c649a49243e5dd01536463%2Fbottles-of-pills.jpg" loading="lazy" > </picture> </a></div> <div class="PagePromo-content"> <div class="PagePromo-category"> <a class="Link" href="https://www.biospace.com/opinion-column">Opinion</a> </div> <div class="PagePromo-title"> <a class="Link" href="https://www.biospace.com/fda/opinion-fda-faces-challenging-decision-on-biomarker-based-label-restrictions">FDA Faces Challenging Decision on Biomarker-Based Label Restrictions</a> </div> <div class="PagePromo-byline"><div class="PagePromo-date">March 10, 2025</div><span class="dot"> · </span><div class="PagePromo-readTime">5 min read</div><span class="dot"> · </span><div class="PagePromo-author"><a class="Link" href="https://www.biospace.com/harpreet-singh">Harpreet Singh</a></div></div> </div> </div> </li> <li class="PageList-items-item"> <div class="PagePromo" data-image-align-vertical="top" data-image-align-horizontal="right"> <div class="PagePromo-media"><a class="Link" aria-label="FDA Weathers Bait-and-Switch Storm as Staff and Sites Come and Go" href="https://www.biospace.com/fda/fda-weathers-bait-and-switch-storm-as-staff-and-sites-come-and-go" ><picture> <source type="image/webp" width="100" height="100" srcset="https://static.biospace.com/dims4/default/b970964/2147483647/strip/true/crop/888x888+146+0/resize/100x100!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fad%2Fa5%2Fe29bf6d547b586fd2dc093684a3c%2Fistock-106549747.jpg 1x,https://static.biospace.com/dims4/default/cd32b11/2147483647/strip/true/crop/888x888+146+0/resize/200x200!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fad%2Fa5%2Fe29bf6d547b586fd2dc093684a3c%2Fistock-106549747.jpg 2x"/> <source width="100" height="100" srcset="https://static.biospace.com/dims4/default/907aece/2147483647/strip/true/crop/888x888+146+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fad%2Fa5%2Fe29bf6d547b586fd2dc093684a3c%2Fistock-106549747.jpg 1x,https://static.biospace.com/dims4/default/05956ff/2147483647/strip/true/crop/888x888+146+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fad%2Fa5%2Fe29bf6d547b586fd2dc093684a3c%2Fistock-106549747.jpg 2x"/> <img class="Image" srcset="https://static.biospace.com/dims4/default/907aece/2147483647/strip/true/crop/888x888+146+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fad%2Fa5%2Fe29bf6d547b586fd2dc093684a3c%2Fistock-106549747.jpg 1x,https://static.biospace.com/dims4/default/05956ff/2147483647/strip/true/crop/888x888+146+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fad%2Fa5%2Fe29bf6d547b586fd2dc093684a3c%2Fistock-106549747.jpg 2x" width="100" height="100" src="https://static.biospace.com/dims4/default/907aece/2147483647/strip/true/crop/888x888+146+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fad%2Fa5%2Fe29bf6d547b586fd2dc093684a3c%2Fistock-106549747.jpg" loading="lazy" > </picture> </a></div> <div class="PagePromo-content"> <div class="PagePromo-category"> <a class="Link" href="https://www.biospace.com/staff-editorial">Editorial</a> </div> <div class="PagePromo-title"> <a class="Link" href="https://www.biospace.com/fda/fda-weathers-bait-and-switch-storm-as-staff-and-sites-come-and-go">FDA Weathers Bait-and-Switch Storm as Staff and Sites Come and Go</a> </div> <div class="PagePromo-byline"><div class="PagePromo-date">March 7, 2025</div><span class="dot"> · </span><div class="PagePromo-readTime">3 min read</div><span class="dot"> · </span><div class="PagePromo-author"><a class="Link" href="https://www.biospace.com/jef-akst">Jef Akst</a></div></div> </div> </div> </li> <li class="PageList-items-item"> <div class="PagePromo" data-image-align-vertical="top" data-image-align-horizontal="right"> <div class="PagePromo-media"><a class="Link" aria-label="Priority Review Vouchers: By the Numbers" href="https://www.biospace.com/business/priority-review-vouchers-by-the-numbers" ><picture> <source type="image/webp" width="100" height="100" srcset="https://static.biospace.com/dims4/default/6a1b63c/2147483647/strip/true/crop/1414x1414+354+0/resize/100x100!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F0b%2Fc6%2F82bbde8d4d10a56443af2fec146c%2Fistock-2194103793.jpg 1x,https://static.biospace.com/dims4/default/c7972c1/2147483647/strip/true/crop/1414x1414+354+0/resize/200x200!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F0b%2Fc6%2F82bbde8d4d10a56443af2fec146c%2Fistock-2194103793.jpg 2x"/> <source width="100" height="100" srcset="https://static.biospace.com/dims4/default/cb4b483/2147483647/strip/true/crop/1414x1414+354+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F0b%2Fc6%2F82bbde8d4d10a56443af2fec146c%2Fistock-2194103793.jpg 1x,https://static.biospace.com/dims4/default/fdb13be/2147483647/strip/true/crop/1414x1414+354+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F0b%2Fc6%2F82bbde8d4d10a56443af2fec146c%2Fistock-2194103793.jpg 2x"/> <img class="Image" alt="Creative photo poster trend art collage image of hands hold poster chart development statistics success growth economy progress." srcset="https://static.biospace.com/dims4/default/cb4b483/2147483647/strip/true/crop/1414x1414+354+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F0b%2Fc6%2F82bbde8d4d10a56443af2fec146c%2Fistock-2194103793.jpg 1x,https://static.biospace.com/dims4/default/fdb13be/2147483647/strip/true/crop/1414x1414+354+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F0b%2Fc6%2F82bbde8d4d10a56443af2fec146c%2Fistock-2194103793.jpg 2x" width="100" height="100" src="https://static.biospace.com/dims4/default/cb4b483/2147483647/strip/true/crop/1414x1414+354+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F0b%2Fc6%2F82bbde8d4d10a56443af2fec146c%2Fistock-2194103793.jpg" loading="lazy" > </picture> </a></div> <div class="PagePromo-content"> <div class="PagePromo-category"> <a class="Link" href="https://www.biospace.com/rare-diseases">Rare diseases</a> </div> <div class="PagePromo-title"> <a class="Link" href="https://www.biospace.com/business/priority-review-vouchers-by-the-numbers">Priority Review Vouchers: By the Numbers</a> </div> <div class="PagePromo-byline"><div class="PagePromo-date">March 5, 2025</div><span class="dot"> · </span><div class="PagePromo-readTime">1 min read</div><span class="dot"> · </span><div class="PagePromo-author"><a class="Link" href="https://www.biospace.com/annalee-armstrong">Annalee Armstrong</a></div></div> </div> </div> </li> </ul> </div> </aside> </div> </div> <div class="Page-below" data-modulewell><div id="googleAdb9fd269a-dc73-405e-a4ba-6d3653d4a43c" data-module class="GoogleDfpAd" data-hide-on-mobile="true" data-slot-name="21692246607/biospace_article" data-slot-sizes="[[728, 90]]" data-slot-adSizeMap="[[[992, 1], [728, 90]]]" data-targeting-data="{"id":"00000193-6b74-d74b-a9db-6fff6ba20000","type":"article","tags":["Drug pricing"],"category":"Business","companies":["Eli Lilly and Company","Novo Nordisk","Pfizer","Vertex Pharmaceuticals","Amgen"]}"> <span class="GoogleDfpAd-placeholder"></span> </div> <div id="googleAd9f4677d9-a702-41a4-8f88-b8152d115f27" data-module class="GoogleDfpAd" data-hide-on-desktop="true" data-slot-name="21692246607/biospace_article" data-slot-sizes="[[300, 50]]" data-slot-adSizeMap="[[[320, 1], [300, 50]]]" data-targeting-data="{"id":"00000193-6b74-d74b-a9db-6fff6ba20000","type":"article","tags":["Drug pricing"],"category":"Business","companies":["Eli Lilly and Company","Novo Nordisk","Pfizer","Vertex Pharmaceuticals","Amgen"]}"> <span class="GoogleDfpAd-placeholder"></span> </div> <bsp-list-loadmore data-module class="PageListStandardB" data-show-loadmore="true" data-column-count="4"> <a class="AnchorLink" href="#more-on-this-topic" id="more-on-this-topic" name="more-on-this-topic"></a> <div class="ModuleHeader"> <div class="ModuleHeader-title">MORE ON THIS TOPIC</div> </div> <div class="PageList-items" data-list-loadmore-items> <div class="PageList-items-item"> <div class="PagePromo" data-image-align-vertical="top" data-mobile-alt-layout="true"> <div class="PagePromo-media" data-animate="fromBottom"><a class="Link" aria-label="FDA Action Alert: GSK, Alnylam, Sanofi and More" href="https://www.biospace.com/fda/fda-action-alert-gsk-alnylam-sanofi-and-more" ><picture> <source type="image/webp" width="1000" height="563" srcset="https://static.biospace.com/dims4/default/371f0eb/2147483647/strip/true/crop/1000x563+0+0/resize/568x320!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F90%2F89%2F88555b0a43bb887cb062a0fa5549%2Faction-alert.png 568w,https://static.biospace.com/dims4/default/b81e14b/2147483647/strip/true/crop/1000x563+0+0/resize/768x432!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F90%2F89%2F88555b0a43bb887cb062a0fa5549%2Faction-alert.png 768w,https://static.biospace.com/dims4/default/3227eef/2147483647/strip/true/crop/1000x563+0+0/resize/1000x563!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F90%2F89%2F88555b0a43bb887cb062a0fa5549%2Faction-alert.png 1000w" sizes="(max-width: 568px) 100px, 300px"/> <source width="1000" height="563" srcset="https://static.biospace.com/dims4/default/728f25b/2147483647/strip/true/crop/1000x563+0+0/resize/568x320!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F90%2F89%2F88555b0a43bb887cb062a0fa5549%2Faction-alert.png 568w,https://static.biospace.com/dims4/default/f6772ad/2147483647/strip/true/crop/1000x563+0+0/resize/768x432!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F90%2F89%2F88555b0a43bb887cb062a0fa5549%2Faction-alert.png 768w,https://static.biospace.com/dims4/default/e259049/2147483647/strip/true/crop/1000x563+0+0/resize/1000x563!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F90%2F89%2F88555b0a43bb887cb062a0fa5549%2Faction-alert.png 1000w" sizes="(max-width: 568px) 100px, 300px"/> <img class="Image" alt="A scientist with pill bottles in front of FDA headquarters" srcset="https://static.biospace.com/dims4/default/728f25b/2147483647/strip/true/crop/1000x563+0+0/resize/568x320!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F90%2F89%2F88555b0a43bb887cb062a0fa5549%2Faction-alert.png 568w,https://static.biospace.com/dims4/default/f6772ad/2147483647/strip/true/crop/1000x563+0+0/resize/768x432!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F90%2F89%2F88555b0a43bb887cb062a0fa5549%2Faction-alert.png 768w,https://static.biospace.com/dims4/default/e259049/2147483647/strip/true/crop/1000x563+0+0/resize/1000x563!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F90%2F89%2F88555b0a43bb887cb062a0fa5549%2Faction-alert.png 1000w" sizes="(max-width: 568px) 100px, 300px" width="1000" height="563" src="https://static.biospace.com/dims4/default/e259049/2147483647/strip/true/crop/1000x563+0+0/resize/1000x563!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F90%2F89%2F88555b0a43bb887cb062a0fa5549%2Faction-alert.png" loading="lazy" > </picture> </a></div> <div class="PagePromo-content" data-animate="fromBottom"> <div class="PagePromo-category"> <a class="Link" href="https://www.biospace.com/regulatory">Regulatory</a> </div> <div class="PagePromo-title"> <a class="Link" href="https://www.biospace.com/fda/fda-action-alert-gsk-alnylam-sanofi-and-more">FDA Action Alert: GSK, Alnylam, Sanofi and More</a> </div> <div class="PagePromo-byline"><div class="PagePromo-date">March 10, 2025</div><span class="dot"> · </span><div class="PagePromo-readTime">7 min read</div><span class="dot"> · </span><div class="PagePromo-author"><a class="Link" href="https://www.biospace.com/tristan-manalac">Tristan Manalac</a></div></div> </div> </div> </div> <div class="PageList-items-item"> <div class="PagePromo" data-image-align-vertical="top" data-mobile-alt-layout="true"> <div class="PagePromo-media" data-animate="fromBottom"><a class="Link" aria-label="This Might Be a Moot Point but the FDA’s Priority Review Vouchers Need Transparency" href="https://www.biospace.com/fda/this-might-be-a-moot-point-but-the-fdas-priority-review-vouchers-need-transparency" ><picture> <source type="image/webp" width="1000" height="563" srcset="https://static.biospace.com/dims4/default/1e6f624/2147483647/strip/true/crop/1254x706+0+65/resize/568x320!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F96%2Fbc%2F48b087214d9dbc7b80078330bbeb%2Fistock-2198318237.jpg 568w,https://static.biospace.com/dims4/default/7044f34/2147483647/strip/true/crop/1254x706+0+65/resize/768x432!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F96%2Fbc%2F48b087214d9dbc7b80078330bbeb%2Fistock-2198318237.jpg 768w,https://static.biospace.com/dims4/default/3620259/2147483647/strip/true/crop/1254x706+0+65/resize/1000x563!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F96%2Fbc%2F48b087214d9dbc7b80078330bbeb%2Fistock-2198318237.jpg 1000w" sizes="(max-width: 568px) 100px, 300px"/> <source width="1000" height="563" srcset="https://static.biospace.com/dims4/default/1870f0a/2147483647/strip/true/crop/1254x706+0+65/resize/568x320!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F96%2Fbc%2F48b087214d9dbc7b80078330bbeb%2Fistock-2198318237.jpg 568w,https://static.biospace.com/dims4/default/934ab59/2147483647/strip/true/crop/1254x706+0+65/resize/768x432!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F96%2Fbc%2F48b087214d9dbc7b80078330bbeb%2Fistock-2198318237.jpg 768w,https://static.biospace.com/dims4/default/9856e29/2147483647/strip/true/crop/1254x706+0+65/resize/1000x563!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F96%2Fbc%2F48b087214d9dbc7b80078330bbeb%2Fistock-2198318237.jpg 1000w" sizes="(max-width: 568px) 100px, 300px"/> <img class="Image" alt="Composite photo collage of hand hold magnifier glass research examine secret object question mark secret isolated on painted background." srcset="https://static.biospace.com/dims4/default/1870f0a/2147483647/strip/true/crop/1254x706+0+65/resize/568x320!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F96%2Fbc%2F48b087214d9dbc7b80078330bbeb%2Fistock-2198318237.jpg 568w,https://static.biospace.com/dims4/default/934ab59/2147483647/strip/true/crop/1254x706+0+65/resize/768x432!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F96%2Fbc%2F48b087214d9dbc7b80078330bbeb%2Fistock-2198318237.jpg 768w,https://static.biospace.com/dims4/default/9856e29/2147483647/strip/true/crop/1254x706+0+65/resize/1000x563!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F96%2Fbc%2F48b087214d9dbc7b80078330bbeb%2Fistock-2198318237.jpg 1000w" sizes="(max-width: 568px) 100px, 300px" width="1000" height="563" src="https://static.biospace.com/dims4/default/9856e29/2147483647/strip/true/crop/1254x706+0+65/resize/1000x563!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F96%2Fbc%2F48b087214d9dbc7b80078330bbeb%2Fistock-2198318237.jpg" loading="lazy" > </picture> </a></div> <div class="PagePromo-content" data-animate="fromBottom"> <div class="PagePromo-category"> <a class="Link" href="https://www.biospace.com/editorial">Editorial</a> </div> <div class="PagePromo-title"> <a class="Link" href="https://www.biospace.com/fda/this-might-be-a-moot-point-but-the-fdas-priority-review-vouchers-need-transparency">This Might Be a Moot Point but the FDA’s Priority Review Vouchers Need Transparency</a> </div> <div class="PagePromo-byline"><div class="PagePromo-date">March 7, 2025</div><span class="dot"> · </span><div class="PagePromo-readTime">3 min read</div><span class="dot"> · </span><div class="PagePromo-author"><a class="Link" href="https://www.biospace.com/annalee-armstrong">Annalee Armstrong</a></div></div> </div> </div> </div> <div class="PageList-items-item"> <div class="PagePromo" data-image-align-vertical="top" data-mobile-alt-layout="true"> <div class="PagePromo-media" data-animate="fromBottom"><a class="Link" aria-label="Atea Pharmaceuticals Cuts 25% of Workforce" href="https://www.biospace.com/biospace-layoff-tracker" ><picture> <source type="image/webp" width="1000" height="563" srcset="https://static.biospace.com/dims4/default/df0bf38/2147483647/strip/true/crop/622x350+3+0/resize/568x320!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fdf%2F68%2F5402c2a343b8aec7f453fef836d4%2Flayoff-tracker.jpg 568w,https://static.biospace.com/dims4/default/38fde17/2147483647/strip/true/crop/622x350+3+0/resize/768x432!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fdf%2F68%2F5402c2a343b8aec7f453fef836d4%2Flayoff-tracker.jpg 768w,https://static.biospace.com/dims4/default/f2769f2/2147483647/strip/true/crop/622x350+3+0/resize/1000x563!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fdf%2F68%2F5402c2a343b8aec7f453fef836d4%2Flayoff-tracker.jpg 1000w" sizes="(max-width: 568px) 100px, 300px"/> <source width="1000" height="563" srcset="https://static.biospace.com/dims4/default/76abfeb/2147483647/strip/true/crop/622x350+3+0/resize/568x320!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fdf%2F68%2F5402c2a343b8aec7f453fef836d4%2Flayoff-tracker.jpg 568w,https://static.biospace.com/dims4/default/96bbf84/2147483647/strip/true/crop/622x350+3+0/resize/768x432!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fdf%2F68%2F5402c2a343b8aec7f453fef836d4%2Flayoff-tracker.jpg 768w,https://static.biospace.com/dims4/default/48c20b0/2147483647/strip/true/crop/622x350+3+0/resize/1000x563!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fdf%2F68%2F5402c2a343b8aec7f453fef836d4%2Flayoff-tracker.jpg 1000w" sizes="(max-width: 568px) 100px, 300px"/> <img class="Image" alt="Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant" srcset="https://static.biospace.com/dims4/default/76abfeb/2147483647/strip/true/crop/622x350+3+0/resize/568x320!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fdf%2F68%2F5402c2a343b8aec7f453fef836d4%2Flayoff-tracker.jpg 568w,https://static.biospace.com/dims4/default/96bbf84/2147483647/strip/true/crop/622x350+3+0/resize/768x432!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fdf%2F68%2F5402c2a343b8aec7f453fef836d4%2Flayoff-tracker.jpg 768w,https://static.biospace.com/dims4/default/48c20b0/2147483647/strip/true/crop/622x350+3+0/resize/1000x563!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fdf%2F68%2F5402c2a343b8aec7f453fef836d4%2Flayoff-tracker.jpg 1000w" sizes="(max-width: 568px) 100px, 300px" width="1000" height="563" src="https://static.biospace.com/dims4/default/48c20b0/2147483647/strip/true/crop/622x350+3+0/resize/1000x563!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fdf%2F68%2F5402c2a343b8aec7f453fef836d4%2Flayoff-tracker.jpg" loading="lazy" > </picture> </a></div> <div class="PagePromo-content" data-animate="fromBottom"> <div class="PagePromo-category"> <a class="Link" href="https://www.biospace.com/layoffs">Layoff Tracker</a> </div> <div class="PagePromo-title"> <a class="Link" href="https://www.biospace.com/biospace-layoff-tracker">Atea Pharmaceuticals Cuts 25% of Workforce</a> </div> <div class="PagePromo-byline"><div class="PagePromo-date">March 7, 2025</div><span class="dot"> · </span><div class="PagePromo-readTime">142 min read</div><span class="dot"> · </span><div class="PagePromo-author"><a class="Link" href="https://www.biospace.com/biospace-editorial-staff">BioSpace Editorial Staff</a></div></div> </div> </div> </div> <div class="PageList-items-item"> <div class="PagePromo" data-image-align-vertical="top" data-mobile-alt-layout="true"> <div class="PagePromo-media" data-animate="fromBottom"><a class="Link" aria-label="Biotech A Bright Spot for Female Founders Amid DEI Pullback" href="https://www.biospace.com/business/biotech-a-bright-spot-for-female-founders-amid-dei-pullback" ><picture> <source type="image/webp" width="1000" height="563" srcset="https://static.biospace.com/dims4/default/d6681f8/2147483647/strip/true/crop/1252x705+0+67/resize/568x320!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F0b%2F80%2Fde44320d4a7b938beec847099beb%2Fistock-1222450693.jpg 568w,https://static.biospace.com/dims4/default/99429ce/2147483647/strip/true/crop/1252x705+0+67/resize/768x432!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F0b%2F80%2Fde44320d4a7b938beec847099beb%2Fistock-1222450693.jpg 768w,https://static.biospace.com/dims4/default/eb0e1f0/2147483647/strip/true/crop/1252x705+0+67/resize/1000x563!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F0b%2F80%2Fde44320d4a7b938beec847099beb%2Fistock-1222450693.jpg 1000w" sizes="(max-width: 568px) 100px, 300px"/> <source width="1000" height="563" srcset="https://static.biospace.com/dims4/default/02d44d1/2147483647/strip/true/crop/1252x705+0+67/resize/568x320!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F0b%2F80%2Fde44320d4a7b938beec847099beb%2Fistock-1222450693.jpg 568w,https://static.biospace.com/dims4/default/ab9c0cd/2147483647/strip/true/crop/1252x705+0+67/resize/768x432!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F0b%2F80%2Fde44320d4a7b938beec847099beb%2Fistock-1222450693.jpg 768w,https://static.biospace.com/dims4/default/2e17d68/2147483647/strip/true/crop/1252x705+0+67/resize/1000x563!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F0b%2F80%2Fde44320d4a7b938beec847099beb%2Fistock-1222450693.jpg 1000w" sizes="(max-width: 568px) 100px, 300px"/> <img class="Image" alt="Recruitment of a key person for a leadership position concept" srcset="https://static.biospace.com/dims4/default/02d44d1/2147483647/strip/true/crop/1252x705+0+67/resize/568x320!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F0b%2F80%2Fde44320d4a7b938beec847099beb%2Fistock-1222450693.jpg 568w,https://static.biospace.com/dims4/default/ab9c0cd/2147483647/strip/true/crop/1252x705+0+67/resize/768x432!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F0b%2F80%2Fde44320d4a7b938beec847099beb%2Fistock-1222450693.jpg 768w,https://static.biospace.com/dims4/default/2e17d68/2147483647/strip/true/crop/1252x705+0+67/resize/1000x563!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F0b%2F80%2Fde44320d4a7b938beec847099beb%2Fistock-1222450693.jpg 1000w" sizes="(max-width: 568px) 100px, 300px" width="1000" height="563" src="https://static.biospace.com/dims4/default/2e17d68/2147483647/strip/true/crop/1252x705+0+67/resize/1000x563!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F0b%2F80%2Fde44320d4a7b938beec847099beb%2Fistock-1222450693.jpg" loading="lazy" > </picture> </a></div> <div class="PagePromo-content" data-animate="fromBottom"> <div class="PagePromo-category"> <a class="Link" href="https://www.biospace.com/c-suite">C-suite</a> </div> <div class="PagePromo-title"> <a class="Link" href="https://www.biospace.com/business/biotech-a-bright-spot-for-female-founders-amid-dei-pullback">Biotech A Bright Spot for Female Founders Amid DEI Pullback</a> </div> <div class="PagePromo-byline"><div class="PagePromo-date">March 6, 2025</div><span class="dot"> · </span><div class="PagePromo-readTime">2 min read</div><span class="dot"> · </span><div class="PagePromo-author"><a class="Link" href="https://www.biospace.com/annalee-armstrong">Annalee Armstrong</a></div></div> </div> </div> </div> </div> <div class="PageList-footer"> </div> </bsp-list-loadmore> </div> <footer class="Page-footer"> <div class="Page-footer-container"> <div class="Page-footer-columns"> <div class="Page-footer-column"> <div class="Page-footer-logo"><a aria-label="home page" href="/" > <picture> <source type="image/webp" width="250" height="75" srcset="https://static.biospace.com/dims4/default/9cd548e/2147483647/strip/true/crop/1000x300+0+0/resize/250x75!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F41%2Fec%2F9e81690b459eaa7f24638948a32f%2Fbsp-logo-vector-in-white.png 1x,https://static.biospace.com/dims4/default/5dae7e5/2147483647/strip/true/crop/1000x300+0+0/resize/500x150!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F41%2Fec%2F9e81690b459eaa7f24638948a32f%2Fbsp-logo-vector-in-white.png 2x"/> <source width="250" height="75" srcset="https://static.biospace.com/dims4/default/3af6dae/2147483647/strip/true/crop/1000x300+0+0/resize/250x75!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F41%2Fec%2F9e81690b459eaa7f24638948a32f%2Fbsp-logo-vector-in-white.png 1x,https://static.biospace.com/dims4/default/776a218/2147483647/strip/true/crop/1000x300+0+0/resize/500x150!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F41%2Fec%2F9e81690b459eaa7f24638948a32f%2Fbsp-logo-vector-in-white.png 2x"/> <img class="Image" srcset="https://static.biospace.com/dims4/default/3af6dae/2147483647/strip/true/crop/1000x300+0+0/resize/250x75!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F41%2Fec%2F9e81690b459eaa7f24638948a32f%2Fbsp-logo-vector-in-white.png 1x,https://static.biospace.com/dims4/default/776a218/2147483647/strip/true/crop/1000x300+0+0/resize/500x150!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F41%2Fec%2F9e81690b459eaa7f24638948a32f%2Fbsp-logo-vector-in-white.png 2x" width="250" height="75" src="https://static.biospace.com/dims4/default/3af6dae/2147483647/strip/true/crop/1000x300+0+0/resize/250x75!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F41%2Fec%2F9e81690b459eaa7f24638948a32f%2Fbsp-logo-vector-in-white.png" > </picture> </a> </div> <div class="PagePromoFooter" data-no-media> <div class="PagePromoFooter-content"> <div class="PagePromo-description"> <i>BioSpace </i>is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. </div> </div> </div> </div> <div class="Page-footer-column"> <div class="Page-footer-navigation" > <nav class="FooterNavigation"> <ul class="FooterNavigation-items" data-column-count="3"> <li class="FooterNavigation-items-item"> <div class="FooterNavigationItem"> <div class="FooterNavigationItem-text"> <span>Explore</span> </div> <ul class="FooterNavigationItem-items"> <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/news"><span class="NavigationLink-text">News</span></a> </li> <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/insights/"><span class="NavigationLink-text">Insights</span></a> </li> <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://jobs.biospace.com/searchjobs/"><span class="NavigationLink-text">Jobs</span></a> </li> <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/career-advice"><span class="NavigationLink-text">Career Advice</span></a> </li> <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/subscribe-to-newsletters"><span class="NavigationLink-text">Newsletters</span></a> </li> <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/podcasts"><span class="NavigationLink-text">Podcasts</span></a> </li> <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/webinars"><span class="NavigationLink-text">Webinars</span></a> </li> <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/reports"><span class="NavigationLink-text">Reports</span></a> </li> <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/companies"><span class="NavigationLink-text">Companies</span></a> </li> <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/nextgen"><span class="NavigationLink-text">NextGen: Top Start Ups To Watch</span></a> </li> <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/best-places-to-work"><span class="NavigationLink-text">Best Places to Work</span></a> </li> <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/hotbeds"><span class="NavigationLink-text">Hotbeds</span></a> </li> </ul> </div> </li> <li class="FooterNavigation-items-item"> <div class="FooterNavigationItem"> <div class="FooterNavigationItem-text"> <span>About</span> </div> <ul class="FooterNavigationItem-items"> <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/about-us"><span class="NavigationLink-text">About BioSpace</span></a> </li> <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/editorial"><span class="NavigationLink-text">Editorial</span></a> </li> <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/join-our-team"><span class="NavigationLink-text">Join Our Team</span></a> </li> <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/contact-us"><span class="NavigationLink-text">Support</span></a> </li> <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/terms-and-conditions"><span class="NavigationLink-text">Terms & Conditions</span></a> </li> <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/privacy-policy"><span class="NavigationLink-text">Privacy Policy</span></a> </li> </ul> </div> </li> <li class="FooterNavigation-items-item"> <div class="FooterNavigationItem"> <div class="FooterNavigationItem-text"> <span>More</span> </div> <ul class="FooterNavigationItem-items"> <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://employer.biospace.com/login"><span class="NavigationLink-text">Employer Login</span></a> </li> <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/employer-resources"><span class="NavigationLink-text">Employer Resources</span></a> </li> <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://employer.biospace.com/pricing/"><span class="NavigationLink-text">Post Jobs</span></a> </li> <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/talent-solutions"><span class="NavigationLink-text">Talent Solutions</span></a> </li> <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/advertise"><span class="NavigationLink-text">Advertise</span></a> </li> <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/press-release-solutions"><span class="NavigationLink-text">Submit a Press Release</span></a> </li> <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/rss-feeds"><span class="NavigationLink-text">RSS Feeds</span></a> </li> </ul> </div> </li> </ul> </nav> </div> </div> </div> <div class="Page-footer-bottom"> <div class="Page-footer-disclaimer"><p>© 1985 - 2025 BioSpace.com. All rights reserved. </p></div> <div class="SocialBar"> <ul class="SocialBar-items"> <li class="SocialBar-items-item"> <a class="SocialLink" rel="noreferrer" href="https://twitter.com/biospace" target="_blank" data-social-service="twitter"> <svg> <use xlink:href="#mono-icon-twitter"></use> </svg> <span class="sr-only"> twitter </span> </a> </li> <li class="SocialBar-items-item"> <a class="SocialLink" rel="noreferrer" href="https://www.instagram.com/biospacenews/" target="_blank" data-social-service="instagram"> <svg> <use xlink:href="#mono-icon-instagram"></use> </svg> <span class="sr-only"> instagram </span> </a> </li> <li class="SocialBar-items-item"> <a class="SocialLink" rel="noreferrer" href="https://www.facebook.com/biospacecommunity" target="_blank" data-social-service="facebook"> <svg> <use xlink:href="#mono-icon-facebook"></use> </svg> <span class="sr-only"> facebook </span> </a> </li> <li class="SocialBar-items-item"> <a class="SocialLink" rel="noreferrer" href="https://www.linkedin.com/company/biospaceinc" target="_blank" data-social-service="linkedin"> <svg> <use xlink:href="#mono-icon-linkedin"></use> </svg> <span class="sr-only"> linkedin </span> </a> </li> </ul> </div> </div> </div> </footer> </body> </html>

CINXE.COM

The Biggest Pharma Share Moves of the Year So Far - BioSpace